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ABSTRACT 
The incidence of female breast cancer is rising globally at unprecedented rates with a near 
doubling in many countries. Oestrogen is a main risk factor and many environmental 
chemicals have been shown to possess oestrogenic activity (xenoestrogens) and to enter the 
human breast from exposure through diet, the domestic environment or personal care 
products. The aims of this project were to investigate whether xenoestrogens also possess 
genotoxic activity. The compounds studied were three cyclosiloxanes (D3, D4, and D5), 
butylphenylmethylpropional (Lilial), triclosan and aluminium salts which are used extensively 
in personal care products, and bisphenol-A which is used widely in the manufacture of 
plastics.  Genotoxicity was assessed from their ability to enable growth in suspension culture, 
to damage DNA in a comet assay and to interfere with cellular DNA repair systems in two 
immortalised non-transformed human breast epithelial cell lines (MCF10A and MCF10F). 
The ability of non-transformed epithelial cells to grow in suspension culture is an established 
marker of transformation. All these compounds enabled growth of MCF10A and MCF10F 
cells in suspension with maximal effects observed at 10-10M D3, 10-5M D4, 10-5M D5, 10-5M 
bisphenol A, 10-7M triclosan and 10-5M butylphenylmethylpropional (Lilial). The comet assay 
showed DNA damage after 1 hour exposure to 17β-oestradiol in both cell lines as well as to 
10-5M D3, 10-5M D4 or 10-5M butylphenylmethylpropional (Lilial). Reverse-transcriptase 
polymerase chain reaction (RTPCR) was used to detect effects of these chemicals on mRNA 
levels in MCF-10A and MCF-10F cells for 14 key DNA repair proteins (BRCA1, BRCA2, 
ATM, ATR, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111). 
Increases in mRNA for BRCA1 were detected after both short-term (1 week) and long-term 
(30 weeks) exposure to 10-5M D3 and 10-5M D4, 10-5M D5 gave an increase only after short-
term exposure (1 week).  Decreases in BRCA2 mRNA were found after both short-term (1 
week) and long-term (30 weeks) exposure to 10-5M D3 and 10-7M triclosan: long-term 
exposure (30 weeks) resulted in increases after exposure to 10-5M D5, 10-5M bisphenol A 
and 10-5M butylphenylmethylpropional (Lilial).  Western immunoblotting showed that BRCA1 
protein was reduced in line with the mRNA results, demonstrating that in this case 
transcription and translation followed the same pattern. A shorter study using long –term 
exposure (20 weeks) to aluminium based antiperspirant salts at 10-4M concentrations 
showed reduced expression also of BRCA1 mRNA and BRCA1 protein together with 
reduced expression of other mRNAs. In summary, all these compounds showed genotoxic 
activity in MCF10A and MCF10F cells and points to the potential for reduction in exposure as 
a strategy for breast cancer prevention. 
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Chapter 1 Introduction 
 
 
1.1 The Cell Cycle 
 
The evolution of large multicellular animals with distinct interacting organ systems requires 
on the one hand that many tissue elements are continually replenished but on the other 
hand that homoeostatic control of this remodelling is maintained.  Individual cells can be 
directed down paths of proliferation or differentiation. Surplus or abnormal cells can be 
removed by various forms of cell death, arguably the most important of which is apoptosis, 
whereby the cell contents are packaged up as apoptotic bodies which can be disposed of 
by the reticulo-endothelial system without the local milieu being swamped with disorganised 
enzymes and other bioactive compounds (Houtgraaf et al., 2006).   
 
There are two main apoptotic pathways, receptor mediated and intrinsic.  The latter is 
initiated through mitochondrial caspases as a result of DNA damage or stress to the 
endoplasmic reticulum and is the mechanism most relevant to the present study.  These 
paths are illustrated in Figure 1.1.  Other forms of programmed cell death exist such as 
extreme forms of autophagy whereby lysosomal membranes invaginate to engulf the 
cytoplasmic content. 
 
This introduces the concept of the cell cycle, depicted schematically in Figure 1.2: 
Cells pass from the resting phase, termed G1, into S phase, where DNA is replicated, on 
completion of which, after a lag period (G2) the cell divides by mitosis (M), the daughter 
cells returning to G1.  This cycle is broken if cells cease dividing and become quiescent 
(G0) or terminally differentiate.  The cycle can be arrested – primarily at the three points 
indicated by red lines at the G1/S and G2/M interfaces, or M phase.  These are known as 
cell cycle checkpoints and are important in assessing the integrity of the cell, diverting 
compromised cells towards destruction by apoptosis.  
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Graphic emphasising the two main routes for inducing apoptosis: a. extrinsic receptor –mediated,involving 
fas/fas ligand interaction, mediated through caspase-8 and bid.   b. intrinsic  pathways of apoptosis initiated 
by growth factor withdrawal, chemotherapy or uv irradiation, mediated through bcl2, cytochrome-c and 
caspase-9.   Key to abbreviations: APAF-1: Apoptotic protease activating factor 1, Bid: a pro-apoptotic 
member of the Bcl-2 family,  Cyt c: cytochrome c RE: reticuloendothelium,  DISC: Death Induced Signalling 
Complex,  MMP:  Matrix Metalloproteinases.  Taken from (Kroemer et al., 2007) 
  
  
 
FIGURE 1.2 SCHEMATIC REPRESENTATION OF THE CELL CYCLE  
Cells may leave cycle from G1 to temporary quiescence or terminal differentiation.  Exit at 
checkpoints (red lines) normally indicates malfunction and initiates apoptosis. Adapted from 
Houtgraaf et al 2006.  
FIGURE 1.1 APOPTOTIC PATHWAYS 
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Controlling the balance of cell proliferation, differentiation and loss is directed by external 
stimuli activating genetic pathways resulting in the production of appropriate gene products.  
Accuracy is essential and abnormal products will malfunction.  The main cause of abnormal 
and ineffectual (or counter-productive) products is mutation in relevant genes.  It is 
therefore appropriate here to describe something of the nature of DNA, which codes for 
amino acids and dictates their sequence in the proteins produced. 
 
 
1.2  DNA structure and replication 
 
DNA structure is illustrated most simply form in Figure 1.3A and more three-dimensionally 
as the double helix, in Figure 1.3B  
 
 
 
 
 
 
 
 
 
The complementary base pairs are held in place by a sugar-phosphate backbone.  In the 
cell protected by histones.  Each three base pairs codes for one amino acid (if that region is 
for translation. Taken from www.biologyonline.org (A) & National Library of Medicine (USA) 
(B) 
 
The first step in replication is for a helicase enzyme to break the hydrogen bonds that hold 
the bases together, splitting the strands.  This preferentially starts at an A-T rich region, A-T 
having only 2 bonds as opposed to the 3 that hold C-G together.  This forms a replication 
A B 
FIGURE 1.3 DNA STRUCTURE 
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fork into which RNA primers can attach and attract the nucleotides for “extension” of the 
DNA strands. In the commonest form of replication, each daughter molecule comprises one 
old and one new strand and is termed “semi-conservative” replication (Figure 1.4) 
 
 
 
 
 
 
 
 
 
 
Schematic showing DNA replication fork:  Taken from: www.dnareplication.info 
Different polymerase enzymes are required for the 5’-3’ “leading” strand and the 3’—5’ 
“lagging” strand, the latter being more complex.  The orientation of the complementary 
strands results from the carbon atom of the sugar molecule to which the phosphate binds 
(Figure 1.5) 
 
 
 
 
 
 
Single strand illustrated: sugar blue, phosphate red.  Taken from: www.vivo.colostate.edu 
This complementary sequencing is important in the design of molecular probes and primers 
for polymerase-chain-reaction based protocols. 
FIGURE 1.4 DNA REPLICATION FORK 
FIGURE 1.5 GRAPHIC ILLUSTRATING THE ORIENTATION OF THE SUGAR-PHOSPHATE BACK 
BONE OF DNA WITH BASE BOUND. 
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 1.3 DNA damage 
   
DNA is under constant attack from various destructive agents including endogenous, as 
well as exogenous sources. Endogenous damage may result from spontaneous base loss 
or various types of base modification (for instance; cytosine deamination, converting it to 
uracil) caused by exposure to metabolic products such as reactive oxygen species, or 
mispairing errors introduced during replication (Lindahl, 1993, Gates, 2009). Exogenous 
damage has many sources including; UV light, X-rays or gamma radiation, thermal 
disruption or chemical exposure. DNA damage types can be broadly subdivided into base 
damage and backbone damage  (Hoeijmakers, 2001). 
  
       1.3.1   Base damage 
1.3.1.1. Deamination/Methylation 
 
Epigenetic changes to DNA (i.e. not involving changes in base sequence) can regulate 
gene expression – often by silencing the gene (Keedy et al., 2009) However, they can lead 
to DNA mutation.This is notably the case with tumour suppressor genes. Cytosine residues 
in DNA can undergo hydrolytic deamination converting them to uracil residues. Up to 500 
deamination of cytosine events take place in human cells per day. Other deamination 
reactions include conversion of adenine to hypoxanthine, 5-methylcytosine to thymine and 
guanine to xanthine.  An example is shown in Figure 1.6. 
 
 
Source:  (Bandarian et al., 2003) 
 
FIGURE 1.6 SCHEMATIC EXAMPLE OF METHYLATION/DEAMINATION 
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Specific DNA damage is categorized by possible endogenous or exogenous sources and 
the corresponding DNA repair pathway for each type of damage. Hydrolysis of the 
glycosidic bonds holding a base to the DNA backbone is also common (Gates, 2009). 
 
 
    1.3.1.2. Oxidation 
 
One of the causes of DNA base damage is exposure to reactive oxygen species generated 
during either normal cellular oxygen metabolism, from exposure to UV light or a wide range 
of other exogenous sources. A frequent oxidative lesion is 8-hydroxyguanine (8-OHdG); 
this mutagenic lesion shows preference to pair with adenine rather than cytosine during 
replication. This lesion is estimated to occur at a rate of up to 500 events per day, the same 
rate as cytosine deamination  (Tudek et al., 2003), Gates, 2009).  This is the most 
commonly studied DNA base oxidation product (Figure 1.7); in another response to 
oxidative stress, thymine converts to thymidine glycol. 
 
 
 
 
 
 
 
 
1.3.1.3.  Alkylation 
Another source of DNA base damage is where an alkyl group attaches to the DNA base 
giving alkylation products such as O2-alkylthymine, O4-alkylthymine, O6-methylguanine 
and O6- ethylguanine. This binding may prevent DNA replication causing mutation or cell 
death. Alkylation can be generated by both endogenous sources (for instance; oxidative by-
product or cellular methyl donors such as S-adenosylmethionine) and exogenous sources 
(fuel combustion, tobacco exposure or anticancer therapies e.g. cisplatin) (Engelbergs et 
al., 2000)  Fu et al., 2012). 
FIGURE 1.7 OXIDATION OF GUANINE 
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  FIGURE 1.8 METHYLATION OF DNA BASES 
TAKEN FROM HTTP://WWW.SLIDESHARE.NET/BENLAUFER/LONGLASTING-ALTERATIONS-TO-DNA-METHYLATION 
 
     1.3.2. Backbone damage 
The DNA backbone is under constant exposure to environmental and endogenous agents 
that create thousands of lesions per cell each day (Lindahl, 1993). While some of these 
lesions like abasic sites or single strand breaks (SSB) are considered to be toxic, double 
strand breaks (DSB) are considered to be the most harmful. There are three major classes 
of DSB structures that can be toxic if not repaired. 
(1) Two-ended DNA double-strand break, created by direct fracture of a DNA duplex.  
(2) One-ended DNA double-strand break, created when a replication fork encounters a 
DNA single-strand break. 
 (3) Daughter strand gap, created when lagging or leading strand progression is 
inhibited by a DNA lesion (Helleday et al., 2007). 
  1.3.2.1. Double strand breaks 
 
DSB are commonly the result of radiation or radiomimetic chemicals, but can also occur 
from physical stresses when polymerase enzymes encounter single strand lesions and the 
replication system fails. Mis-repair of these can cause major rearrangements of genetic 
material. 
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1.4. DNA repair 
1.4.1. Relationship of damage to repair pathways 
8 Methylation of DNA Bases DNA damage can be as simple as single altered or substituted 
DNA bases, or be more extensive, as is evident with lesions in both strands (double strand 
breaks).  Figure 1.9  
 
 
 
 
 
 
 
 
 
 
As implied in Figure 1.9, Repair mechanisms can be classified by the type of damage they 
are adapted to repair:- 
 
The Nucleotide Excision Repair pathway deals with “bulky” base adducts resulting from 
external agents such as drugs or UV radiation as well modifications resulting from oxidative 
stress.  They disrupt transcription or cause it to proceed in an error-prone fashion.  The 
mechanism falls into two categories, a global system that deals with replicating genomic 
DNA (Fagbemi et al., 2011) and a transcription coupled variation that deals with lesions 
affecting RNA polymerase (Diderich et al., 2011). Base Excision Repair corrects non-
“bulky” base modifications that occur frequently and as a result of normal mitochondrial 
production of reactive oxygen species.  For example,180 guanines are estimated to be 
oxidized to 8-oxo-dG per mammalian genome per day (Lindahl, 1993).  Base excision 
repair is initiated by a lesion- and site (nuclear or mitochondrial) specific DNA glycosylase.  
It is active in resting cells as well as dividing ones.  
Adapted from (Lord and Ashworth, 2012) 
FIGURE 1.9 DNA DAMAGE, ITS REPAIR & THE PROTEINS EFFECTING THE REPAIR 
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Mismatch Repair is an evolutionarily well conserved process going back to bacterial 
organisation. It both recognizes and repairs base-base mismatches and insertion-deletion 
loops derived from errors in DNA replication or homologous recombination (in which 
nucleotide sequences are exchanged between DNA molecules, a process designed for 
controlled genetic diversity driving evolution) (Jiricny, 2006, Modrich, 2006).   Double 
strand break repair is designed to cope with serious DNA damage such as translocations.  
Unrepaired, these activate an apoptotic cell death response (Jackson and Bartek, 2009). 
 
If repair is satisfactorily completed, any cell cycle arrest may be cancelled and the cell 
progresses normally to mitosis. If the damage cannot be fixed, then cells will senesce or 
move into apoptosis, with chromatin fragmentation and the formation of apoptotic bodies, 
mediated by caspases from the mitochondria. These bodies are relatively non-toxic, 
compared to the products of necrosis and are mopped up by cells of the reticulo-endothelial 
system. (Houtgraaf et al., 2006) 
It is a third possibility, where the damage is not repaired but the cell persists and can divide, 
which potentially leads to carcinogenesis.  Cancer formation relies on cell proliferation, so it 
is the compartment in tissues (such as in most epithelia) with a relatively high cell turnover 
– not so much the stem- or terminally differentiated cells, but the transit-amplifying region or 
population – that is most susceptible to tumourigenic effects from DNA damage. These 
alternative pathways are represented in Figure 1.10 
 
FIGURE 1.10 FLOW-CHART OF THE CELLULAR RESPONSE TO DNA DAMAGE 
 (ADAPTED FROM HOUTGRAAF ET AL., 2006). 
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In proliferating cells, cell cycle checkpoints will be activated, leading to cell cycle arrest 
allowing activated DNA damage repair machinery to work.  When repair is complete, the 
cell may proceed through the cell cycle. If the damage proves irreparable, the cell cycle can 
be blocked permanently, leading to senescence or apoptosis. If unrepaired damage is not 
detected and persists, this constitutes mutation; genomic instability ensues, potentially 
leading to oncogenesis. (Figure 1.11)  depicts pathways and gives examples of checkpoint 
regulation in eukaryotic cells 
 
                          ADAPTED FROM (KITAGISHI ET AL., 2013) 
 
These and other molecules whose production is modulated from that associated with 
normal cell cycling in response to DNA damage or repair activity are described in detail 
below.  All have been analysed in the present study as potential markers of ongoing 
genotoxicity. 
 
 
 
 
 
 
FIGURE 1.11 SCHEMATIC REPRESENTATION & OVERVIEW OF DNA REPAIR & 
CHECKPOINT REGULATION IN CELL CYCLE SIGNALLING PATHWAYS 
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1.4.2 Fourteen repair DNA genes analysed in this study 
 
BRCA1, P53, ATR and ATM products are essentially concerned with damage detection and 
initiation of cell cycle checkpoints (see Figure 1.11).  The remaining nine genes and 
products are directly related to repair mechanisms 
 
1.4.2.1  p53 
The P53 gene is located on the short arm of chromosome 17 (17p13.1)..(McBride et al., 
1986)The gene spans 20 kb, with a non-coding exon 1 and a very long first intron of 10 kb.  
P53 was originally described in 1979, was pronounced the “guardian of the genome” (Lane, 
1992) and the first gene to be given the label “tumour suppressor”.  These genes exist in 
the germline and if a germline mutation is passed on the host is congenitally one step 
further along the path towards carcinogenesis, requiring just a mutation of the second copy 
to precipitate complete p53 dysfunction. This is loss of heterozygosity.  
 
P53 mutation is the most common genetic change associated with many cancers and lies 
at the centre of a cascade of enzymes, with regulatory kinases (including ATM) upstream of 
it detecting DNA damage and activating the P53 gene.  Lysine acetylation and/or serine 
phosphorylation in the C-terminus of the protein promotes DNA binding to strand ends and 
catalyse renaturation. Published work regarding familial syndromes such as Li-Fraumeni, in 
which there is an association between sarcomas, brain tumours and breast cancer at a 
young age shows a frequent link to abnormalities in the p53 gene (Benson et al., 2009). 
Many human tumour –associated p53 mutants have properties not seen in the normal 
protein. Virally induced cancers are frequently associated viral proteins that degrade p53 or 
inhibit its action (Vogelstein and Kinzler, 2001). Among the actions of P53 are inhibition of 
the cell cycle at the G2 arrest point, inducing a number of pro-apoptotic proteins, the best 
known of which is Bax. Specific down-stream targets of P53 that negatively influence 
invasion and metastasis include the mammary serine protease inhibitor and KAI1.There is a 
correlation between some types of p53 mutation and clinical outcome in breast cancer. 
Mutations impairing DNA binding were found in the more aggressive cancers (Alsner et al., 
2000). 
1.4.2.2  BRCA1  
 
The BRCA1 gene, located on chromosome 17 at q21 codes for the product named breast 
cancer protein-1.  It is a multi-domain protein with an amino-terminal zinc-finger ring 
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domain that has been shown to alter caspase activity in a pro-apoptotic manner (Johnson 
2002).  It is responsible for repairing damaged DNA and involved in the control of cell 
proliferation in mature tissues (Hall et al., 1990) and in embryogenesis (Durant and 
Nickoloff, 2005).  BRCA1 mutations are strongly associated with breast cancer (Miki et al., 
1994).  
BRCA1 was first cloned in 1994 (Miki et al., 1994). The gene product is directly involved in 
repairing damage (Boulton, 2006).  The BRCA1 protein interacts with other molecules – 
including RAD51 and BARD1 gene products, inter alia, to mend breaks in double DNA 
strands.  These breaks can occur as chromosomes exchange genetic material during 
normal mitosis.  BRCA1 is therefore crucial in maintaining genetic integrity (Durant and 
Nickoloff, 2005, Paull et al., 2001).  The BRCA2 gene (coding for breast cancer type 2 
susceptibility protein) was cloned in 1994 by Wooster (Wooster et al., 1994).  Its product is 
also involved in the repair of damaged DNA in the nucleus. 
1.4.2.3 BRCA2 
 
BRCA2 (location 13q12-13) also acts as a tumour suppressor gene.   i.e. it behaves 
recessively and requires loss of heterozygosity to exert a deleterious effect, which is in fact 
an aberration in controlling   the survival and proliferation of genetically compromised cells 
(Abdulrahman and Rahman, 2012b).  BRCA 2 does not appear to interact with BRCA1 and 
complexes between the two proteins has not been demonstrated, BRCA2 interacts directly 
with 70 amino-acid BRC motifs on RAD 51 recombinase (Liu & West, 2002).   
The BRCA2 protein interacts with, inter alia, RAD51 and PALB2 products in repairing DNA 
(Buisson et al., 2010, Wooster et al., 1995, Xia et al., 2006).  As a so-called tumour 
suppressor gene it behaves in recessive fashion, so mutations are only effective where 
there is loss of heterozygosity. Around 50% to 60% of women who inherit BRCA1 (or 
indeed BRCA2) gene mutations will develop breast cancer by the age of 70. (Benson et al., 
2009). All BRCA2 mutations found so far appear to have been inherited, suggesting that 
there is a “founder” effect in play, where the mutation is common in certain relatively closed 
populations and can theoretically be ascribed to a single common ancestor (e.g. 
Neuhausen, 1996) 
1.4.2.4 ATR 
The cytogenetic location of the ATR gene is 3q23.The ATR (ataxia-telangiectasia- and 
Rad3-related) kinase is, collaboratively with the ATM gene product, a critical component of 
the system for maintaining genomic integrity.  It is related to the gene in Saccharomyces sp 
which is responsible for cell cycle arrest by phosphorylating the checkpoint kinase CCHK1 
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(source: genecards.org).  The product is a serine/threonine kinase acting in response to 
genotoxic stresses. 
It functions both in parallel and cooperatively with ATM (joining the ATM process further 
downstream), but in respect of a more diverse range of DNA damage including  ionising 
and non-ionising radiation, hypoxia and stalled replication forks (Abraham, 2001) Activated 
ATR phosphorylates inter alia, p53, BRCA1 and CHK1. Based on its central function in 
DNA damage repair, abnormal ATR is considered likely to cause susceptibility to cancer. 
 
1.4.2.5  ATM 
The ATM gene is located at 11q22.3, comprises 66 exons, 62 encoding a 3056 amino acid 
protein (Savitsky et al., 1995).  The disease Ataxia-telangiectasia is a progressive disease 
affecting cerebellar function, microvascular lesions (telangiectasia), radiation sensitivity and 
immunodeficiency.  ATM is a PI3K-related protein kinase, with the kinase activity 
associated with a highly conserved C-terminal region. It has functions to do with various 
aspects of normal organ development, but in the cancer context its role in double strand 
DNA break repair is crucial.  A protein complex (named MRN) recruits the ATM product to 
sites of damage.  Cascades of activities are initiated that involve the cell cycle checkpoint 
enzyme CHK2 as well as P53.  It is involved in both a rapid and delayed response to 
damaged DNA (Ahmed and Rahman, 2006). Although the disease is associated with an 
increased cancer risk(Taylor and Byrd, 2005), the converse was not true in a study by 
FitzGerald (FitzGerald et al., 1997)so that breast cancer cases did not hold an increased 
rate of ATM mutation.  
 
1.4.2.6  BRIP 1 
This acronym derives from the gene product function, viz. BRCA1 Interacting Protein C-
terminal helicase 1.  The gene is located at 17q22.2 and comprises 184,751 base pairs.  It 
is also known as FANCJ or BACH1.  It is commonly a germ-line mutation, suspected of 
being the product of a founder effect it belongs to a family of DNA helicases that include 
XPD and as such, along with its BRCA association, should in principle act as a tumour 
suppressor.  However, cancer patients do not always show loss of heterozygosity and 
BRIP-1 appears to possess only low-to-moderate penetrance linked to no more than a two- 
to threefold increase in breast cancer risk (Cantor and Guillemette, 2011).  Germ-line 
mutations show a much reduced incidence of childhood cancers than occur with BRCA1 
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1.4.2.7  CHK1 
Human Chk1 is located on chromosome 11 on the cytogenic band 11q22-23. Chk1 is a 
highly conserved protein kinase relatively unchanged through evolution covering all 
eukaryotic organisms. Gene expression analysis indicates an important role for this gene in 
“triple negative breast cancer” i.e. they do not express the oestrogen receptor, 
progesterone receptor or Her2 (human epidermal growth factor) gene products.  It is 
therefore an important potential target in this hard-to-treat group of patients (Cantor and 
Guillemette, 2011).  Its deletion causes catastrophic events during mitosis.  Chk1 is 
essential to the mammalian DNA damage checkpoint, is important in embryogenesis and, 
as ATR regulates Chk1, hence its significance in cancer, both mechanistically and as a 
therapeutic target (Liu et al., 2000).  Phosphorylation of CD25A by CHK1 product is 
required for delaying cell cycle progression in response to double strand breaks.  It also 
integrates signals from ATM and ATR. 
 
  1.4.2.8 CHK2 
 
The CHEK2 gene is located on chromosome 22q12.1. The gene contains 14 exons, and 
encodes a protein of 543 amino acids. The protein Chk2, a serine/threonine kinase, CHK2 
serves as a tumor suppressor by playing  an important role in DSB responses leading to 
cell cycle checkpoint arrest, apoptosis and DNA repair.  Heterozygous germline mutations 
in CHK2 are associated with a p53-independent variant form of the Li-Fraumeni syndrome 
(Bell et al., 1999) also, CHK2 mutations are also found in sporadic cancers (Dong et al., 
2003)   and down regulation of CHK2 protein has been reported in several cancers 
(Bartkova et al., 2004). Of interest, despite this reported importance of Chk2 for G1 and G2 
cell cycle arrest, no gross effect on cell cycle arrest after DNA damage is observed 
in CHK2-deficient mice, suggesting that this role of Chk2 is not essential (Takai et al, 2002).  
Multiple pathways causing redundancy in certain genes is not uncommon (Lynce 2016) 
  
 
1.4.2.9  PALB2 
The PALB2 gene is found in the human genome on the chromosome 16 p (short) arm, at 
location 12.2.  Interacting with the BRCA2 product, the PALB gene product causes Fanconi 
anaemia which is an inherited condition characterised primarily by bone marrow failure. Its 
involvement with DNA repair confers cancer predisposition status on it, with an estimated 
2.3x elevated risk in the presence of a monoallelic mutation (Rahman et al., 2007). It may 
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act independently of the BRCA genes although it also collaborates with them in 
homologous recombination and double-strand break repair.  
 
1.4.2.10   PARP1 
 
Located at 1q42.12, spanning 47,412 base pairs, Parp1 codes for the Poly ADP-Ribose 
Polymerase 1 enzyme.  It is primary involvement is with the repair of single-strand DNA 
breaks through the base excision repair pathway, although it also interacts with the BRCA 
genes in double strand break repair. Among its activities aside from DNA repair, it is 
thought to play a role in the origins of Fanconi anaemia and type-I diabetes.  It tends to be 
upregulated some twofold in 30% of infiltrating ductal carcinomas of the breast 
(Ossovskaya et al., 2010). It is another target molecule of specific interest in “triple 
negative” breast cancer. 
 
1.4.2.11   RAD50  
 
The archetype RAD50 gene is characterised in yeasts of the Saccharomyces genus where 
it is involved in double-strand DNA break repair, but a similar gene is found in the human 
genome, with a cytogenetic location 5q31, coding for a 153kD zinc-binding protein  It forms 
part of the ‘MRN’ complex with MRE11 and NBS1.  Mutations in RAD50 are thought to 
cause an inherited DNA breakage-prone disease similar to Nijmegen breakage syndrome, 
which displays a stunted microcephalic phenotype, with a propensity for cancers of the 
lymphoid system.  Too few Human RAD50 mutations have been described to make firm 
conclusions about their impact, but mice with mutations either die young or, in 20% of 
survivors, succumb to lymphoma or leukaemia (Sheikh et al., 2015) 
 
1.4.2.12 RAD51 
The RAD51 gene, located on the q arm of chromosome 15; it is essential in homologous 
DNA recombination. Mutations may have a greater association with ovarian than breast 
cancer with one study finding no pathogenic mutations in breast cancer only families 
(Pennington and Swisher, 2012). There is also a lack of incidence in particular demographic 
populations. 
 
 16 
 
1.4.2.13  PTEN 
Germline mutations are rare but can cause PTEN Hamartoma Tumour Syndromes the best 
known of which is Cowden syndrome (CS).  ZHANG et al., 2013 reported CS to be 
associated with a high risk of breast cancer. In families with CS, ∼80% have PTEN 
germline mutations; female CS patients have a 25–50% lifetime risk of breast cancer. 
Over 90% of affected individuals will develop some clinical manifestation – usually 
hyperplastic and including muco-cutaneous lesions, during the third decade of life. 
Conversely some 40% of invasive breast cancers exhibit loss of heterozygosity at the 
PTEN locus  (10q 23.3) .  Functionally the normal PTEN product is a negative regulator of 
the PI3K/Akt/mTOR pathway which is overactive in many cancers (Pradella et al., 2014).    
In the cytoplasm PTEN product antagonises the phosphotidylinositol kinase pathway.  It 
also accumulates in the nucleus, where it interacts with a small ubiquitin modifier to 
stabilise DNA.  Cells lacking nuclear PTEN are hypersensitive to oxidative stresses 
(nih.gov/genes).   
 
1.4.2.14  STK11 /LKB1 
STK11 (also known as LKB1) protein is a serine/threonine kinase that acts effectively as a 
tumour suppressor. Mutation in this gene leads to disruption of cell polarity and is 
responsible for Peutz-Jeghers syndrome, an intestinal polyposis disease, that also carries 
an increased risk of breast cancer. (Bardeesy et al., 2002)Up to 8% and 31% of Peutz-
Jeghers syndrome, at ages 40 and 60 years of age develop breast cancer.  
 
1.5  Hallmarks of Cancer 
The clinical result from serial DNA replication damage or mutagenesis from external 
sources as described above is uncontrolled proliferation and tumour formation.  In some 
circumstances this may be spatially confined and lacking in invasive capacity giving risecto 
a benign tumour.  More commonly  a tumour progresses and metastasises, becoming 
malignant and therefore appropriately designated a cancer with attendant activated 
oncogenes, loss of suppressor gene heterozygosity and recruitment of host elements to 
support the continued growth.   
 
Six important alterations in cell physiology required to transform normal cells into malignant 
cancer cells have been proposed  firstly self-sufficiency in growth signals, secondly 
insensitivity to antigrowth signals, thirdly limitless theoretical potential for growth, fourth 
evasion of apoptosis, fifth sustained angiogenesis and finally, tissue invasion and 
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metastasis (Hanahan and Weinberg, 2000).   These are represented schematically in 
figure 1.12 and the basic mechanisms by which they operate are listed below.   
 
(1) Enabling replicate immortality: the self-sufficiency hallmark is characterised 
mechanistically by autocrine stimulation, i.e. the ability of cells to manufacture their own 
growth factors, freeing them from exogenous homoeostatic control.  There is also a 
positive paracrine feedback between cells in a single local milieu. 
(2) Evading growth suppressors: a complementary hallmark is a loss of sensitivity to anti-
proliferative signals. Transforming growth factor-β (TGF-β) is one such signal and disruption 
of its associated pathway is conducive to unregulated growth. 
(3) Sustaining proliferative signalling:  the number of daughter generations of somatic non-
germline) cells are governed by the erosion of telomeres during repeated replication.  It is 
indeed the function of telomeres to act as a buffer zone allowing for errors in the start of 
chromosome replication.  The result is the so-called Hayflick limit – generally around 40 
divisions, after which cells senesce.  The upregulation of the enzyme telomerase reverse 
transcriptase promotes regeneration of telomeres, effectively immortalizing the cell.   
(4) Resisting cell death: apoptosis is a method for arranging the death of effete or 
compromised cells in an organised, packaged fashion capable of removal by the reticulo-
endothelial system without the microenvironment becoming awash with free enzymatic 
cell content.  It is regulated by extrinsic or intrinsic pathways.  In relation to carcinogenesis 
it is compromise in the latter that causes cells with defective DNA to persist. Later in 
tumour progression, resistance to external “death factors” such as FAS become important.  
(5) Inducing angiogenesis : no structure can gain size without nutrition and oxygen.  
Neovasculature is therefore required in the growing tumour, by the process of 
angiogenesis, stimulated invasion of the cancer by vessels of host origin.  Tumour cells 
commonly secrete high levels of vascular endothelial growth factor to this end.  
(6) Activating invasion and metastasis: the final hallmark is tissue invasion and metastasis.  
The normal agents of tissue remodelling such as E-cadherin and the matrix 
metalloproteinases are deployed aberrantly by the tumour to effect expansion of the 
primary tumour, replacing the original tissue architecture (invasion) and detachment of 
cells or aggregates of cells, which can migrate into the lymphatics or bloodstream, trap in a 
downstream capillary bed and cause distant foci of malignancy ((metastasis).  
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The six hallmark capabilities as originally proposed in 2000.  (Graphic taken from Hanahan and 
Weinberg, 2000) 
 
 
 
The scheme represented above has been further developed and alternatively expressed as 
shown in figure1. 13.  This figure shows additionally two emerging hallmarks and two 
enabling characteristics.  Firstly the ability of cancer cells to modify the normal metabolism 
of their cell-type of origin in order to support neoplastic proliferation. In the changed milieu 
within the cancer – particularly relating to oxygen tension - utilising manipulation of the 
inflammatory cytokine system.  This, along with the requirement for neovascularisation and 
tissue remodelling led to the concept of cancer as “wounds that do not heal “(Dvorak, 
1986), or perhaps equally “wounds that will not stop trying to heal” 
 
  
 
 
FIGURE 1.12 THE HALLMARKS OF CANCER 
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FIGURE 1.13 EMERGING HALLMARKS AND ENABLING CHARACTERISTIC. 
TAKEN FROM (HANAHAN AND WEINBERG, 2011). 
 
The overall picture that emerges, then, is of interacting genomic, epigenetic and non-
genomic alterations, driven by intrinsic and environmental factors often involving excess 
free radical formation or the inability to clear these molecular species effectively, producing 
a multistep cascade of chance events enabling a mutant cellular phenotype to emerge that 
does not recognise normal homoeostatic regulators.  The underlying influence is an 
abrogation of the cell’s ability to monitor its genomic integrity and rectify errors in 
replication. The compounds studied in this project, are constituents of cosmetics and which 
have been proposed to exert their influence on breast cancer through stimulation 
proliferation (Darbre, 2006a) but their ability to drive DNA mutation and genomic instability 
were previously unstudied in breast cells.  
 
1.6. Breast cancer 
1.6.1. Overview 
Breast cancer is the formation of a malignant tumour that has developed from cells, 
normally epithelial cells, in the breast. The mammary gland exhibits complex cell kinetics; 
cycles of epithelial proliferation and regression accompany pregnancy and lactation (Pai et 
al., 2015).  This dynamic makes the organ particularly susceptible to diseases dependent 
for their pathology on cell proliferation.  It has been argued that the involution phase of the 
mammary cycle, accompanied by much apoptosis and tissue remodelling is a particularly 
vulnerable period (Schedin, 2006, Lyons et al., 2009).   
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1.6.2. Incidence and mortality  
Breast cancer is heterogeneous in its presentation and diverse in its prevalence, 
stratification, morphology and prognosis (Al Tamimi et al., 2010). Breast cancer currently 
occurs throughout the world, and is the most common reason for death by cancer in women 
(Murray and Lopez, 1997). It has high incidence rates in more developed countries; rates in 
the most underdeveloped countries are low but increasing over time (Key et al., 2001). 
The incidence is lowest in Eastern Asia (Ferlay, 2013) appears relatively low in East Africa 
with about 18,000 new cases and 10,000 cancer related deaths per year. In Western 
Europe, the incidence is five times higher with about 40,000 deaths recorded due to breast 
cancer in 2008 (Abdulrahman and Rahman, 2012a). The incidence is similar in Central and 
Eastern Europe with roughly 115000 new cases and more than 47000 deaths in 2008. 
 Many papers report breast cancer as the most common cancer in women in the UK since 
1997; in 2009, there were 48,788 new cases, 48,417 women and 371 men.  In 2010 there 
were 11,633 deaths from breast cancer in the UK (Marmot et al., 2012, Moss et al., 2012).  
In the Kingdom of Saudi Arabia (KSA), despite the prevalence of breast cancer being lower 
than in Western countries (Al-Kuraya et al., 2005) it is still the most frequent malignant 
tumour in Arabian females, at 21.8%. Breast cancer in Saudi women exhibits differences 
from the disease manifestations in Western countries. According to Ezzat (Ezzat et al., 
1999) breast cancers presenting in Saudi women are normally advanced at the time of 
diagnosis, and affect mostly females of 46-50 years of age.  This differs markedly from the 
characteristic 60-65 years seen in developed countries where also advanced disease is 
relatively infrequent at diagnosis (Al Tamimi et al., 2010, Ezzat et al., 1999). 
 
1.6.3 Risk factors. 
Loss of function of the BRCA1 or BRCA2 genes is a main cause of inherited susceptibility 
to breast cancer (Roy et al., 2012). This has demonstrated the central importance of these 
genes in repair of DNA in breast cells, and the consequences of loss of their function to the 
breast cells. More recently, inherited loss of other components of DNA repair have also 
been suggested to contribute to breast cancer susceptibility (Kitagishi et al., 2013). The 
question still remains, however, as to whether the source of the DNA damage is natural 
replication errors or exposure to exogenous chemicals or radiation. Agents which can 
stimulate excess proliferation in breast cells have greater potential to generate errors at 
replication which if not repaired could result in DNA mutations and genomic instability. Such 
agents may be endogenous hormones, most notably oestrogens, or exogenous chemicals 
which can mimic oestrogen action. However, exposure to environmental radiation could 
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also provide sources of DNA damage which these women cannot repair, as has been 
shown from studies of breast cancer incidence in survivors of the atomic bomb at Hiroshima 
(Tokuoka et al., 1984) Alternatively, the DNA damage might result from exposure to 
environmental chemicals or their metabolites. Even the main endogenous hormone, 
oestradiol, is known to produce metabolites which can damage DNA (Sancar et al. 2004).  
 
Although diet and alcohol consumption have been implicated in breast cancer, the main risk 
factor for breast cancer remains hormonal and in particular lifetime exposure to oestrogen. 
However, many pollutant chemicals enter the human body via oral, respiratory, or dermal 
routes which have endocrine-disrupting properties and can mimic or interfere with the 
action of oestrogen (Key et al., 2001, Lipworth, 1995).  Increased exposure to endogenous 
oestrogens can result from early onset of menarche, late onset of menopause, null parity, 
late age of first pregnancy, lack of breastfeeding, and use of exogenous oestrogens derived 
from personal choices such as using the contraceptive pill or hormone replacement therapy 
(HRT) (Lipworth, 1995, Key et al., 2001). 
 
The source of such chemicals may be phytoestrogens (from plants), pharmacological 
oestrogens, or man-made oestrogen-mimicking chemicals (xeno-oestrogens). They are 
sufficiently common that Darbre has reported that, with oestrogen playing such a prominent 
role in breast cancer, serious consideration needs to be given to the potential ability of 
exogenous oestrogen-like substances to drive the development and growth of breast 
tumours.  In addition to the plant environmental oestrogens are hormones taken 
medicinally, as oral contraceptives  or hormone replacement therapy (HRT).  Oral 
contraceptives and HRT are confirmed as influencing breast cancer risk; so other xeno-
oestrogenic compounds might also act similarly, either alone or in combination, if they enter 
the human breast (Darbre, 2010) 
Environmental oestrogenic chemicals may enter the human body in food contaminated with 
persistent organic pollutants (POPs) as residues in dietary animal fat; and also through 
skin, air and oral exposure in the home to chemical components of plastics, cleaning 
materials, air fresheners, pesticides/herbicides, and soft furnishings. Also, Darbre suggests 
that alternative mechanisms of exposure may be through protracted application of 
cosmetics that contain compounds with oestrogenic activity (Darbre 2006, 2010). 
These  compounds have been studied for their ability to drive proliferation of breast 
epithelial cells but less attention have been given to other properties of these chemicals 
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which could enable other hallmarks of cancer, such as DNA mutation and genomic 
instability,  
 
1.7  Components of Cosmetics 
 
Many personal care products, including cosmetics, are applied to the skin on a regular 
basis as lotions, creams or sprays. Underarm cosmetics are applied to the local area of the 
breast directly, and dermal absorption of component chemicals has been suggested as an 
explanation of why more than half of all breast cancers in the UK start in the upper outer 
quadrant of the breast (Darbre 2005, Darbre and Charles 2010). The component chemicals 
are included in the products for a variety of reasons. The chemicals studied in this thesis 
were added for the purposes of conditioning and spreading (cyclosiloxanes), fragrance/ 
fragrance fixing  (Lilial), antimicrobial deodorant / preservative (triclosan) and antiperspirant 
(aluminium salts). Use of plastic containers for the products may allow leaching of 
bisphenol A into the products. 
 
1.7.1 Cyclosiloxanes 
 
The siloxanes are a large group of compounds with a backbone of alternating silicon and 
oxygen atoms and with hydrocarbon groups attached to silicon side chains. The silicon-
oxygen atoms in the cyclosiloxanes are singly bonded and form a ring. 
Hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane (D4) and 
decamethylcyclopentasiloxane (D5) are common examples(Horii and Kannan, 2008). The 
general chemical structures of cyclosiloxanes are shown in figure 1.14. 
Cyclosiloxanes are used in the manufacture of silicone products. Also, they are used in 
cosmetics as conditioning and spreading agents. (Luu and Hutter, 2001) D5 is the most 
frequent siloxane found in all environmental matrices sampled except for air, where D4 
predominates(Flassbeck et al., 2003). Also, Lu et al pointed out that D4 is permitted in 
personal care products at 60% by weight(Luu and Hutter, 2001).  
D4 is considered toxic in many studies and interferes with the female reproductive system 
(Lieberman et al., 1999a, Hayden and Barlow, 1972).McKim et al (2001) report D4 to 
possesses intrinsic oestrogenic activity in in vitro models and in vivo uterotrophic 
assays(McKim et al., 2001). Studies have not shown D5 to be oestrogenic, however D5 has 
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been demonstrated to cause uterine endometrial adenocarcinomas in some animal studies. 
Also, there are potential dangers related to the possible impact of D5 on the 
neurotransmitter dopamine and the hormone prolactin (Ben-Jonathan, 2001, Besser et al., 
2005).  
 
FIGURE 1.14 GENERAL STRUCTURE OF CYCLOSILOXANES. 
  
Defined as any compound having a ring of alternating silicon and oxygen atoms, bonded 
together. Adapted from(Zheng et al., 2012, Rayeza et al., 1999) 
1.7.2.  Fragrances 
 
Many synthetic musk fragrances are manufactured and used in perfumes, skin creams, 
deodorants, soaps, and detergents. Both polycyclic musks(Gomez et al., 2005, Bitsch et al., 
2002)  and nitromusks(Bitsch et al., 2002) have been shown to have oestrogenic activity as 
have benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) (Charles 
and Darbre, 2009a). Also, Benzyl salicylate, benzyl benzoate and 
butylphenylmethylpropional 
(Lilial TM) are further compounds used currently in a wide range of cosmetics applied around 
the human breast, including underarm cosmetics. They are added primarily as fragrances 
and/or fragrance fixers. Additionally,  in a recent survey, butylphenylmethylpropional and 
benzyl salicylate were found as labelled on 43% and benzyl benzoate on 28% of the 
cosmetic products surveyed (Buckley, 2007)  Some of these musks have been measured in 
human milk (Kuklenyik et al., 2007, Reiner et al., 2007, Darbre and Charles, 2010). The 
general chemical structure of Lilial  is shown in figure 1.15. 
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FIGURE 1.15 CHEMICAL STRUCTURES OF  BUTYLPHENYLMETHYLPROPIONAL [LILIAL] 
CAS no.80-54-6; 2-methyl-3-(4-tert-butylphenyl)propanal; 2-(4-tert-
butylbenzyl)propionaldehyde; p-tert-butyl-α-methylhydrocinnamic aldehyde].(adapted from 
Charles and Darbre, 2009) 
 
1.7.3. Triclosan 
Triclosan (5-chloro-2(2,4-dichlorophenoxy)-phenol) is also known as Irgasan. The chemical 
structure of triclosan is shown in figure 1.16.  It is an antibacterial agent incorporated into 
soaps, toothpastes, first-aid products, fabrics, plastic goods and in cosmetics to improve 
storage properties (James et al., 2010).  Also, it is incorporated into deodorants to stop 
microbial growth on the skin surface, which metabolises sweat producing body odour (Liu 
B, 2002).  Triclosan has been shown to inhibit enoylreductase enzymes involved in type II 
fatty acid syntheses in certain bacteria. Set against these useful properties, Triclosan is 
also cytotoxic to human breast cancer cells (Foran et al., 2000, Darbre, 2006a).  Triclosan 
can be detected in aquatic environments including river and ground water.  It therefore also 
gets into sediments and biomaterial including fish and human breast milk (Adolfsson et al., 
2002, Kim et al., 2011a). In recent times, Gee et al have demonstrated that triclosan exerts 
both oestrogenic and androgenic effects on human breast cancer cells (Gee et al., 2008b). 
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FIGURE  1.16 GENERAL STRUCTURE OF TRICLOSAN 
  CHEMICALLY IT IS 2,4,4'- TRICHLORO-2'-HYDROXYPHENYL ETHER).  FUNCTIONAL GROUPS INCLUDE BOTH PHENOLS 
AND CHLORIDES(DARBRE, 2011) 
 
 1.7.4. Aluminium 
Aluminium (Al) is the third most abundant element after (oxygen and silicon), and its 
compounds make up about 8% of the Earth’s surface (Exley 1998). The human breast is 
exposed to aluminium from many sources including diet and antiperspirants (Krewski,et al.  
2007; Mannello, et al. 2011).  The action of Al salts in antiperspirants arises from their 
ability to prevent sweat reaching the skin surface, this perhaps through the formation of a 
physical plug of precipitated salts and desquamated cells at the superficial orifice of the 
sweat duct (Laden and Hunter 1998; Darbre 2005).  One published paper has 
demonstrated Al at higher levels in breast tissue from outer compared to inner breast 
quadrants, which may result from antiperspirant use in the underarm area (Exley, Charles 
et al. 2007).  Darbre has suggested that the large number of breast cancers developing in 
the upper outer quadrant of the breast might be related to antiperspirant application 
patterns. (Darbre, 2005, Darbre and Charles, 2010). 
Al is, moreover, identified to be capable of causing DNA damage, epigenetic effects and 
many other biochemical aberrations within cells.  Al exposure has been reported to be 
neurotoxic and contributes to neurodegenerative diseases such as Parkinson!s (Flaten, 
1990) and Alzheimers disease  (Zatta et al., 2009; Mannello et al., 2011).  Al is classed as a 
metalloestrogen because in MCF-7 human breast cancer cells it has compromised the 
binding of oestradiol to estrogen receptors and enhanced transcription from an estrogen-
responsive gene in (Darbre, 2006). Recently, Sappino et al have suggested  that aluminium 
chloride (AlCl3) is not generically mutagenic, but functions similarly to an activated 
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oncogene by inducing proliferation stress, DNA double strand breaks (DSBs) and 
senescence in the normal mammary epithelial cell line MCF10 A (Sappino et al., 2012) 
1.7.5. Bisphenol A 
Bisphenol A (BPA) (4,4-isopropylidenediphenol) is not directly applied to the skin as a 
lifestyle choice.  It is relevant here because it is likely to leach from plastic containers.  It is 
involved in the manufacture of polycarbonate plastics and epoxy resins (Vandenberg et al., 
2007a).  In the home BPA is commonplace, found in plastic food containers, baby bottles, 
and  lining metal food cans(Welshons et al., 2006).BPA is a diphenyl compound that has 
two hydroxyl groups in the para position; it thus has similarities (see Figure 1.17) to the 
physiological oestrogen 17β- oestradiol and the synthetic oestrogen diethylstilboestrol(Soto 
et al., 2008), mainly in the presence  of hydroxyl residues at either end of ring-containing 
molecules of similar dimension..  Kang et al (Kang et al., 2006) have reported leaching of 
BPA into food or water from plastic containers. This migration is influenced by the 
manufacturing process, storage environments and heating by end-users(Kang et al., 2006). 
BPA has oestrogenic properties (Bcnefeld-largensen and Long, 2007); in animals BPA has 
been demonstrated to induce mammary hyperplasia (Durande et al., 2007). It is detectable 
in human breast milk., (Kuruto-Niwa et al., 2007). 
 
 
 
 
 
 
 
 
 
The structures of BPA and DES show greater similarities to each other than either are to 
the native hormone 17β oestradiol. This illustrates the range of structures capable of 
binding to the oestrogen receptor.(Soto et al., 2008).    
  
FIGURE 1.17 CHEMICAL STRUCTURE OF BISPHENOL A (BPA), DIETHYLSTILBESTROL (DES) AND 17Β-OESTRADIOL 
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 AIMS OF THIS THESIS 
 
The aims of this project were: 
 To investigate possible genotoxic actions of the environmental chemicals bisphenol 
A, triclosan, three cyclosiloxanes (D3, D4, D5), butylphenylmethylpropional (Lilial) 
and aluminium using MCF10A and MCF10F immortalised non transformed  human 
breast epithelial cells in culture,   The effect of each chemical was studied:-  
o On the ability of MCF10A and MCF10F cells to form colonies in suspension 
culture, a change which constitutes a strong indicator of transformation in 
these cells (Soule,1990). 
o On DNA damage assessed before and after exposure to each chemical 
using the comet assay (Collins, 2004). 
o On expression of mRNAs for DNA repair enzymes in MCF10A & MCF10F 
cells. This was carried out using real time RTPCR for 
BRCA1,BRCA2,p53,ATM,ATR, Rad50&51, CHK1&2, PARP1, BRIP1, 
PALB2, PTEN and STK111 Short term (7days) and long term (30 weeks) 
effects of the chemicals were compared. 
 
o Western immunoblotting was used to assess whether changes in BRCA1 
mRNA are reflected by similar changes in protein production. 
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Chapter 2  Materials and Methods 
 
 
2.1 Cell proliferation experiments 
Cells were suspended from stock dishes by treatment with trypsin- EDTA solution (as 
described in section 2.2) and added to an equal volume of phenol red free DMEM including 
5 % (v/v)   dextran-charcoal-stripped-FCS (DCFCS), penicillin (100 U/ml)  streptomycin 
(100µg/ml) and 2mM  glutamine (Darbre et al., 2003). Cells were counted on a 
haemocytometer and added to the required volume of phenol red free DMEM as above at a 
concentration of 0.2× 105 cells/ml.  Cells were plated in 0.5-ml aliquots into 4-well plastic 
tissue culture dishes (Nunc, Roskilde, Denmark). The medium was replenished after 24 h to 
contain the required concentration of treatment or an ethanol vehicle control and cell counts 
completed by counting released nuclei on a ZBI Coulter Counter as described in section 
2.6, below. Test medium was changed routinely every 3 days and cells were counted at 
time zero after 24 hours of plating and after 7 or 14 days.     
2.2 Cell culture models for studying DNA repair  
Breast cancer is a classic case of hormone dependency in cancer. The sub-clone of the cell 
line MCF10 (MCF10F), as used in this study was instrumental in establishing that 
oestrogens are indeed themselves fully carcinogenic in that natural 17beta oestradiol and 
its metabolites exert as much neoplastic transformation as chemical carcinogens such as 
benzopyrene (Russo and Russo, 2006).  This concept has been reinforced by Darbre 
(Darbre, 2012), contrasting the use of normal cell lines with models derived from metastatic 
tumour although she also points out that supraphysiological concentrations of hormone are 
required.  This background is, however more than adequate to justify the use of the 
immortalised but non-neoplastically transformed MCF10A and MCF10F cell lines as the in 
vitro models of breast cancer here.  
The MCF10 cell line was derived from fibrocystic breast tissue by long-term culture in low-
calcium, serum free medium and characterized by Soule (Soule et al., 1990b).  The 
MCF10A cells were derived from an adherent population in those cultures, while the 
MCF10F line was cloned from floating cells but is now grown on substrates, with anchorage 
dependency.  The cells are non-tumourigenic in vivo, have epithelial morphology and stain 
for epithelial sialomucins, cytokeratins and milk fat globule antigen.  On plastic substrates 
the MCF10A cells are adherent but not fully contact inhibited, tending to pile up to form 
domes. The use of both cell lines in this study is justified as the 10F clone has some 
anchorage independence in its past history and the colony-forming assay described below 
is predicated on assessing growth potential in suspension,  
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2.3 Culture of stock MCF10A and MCF10F cells 
MCF10A and MCF10F immortalized, non-transformed human breast epithelial cells (Soule 
et al., 1990a) were obtained from the American Tissue Culture Collection (ATCC). Cells 
were grown as monolayer cultures in Ham’sF-12and Dulbecco’s modified Eagle’s medium 
(DMEM) containing phenol red(1:1 v:v ratio) (Invitrogen, Paisley, UK) supplemented with 
5% (v/v) horse serum (Invitrogen), 10µgml–1 insulin (Sigma), epidermal growth factor 
(EGF) (Sigma) and 500ng/ml hydrocortisone (Sigma). Media were supplemented with 5ml 
Penicillin/ streptomycin solution containing 10,000 units of penicillin and 10mg/ml 
streptomycin. Cell lines were kept at37°C and in a humidified atmosphere of 10% carbon 
dioxide in air. Cell stocks were sub cultured with 0.0 6% trypsin/ 0.02% 
Ethylenediaminetetraacetic acid, (EDTA) (pH7.3) at weekly intervals. 
 
2.4  Sub culturing of cells 
All stock cells were sub- cultured at weekly intervals. MCF10A cells were taken from one 
9cm diameter dish and medium was sucked off. The cells were washed with 2 ml Hank's 
Balanced Salt Solution (HBSS) (Invitogen, UK) to remove the serum which would inhibit the 
action of trypsin. After that, cells were incubated at 37°C with HBSS containing 0.06% 
trypsin (w/v), 0.02% EDTA, pH 7.3 (Invitrogen, UK) for 15minutes (mins) for MCF10A. The 
cells suspensions were then supplemented with to 2 ml of relevant stock medium and re 
plated at a 1/10 dilution into the relevant culture medium in 9-cm tissue culture dishes 
(Nunc, Denmark). 
2.5 Long term incubation of cells with cosmetic chemicals 
A vial of stock cells (MCF10A) was taken from liquid nitrogen and thawed in order to start of 
the long –term exposure of cells to agents of interest.  This ensured a similar starting 
passage number as used in previous experiments (Daly et al., 1990) and enabled 
comparisons with starting control cells at any point of time.  Cells were grown for 3 weeks 
as stock cells before any experiment commenced. After this period of maintenance, cells 
were washed twice with HBSS (Invitogen, UK) and disaggregated with trypsin/EDTA 
(section 2.2). The cells were seeded into 6-well tissue culture plates (Nunc, Denmark) and 
grown in a humidified atmosphere of 10% carbon dioxide in air at 37°C for up 30 weeks 
with media changed every 3 days.  Stock cells were passaged every 7 days. Cells were 
maintained with or without test compound (See Table 2-1).  
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Table 2-1 The cosmetic –related chemical tested for the study  
Chemical  MW Source CAS No Purity 
Bisphenol A 228.29 Aldrich 
239658-
50G 
80-05-7 99.95% 
Triclosan 289.5 CIBA 
Irgasan 
DP300 
3380-34-5 97-
103.0% 
Butylphenylmethylpropional; 2-
(4-tert-
butylbenzyl)propionaldehyde 
(Lilial) 
204.31 Sigma 
95338-
10MG-F 
80-54-6 90.0% 
Hexamethylcyclotrisiloxane 
(D3) 
222.47 Aldrich 
235687-
25G 
541-05-9 98.5% 
Octamethylcyclotetrasiloxane 
(D4) 
296.62 Aldrich 
23,569-5 
556-67-2 95-
99.8% 
Decamethylcyclopentasiloxane 
D5) 
370.78 Aldrich 
444278-
50ML 
541-02-6 90% 
Al chloride 133.34  563919 
Aldrich 
7446-70-0 99.99% 
Al Chlorohydrate 
 
36.46  258148 
Sigma-
Aldrich 
7647-01-0 
 
  
 
 
Compounds were diluted in ethanol to give stock solutions. Stocks were then diluted 
1:10,000 into culture medium.  Controls contained equivalent amounts of ethanol.  
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2.6 Assay of colony growth in methocel suspension culture 
A solution of 2% methylcellulose (methocel), made from 1gm of methyl cellulose in 
autoclaved 100ml glass bottles with magnetic stirrers, plus 50ml of stock medium MCF10A 
stirred for 2 days in the cold (40C room.)  For experiments, this was diluted with an equal 
volume of the same stock medium without methylcellulose but containing 2×105cells/ml 
together with either ethanol vehicle (control) or treatment 17β-oestradiol, 
hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane (D4), 
decamethylcyclopentasiloxane (D5), bisphenol A (BPA), triclosan or 
butylphenylmethylpropional (Lilial). Subsequently, 2.5ml aliquots were seeded into six-well 
suspension culture plates (Costar) and grown for 21 days. Cells were fed every 7 days by 
the addition of 0.5 ml fresh MCF10A media. The number of colonies in each dish was 
counted manually every 7 days under the microscope. The mean size of colonies was 
measured using a 10× objective on an inverted Nikon EclipseTE200 microscope using 
software NISElementsAR-2.10 with the micron marker facility switched on. The average 
colony size was determined from 10 colonies for each field of view and results were 
calculated as the average colony size ± SEM for 15 fields of view. Results were compared 
statistically by One-way analysis of variance (ANOVA): Dunnett's Multiple Comparison 
Test, using Graph Pad Prism 5™.  
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 2.7  Cell counting using a Coulter counter 
Cells were counted using a Coulter counter after 24 hours (hrs) to provide the plating 
density or after (7, 14 and 21 days) to measure cell growth. In this method, cells were 
counted as nuclei them rather than whole cells. This avoids the problem of cells clumping 
as nuclei appear to have no attraction for one another. Cells were washed twice with 0.25 
ml saline solution (0.9% w/v NaCl in water) and lysed in 0.5 ml HEPES/MgCl solution 
(made from 10ml from 1M HEPES and 0.305 gm MgCl2.6H2O per litre in distilled water) 
were added plus 2 drops of Zapolobin (Beckman Coulter ). They were left for 20-30 min at 
room temperature (RM).  The released nuclei were checked under the microscope and 
counted in Isoton on ZBI Coulter counter (Beckman Coulter).   
2.8  Counting cells from methocel culture by Coulter counter 
Five ml of saline (0.9% w/v NaCl in water) was added to each well. The resulting cell 
suspensions were harvested into 50ml tubes and centrifuged for 20 min at 4000 rpm in an 
Eppendorf centrifuge 5810. The supernatants were removed and the cell pellets washed 
twice with1 ml saline and lysed in 1 ml HEPES/MgCl solution - 10ml of 1M HEPES and 
0.305 gm MgCl2.6H2O per litre in distilled water plus 2 drops of Zapoglobin (Beckman 
Coulter). They were left rocking for one hour at room temperature.  The released nuclei 
were checked under the microscope and counted in 9 ml Isoton™ on a ZBI Coulter counter 
(Beckman Coulter). 
 
2.9  Measurement of DNA damage 
 
 Single cell gel electrophoresis, also known as the ‘comet’ assay, is a rapid and sensitive 
method of assessing, semi-quantitatively, DNA damage in vitro and in vivo, identifying 
individual cells so affected. It addresses factors which modify mutagenesis and 
carcinogenesis (Collins, 2004, Pandey et al., 2006) and as such has particular relevance to 
the present study.  The comet assay works on the principle that strand breakages in DNA 
lead to the relaxation of the super-coiled duplex molecule with the production of smaller 
strands which can be stretched and separated by electrophoresis under alkaline conditions, 
where the breaks are more labile (Singh et al., 1988).  Negatively charged free DNA then 
moves towards the anode.   (Pandey et al., 2006)  DNA migration is a function of both the 
size and the number of broken DNA strands and tail length is directly related to damage.  
The standard comet assay protocol was designed for use with lymphocytes and 
hepatocytes (Singh et al., 1988,Van Dyk and Pretorius, 2005) the method described here 
was adjusted for the current usage with anchorage-dependent epithelial cells such as 
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MCF10A. Comet assays run at different pH measure damage differently.  At neutral pH it 
measures only single strand breaks; at the alkaline pH used here it detects both single and 
double strand breaks. 
 
2.10  Alkaline single-cell gel electrophoresis (SCGE) Comet assay 
The alkaline single gel electrophoresis (SCGE) or comet assay was employed to detect 
single strand and double strand breaks in DNA and alkali-labile DNA adducts in the 
immortalised human breast epithelial cell line MCF10A. It is best not to use transformed 
cells where there is genomic instability and considerable endogenous DNA damage and 
polyploidy. The MCF10A cells are appropriate as they are not transformed and have a 
relatively diploid genome. 
The MCF10A cells were plated out at a concentration of 0.4x10-5 cells/ml, using the same 
stock cell culture medium as described previously in section (2.1.). Cells were seeded into 
9cm dishes containing 10 ml of medium. After 24 hours the medium was changed to the 
same medium containing the required concentration of the test compound, positive control 
or vehicle control for one hour exposure. After one hour, the culture medium was sucked off 
and plate was washed twice with phosphate buffered saline (PBS). The cells were scraped 
from the well into a 15 ml tube in PBS. The cells were counted on the haemocytometer. 
Cells were centrifuged, the supernatant was removed and the cell pellet embedded in 0.5% 
low- melting point agarose (Sigma) at a final concentration of about 104 cells/ml. Slides 
were prepared with 0.5% standard melting point agarose in PBS (0.05g in 10ml PBS)  
heated in a microwave to dissolve and 110 µl pipetted onto a poly-L-lysine-coated frosted 
microscope slide. A coverslip was placed carefully over the agarose and chilled at 4oC for 
10-15 minutes to allow the agarose to solidify. The coverslips were removed carefully. After 
that, 0.5% low melting point agarose was prepared in PBS (0.05g in 10ml PBS) by heating 
in a microwave to dissolve. 65µl of low melting point agarose was mixed at 37oC with 10µl 
of the cell suspension.  
The agarose/cell mixture was placed on top of the previous layer of agarose on the slide. 
Slides were covered with coverslips and chilled at 4oC until solid for 10-15 min.  All steps 
were done with minimal exposure to light to reduce background DNA damage (eg in a dark 
cold room or wrapped in foil on the bench).Then coverslips were removed and slides were 
placed in a chilled lysis solution at 4oC in the dark, for one hour. The slides were removed 
from lysis solution (10mM Tris pH 10 (pH adjusted with NaOH), 2.5M NaCl, 100mM EDTA 
(di-Na salt), 1% triton X-100 added fresh) and placed in the Comet assay tank at 4oC. The 
tank was filled with just enough electrophoresis buffer (0.3M NaOH, 1mM EDTA, pH˃ 10) to 
completely cover the slides. The slides were left in the electrophoresis buffer for 20-30 
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minutes at 4oC in the dark to allow the DNA to unwind. The slides were subjected to 
electrophoresis at 4oC in the dark at 25volts for 20 minutes (or 15V for 30 min). The current 
was restricted to <300milliamps. Following electrophoresis, the slides were removed from 
tank and placed in tray of neutralisation buffer (Tris 0.4M pH7.5) 3 times for 5 minutes each 
time and fixed by placing in cold methanol for 5 minutes. The DNA on the slides was 
visualised by one drop 4',6-diamidino-2-phenylindole (DAPI) per slide and viewed under a 
fluorescence microscope.  
An Axia fluorescence microscope (Carl Zeiss-Axioimage. A1) fitted with anaxiocam 
microscope camera was used to visualise the comets, using a x20-25 objective. The extent 
of the DNA damage is in proportion to the migration of DNA from the head into the comet 
tail. Fifty cells per treatment were scored and tail length was measured in micrometers 
(µm).  The average tail length was determined from 50cells for each field of view and 
results were calculated as the average tail length ± SEM. Statistical analysis constituted 
using One-way ANOVA (analysis of variance) from the SPSS  software package. 
 
N.B. (DES) was used as a control for the comet assay because previous work has 
confirmed that exposure to DES produces DNA damage visible as comet in the assay. 
(Anderson et al 1998).   
  2.11 PCR based techniques 
As an overview, a schematic of the steps required to generate real-time RT-PCR results is 
depicted in figure 2.1.   
 
 
 
 
 
 
 
 
FIGURE 2.1  PROCESS REQUIRED TO GENERATE A REAL TIME RT-PCR RESULT. 
Black arrows indicate points, which should be considered for a good normalization strategy 
(Huggett et al., 2005).  
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2.11.1 Total cellular RNA extraction 
MCF10A cells were added to the required volume of Ham’sF-12 and Dulbecco’smodified 
Eagle’s medium (DMEM) containing phenol red mixed in a 1: 1 ratio by volume, to achieve 
a concentration of 0.8×105 cells/ml, and plated in 16 ml aliquots in 9 cm plastic tissue 
culture dishes to achieve an adherent monolayer. Cells were left for 7 days, when the 
medium was changed to stock medium supplemented with the required concentration of 
test compound, ethanol vehicle or 17β- oestradiol positive control.  The cells in the 4-well 
dishes were counted using the Coulter counter as described in section 2.6. 
After 7 days the cells in the 9 cm dishes were washed with isotonic saline and harvested 
into ice- cold isotonic saline using a rubber policeman, pelleted by centrifugation and cell 
pellets were stored at -80°C. Whole cell RNA was produced using the RNeasy™ Kit with 
on-column DNase treatment as described by the manufacturer (Qiagen)  as follows:- 
Firstly, 600 µl RTL buffer and 6 µl β -mercaptoethanol (β-ME) was added to the cell pellet 
and vortexed thoroughly. Next, the lysate was pipetted onto a QIA shredder spin column 
placed in a 2 ml collection tube and centrifuged for 2 min at maximum speed in a 
microcentrifuge. Then, one volume (600µl) of 70% ethanol was added to the homogenized 
lysate and mixed well by pipetting cleared lysate to precipitate DNA but not RNA. 
Subsequently, 700 µl of the sample was applied, including any precipitate, to an RNeasy 
mini column placed in a 2 ml collection tube. The tube was closed gently, and centrifuged 
for 15s at 8000x g (≥10,000 rpm). The flow-through was discarded. Then the procedure 
was repeated with remaining lysate. The flow through was discarded again.  
After that, 700µl Buffer RW1 was added to the RNeasy column. The tube was closed 
gently, and centrifuged for 15 s at ≥8000xg (≥10,000 rpm) to wash the column. The flow-
through was discarded with collection tube.  Consequently, the RNeasy column was 
transferred into a new 2 ml collection tube. 500 µl Buffer RPE was pipetted onto the 
column.  The tube was closed gently, and centrifuged for 15 s at ≥8000xg (≥10,000 rpm) to 
wash the column. The flow-through was discarded. Next step, another 500 µl buffer RPE 
was supplemented to the RNeasy column. The tube closed gently and centrifuged for 2 min 
at ≥8000xg (≥10,000 rpm) to dry the RNeasy Silica-gel membrane. The RNeasy column 
was placed in a new 2 ml collection tube and the old collection tube with the flow-through 
was discarded.  It was spun in a microcentrifuge at full speed for 1 min. Finally, the RNeasy 
column was placed in to a new 1.5 ml collection tube and 50 µl of RNase–free water was 
pipetted directly onto the RNeasy silica gel membrane. The tube was closed gently and left  
for 1-2 mins, then centrifuged for 1 min at ≥8000xg (≥10,000 rpm) to elute the RNA. The 
concentration of RNA was assessed as OD 260nm using a BioMateTM3 spectrophotometer.  
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2.11.2 RNA Quantification using Agilent Bioanalyzer 
The Agilent 2100 bioanalyzer was used for checking the quality and the integrity of 
extracted RNA samples. For examination with the Agilent 2100 bioanalyzer, the RNA 6000 
LabChip® kit (Agilent Technologies, USA) was used. The guidelines of the assay protocol 
were strictly followed. Firstly, the gel was prepared: 550μl of RNA 6000 Nano gel matrix 
was added into a spin filter then centrifuged at 1500 g for 10 minutes at ambient 
temperature. Secondly, the Gel-Dye Mix was prepared: RNA 6000 Nano dye concentrate 
was vortexed for 10 seconds, and spun down briefly.  1μl of dye was added into a 65μl 
aliquot of filtered gel. After that, the solution was vortexed well and spun at 13000 g for 10 
min at room temperature. Thirdly, the Gel-Dye Mix was loaded onto the chip priming 
station. Gel-dye mix (9.0 μl) was pipetted into the wells marked. Subsequently, the plunger 
was set to 1 ml and then the chip priming station closed. The plunger was pressed until 
held by the clip. The clip was released after waiting for exactly 30 sec; the plunger was 
pulled back slowly to the 1ml position after waiting for 5 sec.  In the next step, the chip 
priming station was opened and 9.0 μl of gel-dye mix was pipetted into the wells marked. 
The remaining gel-dye mix was discarded. After that, 5µl Agilent RNA 6000 Nano Marker 
was loaded in all 12 sample wells and the wells marked. Finally, 1μl ladder or 1μl Sample 
was loaded into appropriate wells. 1 μl of RNA 6000 Nano Marker was pipetted in each 
unused sample well. The chip was placed horizontally in the adapter of the IKA vortexer 
and vortexed for 1 min at 2400 rpm.  The chip was run in the Agilent 2100 bioanalyzer for 5 
min.  
2.11.3 Analysis of RNA quality and quantity  
The main aim of the Agilent 2100 bioanalyzer experiments was to check the quality and the 
integrity of extracted RNA samples.  The example shown relates to the cyclosiloxane series 
of experiments, but applies to all other series. 
 Representative samples of mRNA prepared from MCF10A cells grown with or without 
cyclosiloxanes D3, D4 and D5 for 7 days are shown in Figures 2.2 and 2.3.  Figure 2.2 
shows RNA preparations gave high quality RNA that contain two bands at 42 and 48 kb 
equivalent to 28S and 18S rRNA.  RNA quantitation can be achieved using capillary 
electrophoresis (microfluidics) on the Agilent 2100.  It requires only 25 ng of input RNA.  A 
2:1 ratio in the area under the peaks for 28S and 18S rRNA indicates intact total RNA. 
Degradation is indicated by less pronounced peaks for 28S and 18S rRNA and a 28S:18S 
rRNA ratio significantly less than 2:1.  Figure 2.3 shows a quantitative analysis of the same 
experiment.  Just the two peaks show at the correct location in all samples. 
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FIGURE 2.2 IMAGE OF GEL FROM AN RNA NANO CHIP RUN ON THE AGILENT 2100 BIOANALYZER 
Shows the RNA quality in 5µl RNA samples from MCF10A human breast epithelial cells. 
 
The RNA ladder shows bands of 15-70 KB markers. Cells were grown in stock medium with 
no addition (1), with 10-8 17β- oestradiol (2), with 10-5M Hexamethylcyclotrisiloxane (D3), 
with 10-5M octamethylcyclotetrasiloxane (D4) or with 10-5 decamethylcyclopentasiloxane.  
 
FIGURE 2.3 ANALYSIS OF GEL IMAGE FROM FIGURE 2.5. AGILENT 2100® BIOANALYSER  
Scans of High Integrity Total RNA are shown by the 18S and 28S peaks at 39 and 46 
seconds, respectively. MCF10A Cells were grown in stock medium with no addition 
(control) or in the present of 10-8 17β- oestradiol (E2), 10-5M hexamethylcyclotrisiloxane 
(D3), 10-5M octamethylcyclotetrasiloxane (D4), or10-5M decamethylcyclopentasiloxane (D5) 
for 7 days.  
 38 
 
2.11.4  Selection of β-actin mRNA  loading control for normalisation of PCR 
 
Figure 2.4 shows the Ct values from real-time RT- PCR for expression of the housekeeping 
gene β-actin in MCF10A and MCF10F immortalised non-transformed human breast 
epithelial cells which were untreated or treated with the cyclosiloxanes (D3, D4 and D5), 
Lilial, Triclosan and BPA.   The strong expression of β-actin with similar Ct values 
throughout demonstrates that use of β-actin for normalisation as a loading control is 
technically sound. 
Figures 2.5 and 2.6 show Ct values for β actin mRNA in cells after one week and 30 
weeks incubation respectively.  There is no significant difference in the observed levels of 
this putative normalization control between the agents tested, irrespective of the incubation 
time (1 or 30 weeks). 
 
MCF10A cells                                                                       MCF10F cells 
 
FIGURE 2.4  RT- PCR ANALYSIS OF Β-ACTIN MRNA IN MCF10A AND MCF10F CELLS FOR CYCLOSILOXANES (D3, D4 
AND D5) LILIAL, TRICLOSAN AND BPA 
         
Cells were grown in stock medium with no addition (control) or in the presence of 10-8 17β- 
oestradiol (E2), 10-5M hexamethylcyclotrisiloxane (D3), 10-5M octamethylcyclotetrasiloxane 
(D4) or 10-5M decamethylcyclopentasiloxane (D5) 10-5M  Lilial, 10-7M Triclosan and  10-5M 
Bisphenol A (BPA) , .Average ± SE of 3 technical replicates for RT PCR of β- mRNA.  
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           MCF10A cells                                                                     MCF10F cells 
 
FIGURE 2.5  RT- PCR ANALYSIS OF Β-ACTIN MRNA IN MCF10A AND MCF10F CELLS: SHORT TERM CULTURE FOR 
CYCLOSILOXANES (D3, D4 AND D5), LILIAL, TRICLOSAN AND BPA 
 
Cells were grown in stock medium with no addition (control) or in the present of 10-8 17β- 
oestradiol (E2), 10-5M hexamethylcyclotrisiloxane (D3), 10-5M octamethylcyclotetrasiloxane 
(D4) or 10-5M decamethylcyclopentasiloxane (D5) 10-5M  Lilial, 10-7M Triclosan and  10-5M 
Bisphenol A (BPA). Average ± SE of 3 biological replicates for RT PCR of β- mRNA for 
short term (1week). 
MCF10A cells                                                                         MCF10F cells
           
FIGURE 2.6 RT- PCR ANALYSIS OF Β-ACTIN MRNA IN MCF10A AND MCF10F CELLS: LONG TERM CULTURE FOR 
CYCLOSILOXANES (D3, D4 AND D5), LILIAL, TRICLOSAN AND BPA 
Cells were grown in stock medium with no addition (control) or in the present of 10-8 17β- 
oestradiol (E2), 10-5M hexamethylcyclotrisiloxane (D3), 10-5M octamethylcyclotetrasiloxane 
(D4) or 10-5M decamethylcyclopentasiloxane (D5) 10-5M  Lilial, 10-7M Triclosan and  10-5M 
Bisphenol A (BPA).Average ± SE of 3 biological replicates for RT PCR of β- mRNA for long  
term (30week). 
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Figure 2.7 shows the Ct values from real-time RT- PCR for expression of the housekeeping 
gene β-actin in MCF10A  immortalised non-transformed human breast epithelial cells which 
were untreated or treated with the Alcl3 and Al hydrochloride    The strong expression of β-
actin with similar Ct values throughout demonstrates that use of β-actin for normalisation as 
a loading control is technically sound 
In Figure 2.7   Ct value for β actin mRNA after 20 weeks.  There is no significant difference 
in the observed levels of this putative normalization control between the agents tested 
                    Biologically                                                   
 
FIGURE 2.7  RT- PCR ANALYSIS OF Β-ACTIN MRNA IN MCF10A : LONG TERM CULTURE FOR ALCL3 AND AL 
HYDROCHOLRIDE . 
    
 
Cells were grown in stock medium with no addition (control) or in the present of 10-4 Alcl3, 
10-4M Al hydrochloride, Average ± SE of 3 biological replicates for RT PCR of β- mRNA for 
long term (20 week). 
 
2.11.5 c-DNA synthesis for real time (RT)-PCR 
First strand cDNA was synthesized using the first strand synthesis Qiagen kit according to 
the manufacturer’s instructions.  First, 2 µl DNA buffer, 1µgRNAand RNase – free water  to 
a volume of 11 µl were mixed in a small microcentrifuge tube by pipette and incubated 2 
min at 42 °C, then placed on ice. Secondly, 1 µl   reverse- transcription master mix, 4µl 
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Quanti Script RT buffer and 1µl RT Primer Mix were mixed in another microcentrifuge tube. 
In the next step, the 14 µ template RNA from Step 1 was added to step 2 (total vol 20µl), 
then incubated for15 min at 42°C, then incubated 3 min at 95°C and stored at -20°C/ - 
80°C.The product was diluted 1:20 for RTPCR. 
 2.11.6  Real- time RT- PCR analysis 
For each reaction of RT-PCR, 2x 7µl QuantiTectSyber Green PCR master mix, QuantiTect 
primers (1.4µl) (Table 2.2) and RNase free water (0.6 µl) were mixed in a 96 well plate, 
(Thermo Scientific UK, 1900 High speed low profile PCR plate).  A total of 9 µl of master 
mix as described above was pipetted into each well and 5 µl of cDNA sample was added. 
The 96 well dish was vortexed.  The AB Applied Biosystems method was used for RT-PCR. 
The thermal profile for all reaction was 95°C for 15 min, followed by 40cycles of 94°C for 
15s and 60°C for 1 min. All reactions were performed in triplicate.  The β-actin gene has 
been conventionally used as an internal control or housekeeping gene to normalize the 
expression of the target gene(s) or mRNA levels (Wong and Medrano, 2005) and was used 
here as a reference to normalize the expression value of BRCA1,BRCA2,p53,ATM,ATR, 
Rad50&51, CHK1&2, PARP1, BRIP1, PALB2,PTEN and STK111. 
2.11.7 Statistical analysis of real- time RT- PCR 
The comparative threshold cycle (Ct) method was used to calculate the amplification factor. 
Triple replicates were performed for each gene and average expression values were 
computed for subsequent analysis. The relative expression level of the genes was 
calculated using the 2−△△Ct method. This was then repeated for each of the three 
biological replicates generated from independent cell cultures after 30 weeks of culture, and 
results presented show the average ± SE (n = 3) of the three biological replicates. 
According to the 2− ΔΔCT method, results are presented relative to the control value of 1.0 
for cells grown in the absence of Al. Statistically significant differences were determined 
using ANOVA Dunnett in Graph Pad Prism 5™. 
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TABLE 2-2 Primers for RT-PCR 
 
QuantiTec
t Primers 
Species Gene 
ID 
Amplicon length Detected 
transcript 
Product code  
ATR Human 
(Homo 
sapiens) 
545 125bp (NM_001184) NM_001184 
(8258 bp) 
QT00030779 
ATM Human(Homo 
sapiens) 
472 134bp (NM_000051) NM_000051 
(13147 bp) 
QT-00061593 
β-Actin Human(Homo 
sapiens)
  
60 104bp (NM_001101) NM_001101 
(1852 bp) 
QT-01680476 
BRCA1 Human 
(Homo 
sapiens) 
672  60bp (NM_007294) NM_007294 
(7224 bp) 
 QT-00039305 
BRCA2 Human(Homo 
sapiens) 
675 93bp (NM_000059) NM_000059 
(11386 bp) 
QT-00008449 
BRIP1 Human(Homo 
sapiens) 
83990 97bp (NM_032043) NM_032043 
(8166 bp) 
QT00086548 
CHK1 Human(Homo 
sapiens) 
1111 123bp 
(NM_001114121) 
NM_00111412
1 (2699 bp) 
QT00006734 
CHK2 Human(Homo 
sapiens) 
11200 134bp 
(NM_001005735) 
NM_00100573
5 (1991 bp) 
QT01016155 
p53 Human(Homo 
sapiens) 
7157 112bp (NM_000546) NM_000546 
(2591 bp) 
QT-00060235 
PALB2 Human(Homo 
sapiens) 
79728 100bp (NM_024675) NM_024675 
(4069 bp) 
QT00068523 
PARP1 Human(Homo 
sapiens) 
142 86bp (NM_001618) NM_001618 
(4001 bp) 
QT00032690 
PTEN Human(Homo 
sapiens) 
5728 
 
108 bp(NM_000314) 
 
NM_000314 
(5572 bp) 
QT00086933 
Rad50 Human(Homo 
sapiens) 
10111 131bp (NM_005732) NM_005732 
(6597 bp) 
QT00037170 
Rad51 Human(Homo 
sapiens) 
 
5888  
  
108 bp(NM_001164270) 
 
NM_00116427
0 (2177 bp) 
QT00072688 
STK111 Human(Homo 
sapiens) 
6794 91 bp (NM_000455) NM_000455 
(3286 bp) 
QT01008980 
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2.12 Western Immunoblotting 
 
2.12.1  Preparation of whole cell lysates 
Cells were seeded at a density of 0.8x 105 cells/ ml in growth medium as described in 
section 2.9. These cultures were incubated in a humidified atmosphere of 10 % carbon 
dioxide in air at 37°C for 7 days in 9 cm and 4 well tissue culture dishes (Nunc, Denmark). 7 
days later 4 well dishes were counted in order to calculate cell density at the time of harvest 
for protein preparation.  
2.12.2 Protein Extraction 
Cultured cells were washed twice in situ with ice cold phosphate buffered saline (1M, PBS, 
sigma, UK). Cells were removed from the culture dish using a rubber cell scraper and 
pelleted in 15 ml tubes by centrifugation. The appropriate amount of lysis buffer [ 50nM 
Tris-HCL  pH7.4, 250mM NaCl, 5mM EDTA, 0.3 % triton x-100,0.3 mM 4-(2- Aminoethly) 
benzenesulfonly fluoride hydrochloride (AEBSF), 10 µg/ml leupeptin and  2 µg/ml aprotonin] 
was added to the cell pellet to give a final concentration of 1x105 cells/µl.  These samples 
were kept on ice for 30 minutes and then passed through needles of decreasing size from 
19G to25 G in order to break down cellular organelles and DNA.  These lysates then were 
centrifuged at 13000 rpm for 5 minutes at 4°C in a microcentrifuge. The supernatants were 
transferred to fresh tubes and kept at -80 °C.  
2.12.3  Protein Quantification 
Protein in each cell lysates was quantified using the Pierce BCA reagent (Thermo Scientific, 
USA).  Protein standards were prepared by mixing different amount of bovine serum 
albumin (BSA) (1mg/ml) with lysis buffer and distilled water to obtain a total volume of 10 µl 
in each tube. Cell lysates samples were prepared by mixing 2 µl of cell lysates and 8 µl of 
distilled water in order to have total 10 µl volumes. Protein standards and cell lysate 
samples were prepared in triplicate. Pierce BCA reagent was prepared according to the 
manufacturer’s instructions and 200 µl was added into each tube. These tubes were 
incubated at 60 °C for 30 min. These samples were downloaded into a 96 well plate to be 
read at OD 560 nm in an EMAX plate reader.  Protein in each well was calculated from a 
standard curve of the BSA protein standards. 
2.12.4  Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) 
In order to separate the protein in samples, treated ethanol vehicle or 17β- oestradiol 
positive control sodium dodecyl sulphate- polyacrylmide gel electrophoresis (SDS- PAGE) 
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was performed.  Protein samples were diluted 1:1 v:v with Lamelli buffer (Bio-Rad, UK) and 
incubated at 100 °C for 3 min before loading into the wells of the gel.  Mini protean TGX 
stain free precast gel (7.5%, BioRad, UK) were used for western blot analysis. Precision 
plus Protein TM Unstained Standard (BioRad, UK) was used as a protein marker. Depending 
on the protein amount obtained from the assay, 30 or 50 µg of protein samples were loaded 
into the wells. The gel was then run at 200 volts until the bromophenol blue dye reached the 
bottom of the gel.  
2.12.5  Gel Activation 
The gel was placed on the stain free tray of the Gel Doc TMEZ System in order to activate 
for 5 minutes for best sensitivity by Gel Doc TM EZ System (Bio- Rad, UK) using Image Lab 
software.  
2.12.6  Transfer of protein to PVDF membrane 
Protein samples were transferred onto polyvinylidene difluoride (PVDF) membrane using 
the Trans Blot Turbo Transfer pack mini format containing 0.2 µm PVDF membrane (Bio- 
Rad). 
Firstly, the bottom of the prepared papers from the pack were placed onto the Trans-Blot 
Turbo system cassette. Then the activated gel was placed onto the PVDF membrane 
followed by replacing papers taken from the top part of the pack.  Any bubbles were 
removed with by rolling. The transfer was run for 3 minutes according to the manufacturer’s 
protocol for TGX gels of the Trans-Blot Turbo system.  
2.12.7 Taking PVDF membrane image for total protein calculation 
The transferred PVDF membrane was quickly placed on the stain free tray and imaged 
using the Gel Doc TM EZ System (Bio-Rad, UK) with Image Lab software. If the PVDF 
membrane became dyed, it was washed with methanol for few seconds before placing in 
the Gel Doc TM EZ System. The total protein in each lane was quantified in Image Lab and 
this value used for normalisation of immunoblots.  
2.12.8 Immunostaining of protein 
After transfer, the PVDF membrane was washed in 20 ml TRIS-Buffered Saline (TBS) (50 
mM Tris PH 7.6, 150 mM Nacl, 2mM KCL) for 5 minutes. The membrane was incubated at 
room temperature in 25 ml of blocking buffer (2.5 ml 10x TBS, 22.5 ml double distilled 
water, 1.25 g non- fat dried milk, 25 µl Tween 20). In order to remove blocking buffer the 
membrane was washed with 15 ml of TBS-T (100 ml 10xTBS, 900 ml double distilled water, 
1 ml Tween 20) for three times for 5 minutes each. The membrane then was incubated with 
primary antibody solution at a concentration as given in Table2.3. It was diluted by TBS-T 
with 5% w/v BSA. This antibody solution and the membrane were put into a heat sealable 
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bag and incubated at 4 °C overnight with gentle rocking. Next day the membrane was 
washed with TBS-T three times for 5 minutes each. Then the membrane was incubated 
with appropriate HRP- linked secondary antibody solution containing blocking buffer (Table 
2.3). The membrane was put inside a heat sealable bag with this solution for 1 hour at room 
temperature with gentle shaking. The membrane was washed x3 with TBS-T for 5 minutes 
each time.  
The Amersham ECL prime Western Blotting Detection Reagent (GE Healthcare, UK) was 
prepared according to the manufacturer’s instructions. The membrane was incubated in the 
reagent for 5 min and the membrane was placed, protein side down, on SARAN wrap. 
Images of the membrane were taken using the imager Image Quant LAS 400 Mini (GE 
Healthcare, UK) with different exposure times.  
 
TABLE 2-3: The concentrations of primary and secondary antibodies used in Western 
Blotting 
 
 Manufacturer Source Dilution  
Primary antibodies     
BRCA1 Cell signalling #9010  Rabbit  1:1000 
Secondary 
antibodies 
   
Anti-Rabbit            
 HRP-linked 
Cell signalling #7074 Goat  1:3000 
Precision Protein  
StrpTactin-HRP 
conjugate 
BioRad 
#1610381 
 1:5000 
    
Β-actin Cell signalling #8457  1:1000 
 
2.12.9 Quantification of protein & statistical treatment of results 
Quantification of protein was performed by measuring relative intensities of appropriate 
bands as imaged by Image Quant LAS 400 Mini (GE Healthcare, UK). The numbers 
obtained for each band were divided by the total protein amounts in the lane as obtained 
from the Gel Doc TM EZ System by Image Lab software. Results were plotted and analysed 
using GraphPad Prism™.  
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Band signals were normalised relative to digitally quantified total protein using the Bio-Rad 
stain-free system according to manufacturer instructions. All results show the average ± SE 
(n = 3) of biological replicates generated from three independent cell cultures and were 
analysed for statistical significance using ANOVA post-hoc Dunnett test B 
 
2.12.10 Molecular sizing of BRCA1 protein (His- tag protein)  
 
 
FIGURE 2.8  WESTERN IMMUNOBLOTTING GEL OF HIS-TAGGED BRCA PROTEIN WITH MW MARKER LADDER 
 
The molecular weight markers were biotinylated unstained precision plus from BioRad. Gel 
shows coincidence of 250KDa standard & the purified his-tagged BRCA1 protein.  
 
2.13 Statistical analyses  
 
Statistical analyses for suspension growth and RTPCR were performed as one way 
ANOVA with post-hoc Dunnett test.  The Dunnett test compares a set of means of 
treatment groups against the mean of a single control group (Upton and Cook, 2008). 
Statistical analysis for western immunoblotting was performed using either one way ANOVA 
with post-hoc Dunnett test or a student t-test, comparing two independent groups. (David 
and Gunnink, 1997) 
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Chapter 3: Results 
3.1 Cyclosiloxanes 
Cyclosiloxanes are widely used as conditioning and spreading agents in personal care 
products which are applied around the region of the human breast. In this study, we used 
MCF10A and MCF10F immortalised non-transformed human breast epithelial cells to 
investigate the ability of the cyclosiloxanes hexamethylcyclotrisiloxane (D3), 
octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (D5) to enable 
growth in suspension culture, to damage DNA, and to interfere with DNA repair systems.  
3.1.1 Effect of cyclosiloxanes D3, D4 & D5 on morphology of MCF10A& MCF10F 
colonies in suspension culture: 
The ability of anchorage-dependent epithelial cells to grow in suspension culture has long 
been acknowledged as the property of cells in vitro to be most closely correlated with 
transformation in vivo (Shin et al, 1975). MCF10A and MCF10F cells are spontaneously 
immortalised normal human breast epithelial cells which are normally dependent on 
anchorage to a substratum for their growth. In their stock medium, they grow in monolayer 
culture but not to any great extent in suspension culture unless 70 nM 17β-oestradiol is 
added (Pugazhendhi and Darbre, 2010). In these experiments, MCF10A cells were grown 
in semi-solid suspension culture with a range of concentrations of 17β- oestradiol, D3, D4 
and D5 for up to 21 days. Photomicrographs of colonies after21 days are shown in Figure 
3.1. In the absence of treatment, only small colonies were found (Figure 3.1A) but larger 
colonies were observed with 70nM 17β-oestradiol (Figure 3.1B) or with 10-5M 
concentrations of D3, D4 or D5 (Figure 3.1C-E).  Similar results were found with MCF10F 
cells (data not shown) 
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       (A) No treatment                                   (B) 17β- oestradiol (E2)     
 
        
                              
(C) D3                                                             (D) (D4)                                                (E) (D5) 
 
 
Figure 3.1 Colonies of MCF10A cells growing in semi-solid methocel suspension 
culture after 21 days exposure to cyclosiloxane D3, D4 and D5 
Cells were grown with:- (A) no treatment  (B), 70 nM 17β- oestradiol (C), 10-5M D3 (D), 10-
5M D4 (E),  10-5MD5.  Phase contrast images.  
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3.1.2  Dose response effects of D3 on the size and number of MCF10A and 
MCF10F colonies in suspension culture 
MCF10A and MCF10F cells were grown with17β-oestradiol or hexamethylcyclotrisiloxane 
(D3) in suspension culture for 7, 14 and 21 days. Colony size (Figure 3.2), colony number 
(Figure 3.3) and total cell number (Figure 3.4) were measured after 7, 14 and 21 days.  
Increased colony size demonstrated the enhanced ability of the cells to grow to a greater 
extent under non- adherent conditions. Increased colony number is an indication of a 
greater number of cells able to form colonies. Total cell count is an independent measure of 
number of cells growing in suspension. Increasing concentrations of D3 (10-14 M to 10-5 M) 
gave bell-shaped plots for all three parameters studied, with maximal colony size and 
colony number as well as total cell count, at 10-10M in each case.  
Colony size: (Figure 3.2). Addition of 70nM 17β-oestradiol increased colony size for 
MCF10A cells after 7 days (p<0.01), 14 days (p<0.05) and but not 21 days (p>0.05) 
(Figure 3.2 A) and for MCF10F cells after 7 days, 14 days and 21 days (p<0.001 in all 
cases) (Figure 3.2 B) For MCF10A cells, colony size was increased from control at D3 
concentrations of 10-13M to 10-5M inclusive. Size was greater compared to colonies in the 
presence of 70nM β-oestradiol for D3 concentrations of 10-11 M to 10-8 M (Figure 3.2A) For 
MCF10F cells, colony size was increased from control at D3 concentrations of 10-13M to 10-
5M inclusive. Size was greater compared to colonies in the presence of 70nM β-oestradiol 
for D3 concentrations of 10-11 M to 10-8 M (Figure 3.2B) 
Colony numbers (Figure 3.3). There is a smaller increase in colony numbers and the 
histograms peak at 14 days, falling back slightly by 21days. High concentrations of D3, 
certainly 10-6M and 10-5M  still show significant enhancement of colony numbers over the 
blank control, but less than the standard (70nM) E2.  At all three time periods, 70 nM 17β-
oestradiol stimulates most closely to 10-12 M D3. 
Cell counts (Figure 3.4). The overall shape of the plots is similar between MCF10A and 
MCF10F cells and, indeed the previous plots in Figures 3.2 and 3.3. Peak cell number is 
the same, at 10-10M.  Rather more cells were retrieved from MCF10A than MCF10F wells. 
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A. MCF10A cells 
 
         Day 7    Day 14    Day 21 
B.    MCF10F cells 
 
                    Day 7    Day 14    Day 21 
FIGURE 3.2 Effect of different concentrations of hexamethylcyclotrisiloxane (D3) on 
the size of colonies of MCF10A (A) and MCF10F (B) cells growing in semi- solid 
methocel suspension culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol or with D3 at 
concentrations from 10-14M to 10-5M. Average colony size was calculated from 15 fields per 
of view in each well measured and results are presented as the overall average of readings 
and standard error of triplicate wells from three replicate experiments. * indicates p˂ 0.05, 
** p˂ 0.01 and *** p ˂0.001 compared to no addition (grey bar, black asterisk) and 
cells with 17β-oestradiol (black bar, red asterisk)  
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A. MCF10A cells 
 
         Day 7   Day 14    Day 21 
B. MCF10F cells 
 
           Day 7             Day 14           Day 21 
Figure 3.3 Effect of different concentrations of hexamethylcyclotrisiloxane (D3) on 
number of colonies of MCF10A (A) and MCF10F (B) cells growing in semi- solid 
methocel suspension culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol,with D3 at 
concentrations from 10-14M to 10-5M. Colony growth is shown as the number of colonies per 
well from 7 days to 21 days, as determined under light microscope. Standard error of 
triplicates wells of replicate dishes.* indicates p˂ 0.05, ** p˂ 0.01 and *** p ˂0.001 
compared to no addition (grey bar, black asterisk) and cells with 17β-oestradiol 
(black bar, red asterisk)  
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A. MCF10A cells                                                 B.  MCF10F cells  
 
 
 
FIGURE 3.4 Effect of different concentrations of hexamethylcycloxane (D3) on the 
growth of MCF10A (A) and MCF10F (B) cells in semi-sold methocell suspension 
culture after 21 days 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol,with D3 at 
concentrations from 10-14M to 10-5M. Cell growth is shown as the number of cells per well 
after 21 days, as counted using a Coulter counter. Error bars are the standard error of 
triplicate wells.  
 
* indicates p˂ 0.05,** p˂ 0.01 and *** p ˂0.001 compared to no addition (grey bar, 
black asterisk) and cells with 17β-oestradiol (black bar, red asterisk) 
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3.1.3 Dose response effects of D4 on the size and number of MCF10A and 
MCF10F colonies in suspension culture 
 
MCF10A and MCF10F cells were grown with 70nM 17β-oestradiol or 
octamethylcyclotetrasiloxane (D4) in suspension culture for 7, 14 and 21 days, colony size 
(Figure 3.5) colony number (Figure 3.6) and total cell number (Figure 3.7) were measured 
after 7, 14 or 21 days.  
Colony size   (Figures 3.5) Increasing concentrations of D4 (10-10 M to 10-5M) gave 
increased colony size and colony number.  This direct correlation had not reached 
saturation at the highest concentration tested (10-5M). 
Colony number (Figure 3.6) Colony counts mirrored the results for colony size.  There was 
a direct association between D4 and colony number which persisted through to the 10-5M 
highest concentration. 
Cell counts (Figure 3.7) Absolute cell numbers followed the same pattern, with a positive 
association between D4 concentration and cell count, continuing through the highest 
concentration. 
Overall, therefore, the growth results for D4, however measured, are distinct from those 
using D3 in that stimulation of colony formation does not peak at 10-10M.  Conversely, 
absolute values for the E2 control are consistent with those obtained in the D3 experiments 
in terms of both size and numbers of colonies. 
In all of the plots there are concentrations at which stimulation is lower or exceeds that 
achieved with 70nM 17β-oestradiol.  At 7 days there is a wide range of non-significant pair 
wise comparisons .Blank values are minimal in all in plots of colony size and cell count.  
Only in colony numbers and for day 7 are p values against the weakest D4 solution in the 
0.001-0.01 range (e.g. p=0.0075 for 10-6M D4 against blank, day 7).  Even that is in a range 
commonly ranked “highly” significant. 
There is very little difference between the results for MCF10A and MCF10F cells which is 
consistent with robust experimentation and the strong common ancestry of the cell lines. 
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A. MCF10A cells 
 
                            Day 7              Day 14    Day 21 
B. MCF10F cells 
 
              Day 7                        Day 14    Day 21 
FIGURE 3.5 Effect of concentrations of octamethylcyclotetrasiloxane (D4) on the size 
of colonies of MCF10A (A) and MCF10F (B) cells growing in methocel suspension 
culture from 7 days to 21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with D4 at 
concentrations from 10-10M to 10-5M. Average colony size was calculated from 15 fields per 
well of view and results are presented as the overall average of readings and standard error 
of triplicate wells from three replicate experiments. * indicates p˂ 0.05, ** p˂ 0.01 and *** 
p ˂0.001 compared to no addition (grey bar, black asterisk) and cells with 17β-
oestradiol (black bar, red asterisk)  
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MCF10A cells 
 
 Day 7    Day 14    Day 21 
A. MCF10F cells 
 
                Day 7              Day 14    Day 21 
FIGURE 3.6  Effect of concentrations of octamethylcyclotetrasiloxane (D4) on number 
of colonies of MCF10A (A) and MCF10F (B) cells growing in methocel suspension 
culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with D4 at 
concentrations from 10-10M to 10-5M. Colony growth is shown as the number of colonies per 
well from 7 days to 21 days, under light microscope. Error bars are standard error of 
triplicate wells for each experiment.  ** indicates p˂ 0.01 and *** p ˂0.001 compared to 
no addition (grey bar, black asterisk) and cells with 17β-oestradiol (black bar, red 
asterisk). 
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A. MCF10A cells                                                         B. MCF10F cells  
 
 
 
FIGURE 3.7 Effect of concentrations of octamethylcyclotetrasiloxane (D4) on growth of 
MCF10A (A) and MCF10F (B) cells in semi- solid methocel suspension culture after 
21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with D4 at 
concentrations from 10-10M to 10-5M.Cell growth is shown as the number of cells per well 
after 21 days, as counted using a Coulter counter. Error bars are the standard error of 
triplicate wells.  
* indicates p˂ 0.05, and *** p ˂0.001 compared to no addition (grey bar, black 
asterisk) and cells with 17β-oestradiol (black bar, red asterisk) 
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3.1.4 Dose response effects of D5 on the size and number of MCF10A and 
MCF10F colonies in suspension culture 
MCF10A and MCF10F cells were grown with 17β- oestradiol or 
decamethylcyclopentasiloxane (D5) in suspension culture for 7, 14 and 21 days, Colony 
size (Figure 3.8), colony number(Figure 3.9) and total cell number (Figure 3.10) were 
measured after 7, 14 or 21 days.  
Colony size (Figure 3.8) Increasing concentrations of D5 (from 10-10 M to 10-5) gave 
increased colony size and colony number.  No saturation of this effect was observed 
continued to rise   between 10-6M and 10-5M. As with D4, while significant stimulation of 
colony growth (however measured) is seen relative to blank controls for all concentrations, 
the lower (10-10 & 10-9M) concentrations of D4 fail to stimulate to the level of 70nM 17β-
oestradiol with statistical significance.  The crossover into significantly enhanced colony 
stimulation over 70nM 17β-oestradiol happens around 10-8M except for the 7 and 14 day 
cultures of MCF10F cells, where it occurs at 10-7M. In absolute values, the colony size for 
MCF-10A and MCF10F are comparable. Unlike D3 and D4, 10-10M D5 is ineffective in 
stimulating colony formation even at day 21.  Otherwise D5 results are consistent with 
those obtained with D4.  MCF10A and MCF10F also give mutually consistent results,  
Colony numbers (Figure 3.9) Results for colony counts follow closely those for colony size.  
Increasing concentrations of D5 (from 10-10 M to 10-5) gave increased colony size and 
colony number. No saturation of this effect was observed; numbers were continuing to rise   
through 10-5M 
Cell numbers (Figure 3.10) the total cell counts of MCF10A cells tend to plateau between 
10-7M and 10-8M, while MCF10F cell counts rise up to 10-5M. Plotted as a line graph and 
subjected to curve-fitting, the coefficient of determination (r2) value against an exponential 
fit is 0.948. 
 
 
 
 
 
 
 
 
 
 
 58 
 
A. MCF10A cells 
 
                       Day 7    Day 14    Day 21 
B. MCF10F cells 
 
 Day 7    Day 14    Day 21 
FIGURE 3.8 Effect of concentrations of decamethylcyclopentasiloxane (D5) on size of 
colonies of MCF10A (A) and MCF10F (B) cells growing in methocel suspension 
culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70nM 17β-oestradiol, with D5 at 
concentrations from 10-10M to 10-5M. Average colony size was calculated from 15 fields per 
well of view and results are presented as the overall average of readings and standard error 
of triplicate wells from three replicate experiments.* indicates p˂ 0.05, ** p˂ 0.01 and *** p 
˂0.001 compared to no addition (grey bar, black asterisk) and cells with 17β-
oestradiol (black bar, red asterisk.) 
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A. MCF10A cells 
 
              Day 7           Day 14                         Day 21 
B. MCF10F cells 
 
              Day 7    Day 14    Day 21 
FIGURE 3.9  Effect of concentrations of decamethylcyclopentasiloxane (D5) on 
number of colonies of MCF10A (A) and MCF10F (B) cells growing in methocel 
suspension culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with D5 at 
concentrations from 10-10M to 10-5M. Colony growth is shown as the number of colonies per 
well from 7 days to 21 days, under light microscope. Error bars are standard error of 
triplicate wells for each experiment.  * indicates p˂ 0.05, ** p˂ 0.01 and *** p 
˂0.001compared to no addition (grey bar, black asterisk) and cells with 17β-
oestradiol (black bar, red asterisk). 
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A. MCF10A cells                                                                      B.  MCF10F cells 
 
FIGURE 3.10 Effect of different concentrations of decamethylcyclopentasiloxane (D5) 
on growth of MCF10A (A) and MCF10F (B) cells in semi- solid methocel suspension 
culture after 21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with D5 at 
concentrations from 10-10M to 10-5M.  Cell growth is shown as the number of cells per well 
after 21 days, as counted using a Coulter counter. Error bars are the standard error of 
triplicate wells.  
** p˂ 0.01 and *** p ˂0.001compared to no addition (grey bar, black asterisk) and cells 
with 17β-oestradiol (black bar, red asterisk) 
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3.1.5  Comet assay of DNA damage after exposure to Cyclosiloxanes (D3, D4 
and D5) 
An alkaline single-cell gel electrophoresis (SCGE) technique was employed to detect single 
strand and labile DNA adducts in the immortalised human breast epithelial cell lines 
MCF10A and MCF10F following exposure to D3, D4, D5 for periods of between 1 hour and 
24 hours. Cells were lysed and embedded into agarose on microscope slides. Following 
electrophoresis and staining the DNA was visualised either as high molecular weight DNA 
contained within the area of the cell or with low molecular DNA bands which appear as a 
comet tail from the cell. Comets were analysed as average length of comet tail or as % of 
cells showing any comet tail.  
 
MCF10A and MCF10F cells were exposed to 10-5M concentrations of diethylstilboestrol or 
cyclosiloxanes for 1 hour or 24 hours and representative photographs are shown for 
MCF10A cells in Figure 3.11.Cells in the photomicrograph in Figure 3.11 Panel C (D3) 
show strong classical comet formation after 1 hour of exposure to 10-5M D3.  Some 
indications of comet formation are seen in Figure 3.11 panels B and D.   
 
The bar charts show the effect on DNA tail length and % of cells with comets following 
exposure of MCF10A cells and MCF10F cells to D3 (Figure 3.12), D4 (Figure 3.13) and D5 
(Figure 3.14).  
For MCF10A cells, there was no detected response at dilutions to 1011M  but the tail length 
rose dramatically at 10-10M and fell thereafter at higher concentrations of D3 (Figure 3.12). 
The exception being DES, which yielded large numbers of poorly developed comets in both 
cell lines.  The single concentration comets were measured in MCF10F cells at 10-5M 
concentrations (Figure 3.12 C ,D) series of assays using MCF10F cells  show increased 
tail length and numbers (%) over the blank control, but as noted above, DES stimulated 
large numbers of weak comets.  The numbers in the treated MCF10F cultures are 
comparable to those for MCF10A cells at the same concentration. However, this was at 10-
5M which was at the end of a sharp decline from its peak at 10-10M in MCF10A.Tail length 
was also poor with MCF10F, peaking at 80 microns compared to 300 microns for MCF10A 
cells. 
Numerical comet parameters for octamethylcyclotetrasiloxane (D4) are shown in (Figure 
3.13) and decamethylcyclopentasiloxane (D5) (Figure 3.14) after 1 and 24 hours exposure 
for MCF10A 10-5 and 10-6M concentration) and 10-5M only for MCF10F.  
The bar charts show comet tail length to correlate with percent of cells with damaged DNA, 
the exception being DES, which yields large numbers of poorly developed comet cells.  The 
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range of actual numbers of comets, as assessed by the maximum y-axis values were 
similar to those obtained with D3. 
A difference in response to D4 (Figure 3.13) and D5 (Figure 3.14) was that D4 gave large 
numbers of well-formed comets at 1hr but not at 24 hours. The opposite was true for D5, 
where length was not overall different to control levels, although the maximum number of 
comets formed was less than half of that in response to D4. 
 
                         
A: Untreated MCF10A cells       B: Diethylstilboestrol (DES)            C: (D3) 
    
D:  (D4)                                                E: (D5 after 24 hrs)                 
FIGURE 3.11 Comet assay for detection of DNA damage in MCF10A cells after 
exposure to cyclosiloxanes (D3, D4 and D5). 
 
Panel A is of untreated cells (control). B) Cells treated with 10-5 M Diethylstilboestrol (DES) 
for one hour, (positive control). C) Cells treated with 10-5D3 for one hour. D3) Cells treated 
with 10-5M D4for one hour. E) Cells treated with 10-5M D5 for 24 hours. Cells viewed by 
fluorescence microscopy. 
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MCF10A cells 
 
MCF10F cells  
 
FIGURE 3.12 Effect of hexamethylcyclotrisiloxane (D3)) on DNA damage in MCF10A 
(A, B) and MCF10F (C, D) human breast epithelial cells as assessed by a comet assay 
measuring DNA tail length (A,C) or % of cells with comets (B,D). 
 
Cells were grown in stock medium and treated for 1 hour as untreated cells (control) and 
DES treated cells.  Treatment was with 10-5 M DES (positive control) and 10-5M D3. Error 
bars represent standard deviation of 50 comets scored.  
 64 
 
A. MCF10A cells  
    
B. MCF10F cells  
 
 
FIGURE 3.13 Effect of octamethylcyclotetrasiloxane (D4) on DNA damage in MCF10A 
(A) and MCF10F (B) human breast epithelial cells as assessed by a comet assay 
measuring DNA tail length (A, C) or % of cells with comets (B, D) 
Cells were grown in stock medium and treated 1 hour with untreated cells (control).  
Treated cells with 10-5 M diethylstilboestrol (DES), (positive control) for one hr .Treated cells 
with 10-5M D4 for one hr. Error bars represent standard deviation of 50 comets scored.  
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A. MCF10A cells  
         
 
B. MCF10F cells  
 
FIGURE 3.14  Effect of decamethylcyclopentasiloxane (D5) on DNA damage in MCF10A 
and MCF10F human breast epithelial cells as assessed by a comet assay measuring 
DNA tail length (A, C) or % of cells with comets (B, D) 
 
Cells were grown in stock medium and treated 1 hour with untreated cells (control).  
Treated cells decamethylcyclopentasiloxane (D5) for 24 hrs. Treated cells 10-6M 
decamethylcyclopentasiloxane (D5) for 24 hrs. Treated cells 10-7M 
decamethylcyclopentasiloxane (D5) for 24 hrs. Error bars represent standard deviation of 
50 comets scored.   
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3.1.6  Cyclosiloxanes:  Effect on mRNA expression of DNA repair genes:  
The ability of cyclosiloxanes hexamethylcyclotrisiloxane (D3), octamethylcyclotetrasiloxane 
(D4) and decamethylcyclopentasiloxane (D5) to enable growth of non-transformed MCF10A 
and MCF10F cells in suspension culture and to bring about damage to DNA in a Comet 
assay suggests that they may have genotoxic properties. However, a further important 
question is whether they might also impair DNA damage detection and DNA repair 
pathways. In an initial investigation, levels of mRNA for BRCA1, BRCA2, ATM, ATR, 
BRIP1, CHK1, CHK2, p53,PALB2, PARP1, PTEN ,Rad50,Rad51 and STK111  have been 
investigated in the MCF10A and MCF10F  cells after short term (1 week) and longer term 
(30weeks) exposure to these cosmetic chemicals. 
Levels of BRCA1 mRNA after exposure to D3, D4 and D5 
Short (1 week) and long term (30 weeks) effects of exposing  MCF10A cells (Figure 3.15) 
and MCF10F cells (Figure 3.16)  to hexamethylcyclotrisiloxane (D3), 
octamethylcyclotetrasiloxane (D4), and decamethylcyclopentasiloxane( D5), in terms of 
levels of mRNA for BRCA1, was investigated using RT-PCR.  Significant (p<0.001) 
elevation of BRCA1 mRNA was found after short term exposure to 10-5 M concentrations of 
D3 and D4 exposure in MCF10A cells (Figure 3.15A). However, after long term exposure 
to 10-5M concentrations of chemicals D3, D4 and D5 there was significant reduction of 
BRCA1 mRNA in MCF10A cells for these chemicals (p<0.001 for D3, <0.01 for D4 and D5).  
Short term (1 week) exposure to 10-5M D3, D4 or D5 did not increase BRCA1 mRNA levels 
in MCF10F cells (Figure 3.16).  However, it must be acknowledged that error bars were 
large in these experiments.  Long term exposure of 30 weeks showed a significant 
reduction in expression of BRCA1 mRNA in MCF10F cells with D4 and D5 (p <0.01) but not 
with D3 (p <0.01). 
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MCF10A cells 
 
FIGURE 3.15 Real -time RT- PCR analysis of BRCA1 mRNA in MCF10A cells following 
short term (A) or long term (B) exposure to cyclosiloxanes D3, D4 and D5. 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2), or in the presence of 10-5M 
hexamethylcyclotrisiloxane (D3), 10-5M octamethylcyclotetrasiloxane (D4) or 10-5M 
decamethylcyclopentasiloxane (D5). The relative expression of BRCA1 mRNA was 
normalised to that of the endogenous control β-actin mRNA, and average values calculated 
for triplicate technical replicates. Results are shown ± standard error for biological triplicate 
values. * indicates p˂ 0.05, ** p˂ 0.01 and *** p ˂0.001 compared to control by one way 
ANOVA with post-hoc Dunnett test.  
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MCF10F cells 
 
FIGURE 3.16 Real -time RT- PCR analysis of BRCA1 mRNA in MCF10F cells following 
short term (A) or long term (B) exposure to cyclosiloxanes (D3, D4 and D5). 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-5M 
hexamethylcyclotrisiloxane (D3), 10-5M octamethylcyclotetrasiloxane (D4) or 10-5M 
decamethylcyclopentasiloxane (D5). The relative expression of BRCA1 mRNA was 
normalised to that of the endogenous control β-actin mRNA, and average values calculated 
for triplicate technical replicates. Results are shown ± standard error for biological triplicate 
values. ** indicates p˂ 0.01 compared to control by one way ANOVA with post-hoc 
Dunnett test.  
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Levels of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, 
Rad51 and STK111  mRNA after exposure to cyclosiloxanes D3, D4 and D5 
The effect of D3 in MCF10A cells on short (1 week) exposure of MCF10A cells (Figure 
3.17A) to hexamethylcyclotrisiloxane (D3) was no significant change in the measured 
mRNA levels.  Long term exposure of MCF10A cells yielded mixed responses. BRCA2, 
BRIP1, PALB2 and PARP1 mRNAs were reduced after 30 weeks exposure to 10-5M D3 (all 
p<0.05), mRNA levels for RAD51 were significantly increased (Figure 3.17B). Results for 
effects of D3 in MCF10F cells with short-term exposure gave lowered mRNA levels for 
CHK2 and raised mRNA levels for RAD50 (Figure 3.18A).  On long-term exposure mRNA 
for PALB2 was reduced (p<0.05), CHK1, CHK2, PTEN and STK111 were all lowered with a 
two-star (p<0.01) level of significance (Figure 3.18B). 
High mean values in these plots are associated with large variances and do not reach 
statistical significance. The effects on mRNA levels of Short (1 week) and long term (30 
weeks) exposure of  MCF10A and MCF10F cells to octamethylcycloterasilxane (D4) are 
shown in Figures 3.19 and 3.20 respectively.  In MCF10A cells, For ATM, ATR, BRCA2, 
BRIP1, PALB2 and PARP1 there were significant reductions in mRNA after on long term 
exposure to 10-5M D4.  No significant effects were seen after one week of incubation.  
MCF10F cells did yield significant results after one week incubation with D4. There was a 
significant reduction in expression of BRCA2 and CHK2 mRNA. Long term exposure to D4 
produced more extensive change in gene expression.  Thirty weeks of incubation with D4 
showed a significant reduction in expression of BRIP1, CHK1, CHK2, PARP1, PTEN and 
Rad51 mRNA in MCF10F cells. All changes except BRCA2 (p<0.05) were highly significant 
(p<0.01).  Physical DNA damage (comet assay) wascnot measured after these long 
exposure periods. 
Effects on mRNA levels after short (1 week) and long term (30 weeks) exposure of 
MCF10A and MCF10F cells to decamethylcyclopentasiloane (D5) are shown in Figures 
3.21 and 3.22 respectively.  In the short-term experiments a significant elevation in 
expression of CHK1 mRNA was seen in MCF10A cells. The long-term effect of exposure to 
D5 showed a significant elevation of Rad51 mRNA and a significant reduction in expression 
of ATM, ATR, BRCA2, CHK1, CHK2, PALB2, and PARP1 mRNA.  In MCF10F cells the 
effect of 1-week exposure to decamethylcyclopentasiloane (D5) was a significant reduction 
in expression of CHK2 mRNA.  The long-term effect of exposure showed a significant 
reduction in expression of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, 
PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells, with BRCA2, PALB2 and 
PARP1 achieving a significance level p<0.001, the highest of any treatment in this group of 
experiments. Table 3.1  shows the differences in response between MCF10A and MCF10F 
cells 
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MCF10A cellsD3 
 
 
FIGURE 3.17  Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells 
following short term (A) or long term (B) exposure to hexamethylcyclotrisiloxane 
(D3). 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M hexamethylcyclotrisiloxane (D3).The relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05 compared to control by one way 
ANOVA with post-hoc Dunnett test.  
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MCF10F cellsD3 
 
 
 
FIGURE 3.18 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells 
following short term (A) or long term (B) exposure to hexamethylcyclotrisiloxane (D3) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M hexamethylcyclotrisiloxane (D3), the relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05, **p˂ 0.01 compared to control by 
one way ANOVA with post-hoc Dunnett test. 
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MCF10A cellsD4 
 
FIGURE 3.19 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells 
following short term (A) or long term (B) exposure to octamethylcycloterasilxane (D4) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M octamethylcycloterasilxane (D4), The relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05, ** p˂ 0.01 compared to control 
by one way ANOVA with post-hoc Dunnett test.  
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MCF10F cellsD4 
 
FIGURE 3.20 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells 
following short term (A) or long term (B) exposure to octamethylcycloterasilxane (D4) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M octamethylcycloterasilxane (D4), The relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05, ** p˂ 0.01 compared to control 
by one way ANOVA with post-hoc Dunnett test.  
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MCF10A cellsD5 
 
FIGURE 3.21 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells 
following short term (A) or long term (B) exposure to decamethylcyclopentasiloane 
(D5) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M decamethylcyclopentasiloane (D5). The relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared 
to control by one way ANOVA with post-hoc Dunnett test. 
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MCF10F cellsD5 
 
FIGURE 3.22 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells 
following short term (A) or long term (B) exposure to decamethylcyclopentasiloane 
(D5) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M decamethylcyclopentasiloane (D5). The relative expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. * indicates p˂ 0.05, ** p˂ 0.01, ***p˂ 0.001compared 
to control by one way ANOVA with post-hoc Dunnett test. 
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3.1.7  Level of BRCA1 protein after exposure to D3, D4 and D5 
The effect of long term exposure to cyclosiloxanes on expression of BRCA1 protein was 
investigated in MCF10A and MCF10F cells using Western Immunoblotting. By comparison 
with molecular weight markers, a band at 220KDa was identified as BRCA1 protein. For 
MCF10A cells, a representative immunoblot is shown in Figure 3.23A.  Figure 3.23B 
shows calculated values from three biological replicates taken from independent cell 
cultures. BRCA1 protein levels were reduced after long-term exposure to 10-8M 17β-
oestradiol, or to 10-5M concentrations of D4 or D5 (Figure 3.23B). 
For MCF10F cells a representative immunoblot is shown in Figure 3.24 A.   Figure 3.24B 
shows calculated values from three biological replicates taken from independent cell 
cultures. BRCA1 protein levels were significantly reduced after long-term exposure to   10-
5M concentrations of D3, D4 or D5 (p<0.5, <0.5 and <0.001) respectively (Figure 3.24B) 
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FIGURE 3.23 Level of BRCA1 protein after long term exposure to cyclosiloxane (D3, D4 
and D5) in MCF10A cells using western Immunoblotting. A - Photograph of excised 
bands, B - quantitative plot.  
 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10A human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M hexamethylcyclotrisiloxane (D3), 
10-5M octamethylcyclotetrasiloxane (D4), 10-5M decamethylcyclopentasiloxane (D5) 
compared to 10-8M oestradiol (E2). * indicates p˂ 0.05, ** p˂ 0.01 and compared to 
control by one way ANOVA with post-hoc Dunnett test. ‡ indicated p˂ 0.05 compared 
to control by t-test. 
 
A
A 
B 
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FIGURE 3.24  Level of BRCA1 protein after long term exposure to cyclosiloxanes (D3, 
D4 and D5) in MCF10F cells using western Immunoblotting. Upper - photograph of 
excised bands, lower, quantitative plot. 
 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10F human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M hexamethylcyclotrisiloxane (D3), 
10-5M octamethylcyclotetrasiloxane (D4), 10-5M decamethylcyclopentasiloxane (D5) 
compared to 10-8M oestradiol (E2). * indicates p˂ 0.05, *** p˂ 0.001 and compared to 
control by one way ANOVA with post-hoc Dunnett test.‡ indicated p˂ 0.05 compared 
to control by t-test.  N.B. Western blot data showed that the his-tagged BRCA1 band 
had a higher molecular weight in comparison to BRCA1 bands of breast cell lysates, 
which is likely due to extra molecular weight of his-tag molecules that altered the 
protein mobility on the gel. His-tag modification increases effective size by 30 KDa. 
(Zhao et al., 2010) 
A
A 
B 
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3.1.8. Summary of Results  
The results are encapsulated in Table 3-1 below.  Both MCF10A cells and MCF10F cells 
perform comparably in the anchorage independent growth assay.  Moreover the various 
ways of quantifying the results show the same effects, be it by colony number, colony size 
or total cell number in the colonies.  D3 yields a dose response peaking at 10-10M, D4 and 
D5 show a continued rise in colony formation parameters with concentration of agent up the 
maximal amount tested.  Comet assays give a positive indication of DNA damage.  
Reductions in DNA repair capability as measured by either mRNA or protein expression 
were seen after prolonged exposure to agents. 
 
TABLE 3-1 Summary of cyclosiloxane results  
 
ASSAY MCF10A MCF10F 
Colony growth in methocel: 
number or size of colonies 
D3 Bell shaped response 
curve 
D4, D5 exponential positive 
correlation with 
concentration 
D3 Bell shaped response 
curve 
D4, D5 exponential positive 
correlation with 
concentration  
Colony growth in methocel: 
total cell count 
Mirrors colony growth Mirrors colony growth 
Comet assay D3, D4 strongest response 
at 1 hour incubation. 
 D5 strongest response after 
24 hour incubation 
Similar to MCF10A, except 
responses not as strong and 
the single dose chosen was 
not the strongest modifier 
with MCF10A  
BRCA1 mRNA & protein 70 nM E2 caused significant 
reduction over 30 weeks.  
D3 did  not reduce m-RNA 
or protein (large 70 nM E2)  
D5 reduced values more 
than D4 
Reduction in m-RNA and 
protein after 30 weeks 
showed reductions 
D5>D4>D3.  DES caused 
no reduction. 
Other DNA repair mRNAs Most m-RNAs suppressed 
by 30 weeks exposure to 
D5, exceptions being  P53, 
RAD50, RAD51, STK111  
Patchy reductions achieved 
by D3 & D4   
All m-RNAs reduced after 
30 weeks exposure to D5.  
Patchy reductions achieved 
bt D3 & D4 
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3.1.9  Discussion of results of exposure of MCF10 cells to Cyclosiloxanes 
D3, D4 &D5 in vitro. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
The results demonstrate that exposure of non-transformed human breast epithelial cells to 
cyclosiloxanes can enable anchorage-independent growth in methocel culture, can cause 
DNA damage as measured by comet assays and can reduce levels of mRNAs encoding 
DNA repair proteins. Most notably, levels of both BRCA1 mRNA and BRCA1 protein were 
reduced after long-term exposure to the cyclosiloxanes. Differences were noted in the 
dose-responses of the three cyclosiloxanes and effects in the short-term (1 week) were not 
equivalent to those after longer exposure times (30 weeks). An overall summary of the 
results is given in Table 3-1 
3.1.9.1 Anchorage-independent colony formation  
Exposure to cyclosiloxanes D3, D4 and D5 all caused anchorage-independent colony 
formation and did so in both the immortalised non-transformed human breast epithelial cell 
lines MCF10A and MCF10F. Colonies of MCF10A and MCF10F cells were observed after 
7 days which increased in size and number up to 14 days and then 21 days. Cyclosiloxane 
D3 gave colonies at and above concentrations of 10-13M with maximal size and number 
observed at 10-10M for both cell lines. Cyclosiloxane D4 gave colonies at and above 10-9M 
with maximal size and number at 10-5M for both cell lines. Cyclosiloxane D5 gave colonies 
at and above concentrations of10-7M after 7 days and some increases at 10-8M visible after 
14-21 days, with maximal size and number at 10-5M for both cell lines.   In a publication 
from the same laboratory where this work was performed, comparable results have been 
obtained using parabens (esters of para-hydroxybenzoic acid with antimicrobial/antifungal 
properties and used as preservatives in products for domestic use) on the MCF10A cell 
line (Khanna and Darbre, 2013).  The ability of anchorage-dependent cells to grow under 
anchorage-independent conditions has been shown to be a property closely related to 
transformation (Soule et al,1990) thus by inducing colony growth in methocel, 
cyclosiloxanes as well as parabens have the ability to induce a transformed phenotype  
In the present study the results for anchorage-independent colony growth show D3 to be 
distinct from D4 and D5 in that D3 gives peak activity at 10-10M in a bell-shaped curve, 
whereas D4 and D5 both yield a strong positive association between effect and 
concentration, not peaking or plateauing out at 10-5M, the highest concentration used.  
Interestingly, in the 2010 European Scientific Committee on Consumer Safety 
(SCCS/1450/2016) report D3 is also considered as having separate effects from D4 and 
D5, although no reason is given.   Whatever the differences in the detail of dose 
responsiveness it is clear that all of the cyclosiloxanes tested can increase the size and 
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number of colonies, an effect that is widely regarded as indicative of transformation 
towards neoplasticity, as discussed in the introduction to this thesis. 
3.1.9.2 DNA damage as measured by a comet assay    
Exposure to cyclosiloxane D3 caused DNA damage in MCF10A cells measurable on a 
comet assay after 1 hour of exposure to concentrations at and above 10-10M. A single 
concentration experiment using MCF10F cells showed DNA damage was visible after 1 
hour of exposure to 10-5M D3. DNA damage was visible in both cell lines after exposure to 
10-5M D4 for 1 hour. For cyclosiloxane D5, DNA damage was only visible after 24 hours 
exposure to 10-5M concentrations. 
The comet assay results in the present study were not visually strong and the lengths of 
tail quantified were inversely related to the percentage of cells affected.  The agents 
showed increasing efficacy with time between 1 and 24 hours exposure, which is 
consistent with susceptibility being maximal when DNA strands are exposed and given 
typical cycling times of cells in culture (NCBI bookshelf: 
https://www.ncbi.nlm.nih.gov/books/NBK9876) 
 
The validity of the comet assay for the compounds tested was tested in an overview of 
over 95 compounds in which 88% of known carcinogens were comet positive.  Specificity 
(non-carcinogens yielding comets) was 64% (Anderson et al 1998).  The assay was also 
successfully employed in an investigation of dietary protection from reactive oxygen 
species damage (Erkekoglu 2014). The protocol was also validated by Darbre in studies 
on cyclosiloxanes (Farasani and  Darbre 2016 & section 2.10 above).  The continuity with 
previous studies in the Reading laboratories is the reason for using the non-steroidal, 
synthetic product DES (Elks, 2014) as control in these experiments, as opposed to the 
physiological E2 used elsewhere in these studies.  DES has a chequered history, having 
been proposed and used in the mid-20th century as a preventive agent against pregnancy 
problems, but subsequently having its licences withdrawn due to associations with cancer 
in treated patients (Apfel, 1984). However, it is a potent synthetic oestrogen which has 
been shown previously to cause comets in the comet assay (Anderson et al. 1998). 
The overall implication of this study is that effects on DNA damage were observed on 
human breast cells not seen previously in the Ames test (Ames et al,1973). The Ames test 
uses genetically manipulated bacteria that are sensitive to nutrient substrate changes so 
that genotypic changes cause failure to thrive (Ames et al 1973, Mortemans and Zeiger 
2000). Phenotypic, DNA clastogenic and molecular expression changes consistent with a 
tumour promoting effect are seen with these compounds when applied to near-normal 
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mammary epithelial cell lines, suggesting a role for them in mammary cancer initiation.  
The use of eukaryotic and tissue specific cells from the organ of interest in this study may 
account for the positive results obtained here rather than the negative outcome of the tests 
based on bacteria.  
 
3.1.9.3  BRCA1 mRNA and protein 
Loss of heterozygosity in the recessive (‘tumour suppressor’) BRCA genes lead to 
defective double strand DNA break repair, which in turn constitutes a well-established risk 
factor for inherited susceptibility to breast carcinogenesis (Roy et al., 2012) In this project, 
using MCF10A cells, exposure for 1 week to 10-5M of cyclosiloxanes D3, D4 or D5 caused 
increased levels of BRCA1 mRNA but decreased levels of BRCA1 mRNA after longer-
term exposure - for 30 weeks. In MCF10F cells, there were no significant increases in 
BRCA1mRNA after 1 week or 30 weeks exposure to any of the cyclosiloxanes, but D5 
caused an immediate decrease, already apparent after 1 week and decreases were 
observed after exposure to D4 or D5 after 30 weeks. This was one of the few instances of 
marked differential responsiveness between the two cell lines, and there are known 
differences in properties of their lines such as proliferation rate and adhesion (Russo et al, 
2006). Western Immunoblotting confirmed that there was a loss of BRCA1 protein after 
long-term (30 weeks) exposure to 10-5M concentrations of D4 or D5 in both cell lines.  
Inherited loss of BRCA1 is associated with increased breast cancer risk (Roy et al 2012) 
but these results suggest that BRCA1 function can also be lost by exposure to 
cyclosiloxanes. The different results observed after 1week and 30 weeks are very 
important in interpreting these results into the environmental situation where the human 
breast would be exposed also in the long term and not just for a few days. 
 
3.1.9.4 DNA repair related mRNAs 
DNA double strand break repair processes are associated with increased risk of breast 
cancer when lost (Kitagishi et al., 2013).  Of the panel of 14 DNA repair related mRNAs, 
MCF10A cells showed no changes in expression after one week exposure to D5 except 
for a rise in CHK1, but universally depressed expression at 30 weeks.  MCF10A cells 
also were unaffected at one week; reduced expression at 30 weeks was seen with all 
genes except P53, PTEN, RAD51, RAD52 and STK111. D4 exposure for 1 week caused 
reductions in BRCA2 and CHK2; long term exposure caused reductions in all mRNAs 
except ATM, ATR and STK111.  D4 exposure yielded no changes at one week in 
MCF10A cells and reductions only in ATM, ATR, BRCA2, BRIP2, PALB2 and PARP 
after 30 weeks. D3 reduced mRNA levels for CHK2 after one week, CHK1, CHK2, 
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PALB2, PTEN and STK111 at 30 weeks in MCF10F cells; no changes at one week and 
reductions in BRCA2, BRIP1 PALB2, PTEN and RAD51 in MCF10A cells. Overall, D5 
caused disruption of expression in more repair genes than D4 or D3. In these 
experiments the differences in short and long term changes in repair gene expression 
between the two cell lines largely reproduce those described above for the BRCA1 gene. 
The results are therefore indicative of a more generalised loss of DNA repair in the cells 
beyond BRCA genes following exposure to the cyclosiloxanes. 
 
3.1.9.5  Cyclosiloxanes give effects at concentrations measurable in human tissues.  
In discussing the above results, it is of note that there are relatively few publications giving 
plasma concentrations of cyclosiloxanes.  Hanssen (Hanssen et al., 2013) quotes 
maximum values of 12.7ng/ml (median is 40nM (4x10-8M) for D4 in a 2013 publication 
measuring levels in human plasma in Norwegian women.  Values for other cyclosiloxanes 
listed fall into the same range.  In a study from Germany ((Fromme et al., 2015) 
concentrations are mostly given as ng/g l.w. (lipid weight), however a value of 8µg/l is given 
for plasma D6; representing 21.6nM (2.16x10-8M).  These values are towards the middle of 
the range of molar concentrations tested in this study supporting the physiological 
relevance of the work.  The relevance of plasma concentrations is not necessarily 
representative of levels experienced by cells in intact epithelia, still less breast cancer foci, 
which are often encased in a very hard and dense matrix.  The density of matrix in normal, 
pre-cancerous breasts is a risk factor for subsequent tumour development (Pettersson et 
al., 2014). Therefore, these results necessitate that future work includes measurements of 
the cyclosiloxanes in human breast tissue itself. 
 
3.1.9.6 Socio-political & regulatory considerations relating to commercial 
cyclosiloxane use 
 
Cyclosiloxanes are used as solvents in conditioning/spreading agents in a wide range of 
personal care products (Johnson et al., 2011; Dudzina et al., 2014). 
Octamethylcyclotetrasiloxane (D4) and decamethylcyclopentasiloxane (D5) are combined 
and termed cyclomethicone which may also include, as an impurity, 
hexamethylcyclotrisiloxane (D3) (Johnson et al.,2011). Due to their extensive use in 
consumer products, these substances are ubiquitous in the environment (Genualdi et al., 
2011; Wang et al., 2013), to the extent that D4 and D5 are defined as very persistent very 
bioaccumulative substances of environmental concern (Brooke et al., 2009) triggering a 
proposal for their restriction in Europe (ECHA, 2016). The results presented in this thesis 
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suggest that future regulation should consider not only the environmental impact of these 
compounds but also their effects on human breast cells and the potential for them to enable 
breast cancer development if sufficient concentrations are demonstrated to be entering 
breast tissues. 
Cyclosiloxanes are the objects of periodic regulatory scrutiny as they are incorporated into 
a number of cosmetic formulations in quite high concentrations.  Sixty-two percent appears 
to be taken by the authorities as a standard degree of incorporation.  Of that, absorption 
through skin is reported by the SCCS (Scss/1450/2016) as 0.94%, with the possibility of 
release back to the exterior through 2-way solvent traffic.  The most recent SCCS report 
suggests Low Observed Adverse Effects Levels of around 100mg/kg, measuring changes 
in vital organ weight. (Scss/1450/2016). There is therefore the potential for high exposure in 
the human population and these results showing adverse effects on breast cells should be 
taken into consideration in future risk assessment. 
Previous work has not reported any ability of the cyclosiloxanes to damage DNA but most 
previous work has been based on the Ames test using bacteria and not human breast cells 
as used in this study. The paragraph on mutagenicity of D5 in the 2010 European Union 
Opinion (SCCS_1241/10) - 
(ec.europa.eu/health/scientific_committees/consumer.../sccs_o_029.pdf) reads as follows 
under the heading Mutagenicity:-“The negative results obtained in bacteria (reverse 
mutation assay) or in mammalian cells, i.e. in vitro chromosomal aberration and SCE [Sister 
Chromatid Exchange] test, along with an in vivo micronucleus assay and dominant lethal 
test, indicate that D5 does not possess mutagenic or genotoxic potential.” 
The results presented in this thesis are not in complete agreement with this conclusion, a 
possible reason for the discrepancy being the very different time-frames involved using 
bacteria which divide very much more quickly than eukaryotic cells (doubling time in 
minutes compared with between 1 and 2 divisions per day respectively).  This difference is 
also relevant to results using the Ames test, discussed below.  In real life situations the 
exposure to these compounds is characteristically chronic and at low concentration levels. 
In this study, the D3 and D4 comet assay results proved positive. 
PubMed™ searches using the terms cancer and cyclosiloxane together or any of the full or 
abbreviated names of D3 – D5 yield no results.  Cyclosiloxane on its own yields 14.  Eight 
are to do with physical chemistry and/or nanostructures, six have clinical implications (one 
of these is written in Japanese, concerning cycloxilanes in food & baby products, such as 
teats and will not be further discussed). Three are technically driven publications 
concerning breast implant materials ((Ali et al., 1998)) characterising cyclosiloxanes using 
infra-red and Raman spectroscopy purely to acquire data on implant material as a “starting 
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point for …surveillance studies”. Shimono et al (Inoue et al., 1997, Shimono et al., 1997) 
described the use of these compounds for coating membranes in arterial bypass 
equipment, without adverse comments on safety. This demonstrates that there has been 
very little research on the cyclosiloxanes, arguably an inadequate amount, given their 
extensive use and potential for widespread exposure of the human population. 
More physiologically, Kala (Kala et al., 1998) studied distribution in mice after sub-
cutaneous injection and found it to be “wide”.  In another rodent study, Lieberman et al 
(Lieberman et al., 1999) described fatal liver and lung damage in treated mice, with 20x 
normal free radical presence in the liver and 7xin the lungs.  The study was controversial 
however; that this is the only animal study highlights the need for more such in vivo work. It 
is a limitation of the work described here that monocultures of cell lines can never fully 
reproduce effects seen interacting multi-organ system such as exist in whole animals.  
Much of the work in this area relies on the Ames test.  This test uses bacteria that are 
genetically modified to carry mutations in genes coding for histidine biosynthesis. They 
therefore require histidine for growth. The method tests for mutations that can result in a 
reversion back to the wild type, permitting growth on a histidine-free medium.  However, the 
test has limitations.  For example, mutagens may act differently in a bacterial strain-
dependent manner, compared to their effects in more complex eukaryotic cells.  The DNA 
is organised differently, in chromosomes, as compared to the ring structures found in 
bacteria.  Also the test is geared towards frame-shift mutations; mutagens having other 
effects on the genome point mutations may not be detected.  The conversion of pro-
mutagenic compounds by metabolism in the host will necessarily remain undetected.  
Mutagens identified in the Ames test need not necessarily be carcinogenic, an example 
being nitroglycerin (Benigni and Bossa, 2011). Combining the results from the present work 
and that published in the literature, it can be concluded that cyclosiloxanes show potentially 
mutagenic properties in mammary epithelial cells in addition to the effects apparent in 
bacterial based studies.  
In summary, all of the three cyclosiloxanes tested showed consistent genotoxic and growth 
pattern modulating effects on the near-normal breast epithelial cell lines studied.  While the 
experimental model itself has limitations, the results should act as a stimulus for more 
physiological studies probably necessarily using animals until practical tissue engineering 
evolves to a more mature discipline than presently exists. 
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3.2  Butylphenylmethylpropional (Lilial) 
Chemical constituents of personal care products may be contributory to carcinogenesis in 
the breast (Darbre and Harvey, 2008). Butylphenylmethylpropional also known as 2-(4-
tertbutylbenzyl) proplonaldehydeLilial (CAS 80-54-6) is added for purposes of fragrance at 
up to 2.5% concentration to a range of cosmetic products. (International Fragrance 
Association, Code of Practice 1999, Geneva).  It has been demonstrated to exhibit 
oestrogenic activity and exposure to oestrogen itself is a risk factor for breast cancer 
(Charles and Darbre, 2009a). However, it has yet to be investigated in breast cells for 
effects on genomic stability which is an enabling characteristic underlying cancer 
development.  Its absorption and accumulation in breast tissue is as yet unknown.   
3.2.1Suspension growth of MCF10A & MCF10F cells after exposure to 
butylphenylmethylpropional (Lilial): morphology 
MCF10A and MCF10F cells were grown in semi-solid suspension culture with 10-8M 17β- 
oestradiol and varying concentration of butylphenylmethylpropional (Lilial).  
Photomicrographs of colonies after 21 days are shown in Figure 3.25.   In the absence of 
treatment, only small colonies of a few cells were present, having diameters less than 20 
microns. A high proportion of much larger colony sizes were found with all the treatments 
shown in Figures 3.25 B-C.  Colony shapes were irregular, but maximal diameters 
exceeded 100 microns in each case 
3.2.2  Suspension growth parameters in the presence of Lilial: quantitation 
MCF10 A and MCF10F cells were grown with 17β-oestradiol or Lilial in suspension culture 
for up to 21 days, colony size (Figure 3.26), colony number (Figure 3.27) and total cell 
number (Figure 3.28) were measured after 7, 14 or 21 days. Increasing concentrations of 
Lilial. (10-10 M to 10-5M) gave increased colony size and colony number.  Responses were 
similar in both cell lines and also similar to those for cyclosiloxanes D4 and D5.  The 
concentrations at which the effect of Lilial exceeded that of E2 were 10-8M for colony size 
and number.  Probability values for concentrations higher than E2 were in all but 2 cases 
<0.001, the weaker responses at higher dilutions tended to be less robustly demonstrated, 
but within the standard <0.05 convention. 
Cell numbers assessed by coulter counter also were higher than control values in all cases 
and exceeded E2 values (p<0.001) by 10-8M.  The trend was of increasing cell numbers 
with concentration through the lowest dilution used (10-5M). 
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    (A) No treatment                 (B) 17β- oestradiol (E2)                      (C) Lilial 
 FIGURE 3.25 Colonies of MCF-10A cells growing in semi-solid methocel suspension 
culture after 21 days exposure to Lilial    
 
Cells were grown with: - (A) no treatment (B), 70 nM 17β- oestradiol (C), 10-5M 
butylphenylmethylpropional (Lilial). Phase contrast images.   
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A. MCF10A cells:  
 
              Day 7           Day 14          Day 21 
B. MCF10F cells 
 
 Day 7            Day 14          Day 21 
FIGURE 3.26  Effect of concentrations from 10-10M to 10-5 M of Lilial on the size of 
colonies of MCF10A (A) and MCF10F (B) cells growing in methocel suspension 
culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70nM 17β-oestradiol, with10-5M 
Lilial, with10-6M Lilial, with10-7M Lilial, with10-8M Lilial, with10-9M Lilial or with10-10M Lilial. 
Average colony size was calculated from 15 fields per well of view and results are 
presented as the overall average of readings and standard error of triplicate wells from 
three replicate experiments.* indicates p˂ 0.05, ** p˂ 0.01 and *** p ˂0.001 compared to 
no addition (grey bar, black asterisk) and cells with 17β-oestradiol (black bar, red 
asterisk)  
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A. MCF10A cells 
 
                    Day 7                    Day 14      Day 21 
B. MCF10F cells 
 
                    Day 7                    Day 14      Day 21 
FIGURE 3.27 Effect of different concentrations from 10-10M to 10-5 M Lilial on number 
of colonies of MCF10A (A) and MCF10F (B) cells growing in semi- solid methocel 
suspension culture from 7 to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with10-5M 
Lilial, with10-6M Lilial, with10-7M Lilial, with10-8M Lilial, with10-9M Lilial or with10-10M Lilial. 
Colony growth is shown as the number of colonies per well from 7 days to 21 days, as 
determined under light microscope. Error bars are standard error of triplicate wells for each 
experiment.  * indicates p˂ 0.05, ** p˂ 0.01 and *** p ˂0.001compared to no addition 
(grey bar, black asterisk) and cells with 17β-oestradiol (black bar, red asterisk). 
 
 
 90 
 
 
A. MCF10A cells                                                                           B. MCF10F cells 
 
 
 
FIGURE 3.28  Effect of concentrations of Lilial on growth of MCF10A cells (A) and MCF 
10F cells (B) in semi- solid methocel suspension culture after 21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with10-5M 
Lilial, with10-6M Lilial, with10-7M Lilial, with10-8M Lilial, with10-9M Lilial or with10-10M Lilial. 
Cell growth is shown as the number of cells per well after 21 days, as counted using a 
Coulter counter. Error bars are the standard error of triplicate wells.   
*** indicates p ˂0.001 compared to no addition (grey bar, black asterisk) and cells 
with 17β-oestradiol (black bar, red asterisk) 
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3.2.3  Comet assay of DNA damage after exposure to Lilial 
An alkaline single-cell gel electrophoresis (SCGE) technique was employed to detect single 
strand and labile DNA adducts in the immortalised human breast epithelial cell lines 
MCF10A and MCF10F after exposure to Lilial at 10-5M concentration. 
Cells in the photomicrograph in Figure 3.29 panel C (Lilial) show strong classical comet 
formation in MCF10A cells.  Some indications of comet formation are seen in panel B 
(DES).   
The bar charts for the comet assays, shown in Figure 3.30 show both comet numbers as 
percent of total count and tail length in MCF10A cells to correlate positively with 
concentration of agent.  Lilial at 10-8 M did not produce comets. DES at 10-5M yielded large 
numbers of poorly developed comet cells.  MCF10F cells developed a high proportion of 
comets with long tails at 10-5 M Lilial.  In both cell lines 10-5 M DES produced more comets 
and with longer tails than 10-5 M Lilial. 
            
A: Untreated MCF10A cells     B: Diethylstilboestrol (DES)      C: Lilial 
FIGURE 3.29   Comet assay for detection of DNA damage in MCF10A cells exposed to 
Lilial  
Panel A is of untreated cells (control). B) Cells treated with 10-5 M Diethylstilboestrol (DES) 
(positive control). C) Cells treated with 10-5M butylphenylmethylpropional (Lilial). All cells 
were treated for one hour. Cells viewed by fluorescence microscopy. 
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MCF10A cells 
          
MCF10F cells 
 
FIGURE 3.30 Effect of butylphenylmethylpropional (Lilial) on DNA damage in 
MCF10Aand MCF10Fcells as assessed by comet assay. Measuring DNA tail length 
(A, C) or % of cells with comets (B, D) 
 
Cells were grown in stock medium and treated one hour with untreated cells (control).  Cells 
were treated with DES (positive control) or Lilial at concentrations between 10-5 and 10-8. 
Error bars represent standard deviation of 50 comets scored.  
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3.2.4 Lilial: Effect on mRNA expression of DNA repair genes: 
Effect of Lilial were studied  in the short term (1 week) and long term (30 weeks) using 10-
5M concentration because these were the highest concentration studied on suspect growth 
which did not cause toxicity over 21 days. This concentration has also been published as 
not detrimental to proliferation of MCF7 cells (Charles and Darbre, 2009a).    
Levels of BRCA1 mRNA  after exposure to Lilial 
Short (1 week) and long term (30 weeks) effects on BRCA1 mRNA expression of exposing 
MCF10A (Figure 3.31) and MCF10F (Figure 3.32) cells to Lilial in terms of levels of mRNA 
for BRCA1, was investigated using RT-PCR.  Expression was halved after long term 
exposure to E2 and Lilial in MCF10A cells (p<0.001 in both cases). A drop at 1 week 
exposure was not statistically significant.  
The long-term effect of exposure of MCF10F cultures to both E2 and Lilial showed a greater 
reduction in relative expression of BRCA1 mRNA (p<0.001 in both cases).  Standard errors 
were much tighter than in the short exposure experiment.  
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MCF10A cells 
 
FIGURE 3.31  Real-time RT- PCR analysis of BRCA1 mRNA in MCF10A cells following 
short term (A) or long term (B) exposure to Lilial. 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-5M Lilial. The relative 
expression of BRCA1 mRNA was normalised to that of the endogenous control β-actin 
mRNA, and average values calculated for triplicate technical replicates. Results are shown 
± standard error for biological triplicate values.  
* indicates p˂ 0.05, compared to control by one way ANOVA with post-hoc Dunnett 
test.  
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MCF10F cells 
 
FIGURE 3.32 Real-time RT- PCR analysis of BRCA1 mRNA in MCF10F cells following 
short term (A) or long term (B) exposure to butylphenylmethylpropional (Lilial). 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2)or in the presence of 10-5M Lilial. The relative 
expression of BRCA1 mRNA was normalised to that of the endogenous control β-actin 
mRNA, and average values calculated for triplicate technical replicates. Results are shown 
± standard error for biological triplicate values.  
* indicates p˂ 0.05,***  p ˂0.001  compared to control by one way ANOVA with post-
hoc Dunnett test.  
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Levels of   ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, 
PTEN,Rad50, Rad51 and STK111  mRNA  on after exposure to Lilial 
In MCF10A cells, short (1 week) and long term (30 weeks) effects of exposure to Lilial are 
shown in Figure 3.33. The short-term effect of exposure to Lilial showed a significant 
elevation in expression of CHK1, PALB2 and PARP1 mRNA in MCF10Acells.The long-term 
effect of exposure showed a significant elevation of p53 and Rad51 mRNA and a significant 
reduction in expression of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, PALB2, PARP1 and 
RAD50 mRNA. 
The effects of exposure of MCF10F cells to Lilial are shown in Figure 3.34.  MCF10F cells 
were more affected by short-term exposure to Lilial.  One week incubation resulted in a 
significant reduction in expression of ATM, BRIP1, PALB2 and STK111 mRNA in MCF10F 
cells (all p values <0.01).  However, the long-term effect of exposure showed a significant 
reduction in expression of BRIP1, CHK2, p53, PALB2, PARP1, PTEN and  Rad51  mRNA.  
The net result was that over time ATM expression lost its significant reduction, while CHK2, 
PARP1 and RAD51 expression became reduced contrasting with the results at one week. 
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FIGURE 3.33 Real-time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells after 
short (A) or long term (B) exposure to Lilial   
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M Lilial. The relative expression of ATM, ATR, BRCA2, BRIP1, 
CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, Rad51 and STK111mRNA were 
normalised to that of the endogenous control β-actin mRNA, and average values calculated 
for triplicate technical replicates. Results are shown ± standard error for biological triplicate 
values.  
* indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared to control by one way ANOVA 
with post-hoc Dunnett test.   
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MCF10F cells 
 
FIGURE 3.34  Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells 
following short term (A) or long term (B) exposure to Lilial  
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M Lilial. The relative expression of ATM, ATR, BRCA2, BRIP1, 
CHK1, CHK2, p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111mRNA were 
normalised to that of the endogenous control β-actin mRNA, and average values calculated 
for triplicate technical replicates. Results are shown ± standard error for biological triplicate 
values.  
* indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared to control by one way ANOVA 
with post-hoc Dunnett test.  
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3.2.5 Level of BRCA1 protein after exposure to Lilial 
Long term exposure of MCF10A cells to Lilial and E2 showed expression of BRCA1 protein 
using western Immunoblotting to be significantly reduced (Figure 3.35) (p<0.001). The 
reduction with Lilial was greater than with E2 
MCF10F cells showed, on long term exposure to Lilial but not E2, a significant reduction in 
expression of BRCA1 protein by Western blotting, both qualitatively (A) and quantitatively, 
(B) in Figure 3.36 
 
              
FIGURE 3.35  Level of BRCA1 protein in butylphenylmethylpropional (Lilial) treated 
MCF10A cells using western Immunoblotting. A- Photograph of excised bands, B, 
quantitative plot. 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10A human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M butylphenylmethylpropional (Lilial) 
compared to 10-8M oestradiol (E2). * indicates p˂ 0.05, ** p˂ 0.01 and compared to 
control by one way ANOVA with post-hoc Dunnett test.  
 
A 
B 
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FIGURE 3.36 Level of BRCA1 protein in butylphenylmethylpropional (Lilial) treated 
MCF10F cells using western Immunoblotting. Upper - photograph of excised bands, 
lower, quantitative plot. 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10F human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M Lilial compared to 10-8M 
oestradiol (E2). ** indicates p˂ 0.01 compared to control by one way ANOVA with 
post-hoc Dunnett test. N.B. Western blot data showed that the his-tagged BRCA1 
band had a higher molecular weight in comparison to BRCA1 bands of breast cell 
lysates, which is likely due to extra molecular weight of his-tag molecules that 
altered the protein mobility on the gel. His-tag modification increases effective size 
by 30 KDa. (Zhao et al., 2010) 
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3.2.6 Summary & discussion of Lilial results 
The results with Lilial are tabulated below (Table 3-2).  In this tabulation there is a 
continuous correlation of agent concentration with `anchorage independent growth across 
all concentrations.  The comet assays show actual DNA damage and expression of DNA 
repair related mRNA and protein reflect a reduction in homoeostatic capacity. 
TABLE 3-2 Summary of Lilial results 
 
ASSAY MCF10A MCF10F 
Colony growth in methocel: 
number or size of colonies 
 Positive correlation with 
max 10-5 M concentration of 
Lilial 
 Positive correlation with 
max 10-5 M concentration of 
Lilial 
Colony growth in methocel: 
total cell count 
Mirrors colony growth Mirrors colony growth 
Comet assay Lilial induces particularly 
classical comet formation.  
Tail length increased vs 
DES, numbers of comets 
less than DES but showing 
positive dose response 
Similar to MCF10A, except 
responses not as strong and 
only a single concentration 
tested 
BRCA1 mRNA & protein Both Lilial and E2 caused a 
reduction in protein 
expression. mRNA 
expression was reduced 
after 30 weeks exposure. 
Lilial, but not E2 caused  a 
reduction of protein 
mRNA expression was 
reduced after 30 weeks 
exposure 
Other DNA repair mRNAs One week exposure - 
increased expression in 
CHK1, PALB2 & PARP.  30 
weeks – all expression 
reduced except P53, RAD51 
increased and STK111 
unchanged 
At one week – reduced 
ATM, BRIP1, PALB2 PTEN 
& STK111 expression.  At 
30 weeks BRIP1, PALB2 
PTEN & CHK2 were 
reduced 
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3.2.7 Discussion of results of exposure of MCF10 cells to Lilial 
The results presented here demonstrate that exposure of non-transformed human breast 
epithelial cells to Lilial can enable anchorage-independent growth in methocel culture, can 
damage DNA in comet assays and can alter, generally reducing levels over time, mRNAs 
encoding DNA repair proteins. Most notably among these changes levels of both BRCA1 
mRNA and BRCA1 protein were reduced after long-term exposure to Lilial. Differences 
were noted in the dose-responses to Lilial and effects in the short-term (1 week) were not 
equivalent to those after longer exposure times (30 weeks). An overall summary of the 
results is given in Table 3-2.   
3.2.7.1  Anchorage-independent colony formation 
The results presented above demonstrate that exposure of non-transformed human breast 
epithelial cells to Lilial can enable anchorage-independent growth in methocel culture. The 
colony forming response of both MCF10A and MCF10F cells showed a clear positive 
association, with dose response across the range used, measuring average colony size.  
The association neither disappeared at lower concentrations nor tended to plateau at high 
concentrations.  The plots for colony numbers mirror those for colony size.  There was no 
peak or plateau effect. The effect noted for the size and numbers of colonies was 
comparable – i.e. an approximately tenfold increase in measurement over the five orders of 
magnitude in dose applied the when assessed as total individual cell numbers at 7, 14 and 
21 of days culture.  
As with the all the agents studied here, the colony formation assay may rely on actions 
other than genotoxicity.   Usta (2013) detected the fragrance chemicals lyral and Lilial 
decreasing viability of HaCat cells by increasing free radical production and lowering 
antioxidant protection. These HaCat cells are transformed but the effects were not seen in 
MCF-7 cells which are also tumour-derived.  They postulated lyral and Lilial as being toxic 
to mitochondria, disrupting the electron transport chain, increasing ROS production, thus 
affecting mitochondrial membrane potentials, decreasing ATP concentrations, culminating 
in cell death. 
 
3.2.7.2  DNA damage as measured by comet assay    
 The comet assays were conducted in alkaline conditions which detects single strand as 
well as double strand DNA breaks.  The comet tails were markedly bigger and of better 
conformation in the Lilial treated cells than in those exposed to diethylstilboestrol, but a 
smaller percentage of cells were affected.  There is no clearly demonstrable cause for this, 
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but it could be could be interpreted as  evidence for more extensive toxicity of Lilial, leading 
to disintegration of  some cells making them unavailable for comet formation.    
Previous work by Di Sotto et al (2014) showed no genotoxicity at chromosomal level 
measured by DNA fragmentation (comet assay) or abnormal chromosome count or 
conformation (aneuploidy) using cancer-derived cells.  Such cells are abnormal to start 
with, compared to the near-normal cells used with this study. These results therefore 
underline the importance of using non-cancerous breast cells to assess the potential for 
compounds to damage DNA. 
3.2.7.3  BRCA1 mRNA and protein 
Assessing the molecular results, BRCA-1 mRNA detected was quantitatively reduced after 
long-term exposure of MCF-10A cells to Lilial.    The MCF10F cell line gave unchanged m-
RNA levels at one week irrespective of treatment but again exposure to Lilial or E2 reduced 
expression in the long term.  Viewing the gene as a promoter of DNA repair, it would be 
intuitive to see short-term up-regulation but once repair mechanisms were overcome, it 
would be reasonable for production to slow.   Reduced protein expression for BRCA1 after 
exposure to Lilial is consistent with reduced m-RNA levels at the same time period. 
BRCA1 mRNA and protein rose in the short term on treatment of MCF10A or MCF10F.  
Long-term exposure to Lilial or E2, however, resulted in mRNA level reduced to below 
blank control levels.  This is suggestive of an initial burst of repair activity  which receded on 
being overwhelmed by the continued burden of damage.   This study is the first to examine 
such changes in non- transformed cells and to do so over the longer term. 
3.2.7.4  DNA repair related mRNAs 
Such a trend was also seen with the panel of repair-related genes in MCF10A cells, with 
CHK1 m-RNA being particularly elevated at one week exposure.  The long-term trend was 
for expression to be below that of controls, except for P53 and Rad-51.  MCF10F cells gave 
few statistically significant differences in m-RNA, but short-term increases with relatively 
high variability rendering the results below the p=0.05 significance threshold. 
As with the BRCA genes, previous studies are largely confined to the work of Di Sotto 
(2014). Single strand breaks were observed and a  lack of mutagenicity was observed for 
Lilial in all of the Ames tests using different  bacterial strains, albeit in neoplastic MCF-7 
cells. His group further showed no effects in MCF7 cells and that, in the presence of 
exogenous metabolic activators, no genotoxic derivatives were produced by CYP450-
mediated biotransformations such as might occur in the liver. 
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3.2.7.5 Socio-political and environmental studies relating to Lilial 
Lilial can occur in personal care products at concentrations up to 2.5%, approximately 
equivalent to 0.1M, given a relative density for the product close to unity.  Sgorbini et al 
(2010) have estimated by thermal desorption gas chromatography-mass spectrometry 
following contact sorptive tape extraction that skin absorption is high, at 52.3%, from a 
standard cream formulation.  The highest concentration used in this study of 10-5M, diluting 
to 10-10M cannot be considered supraphysiological. 
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the human 
biomonitoring of non-occupational exposure to the fragrance is reported by  Pluym 2016).  
This was undertaken within the framework of the Cooperation Project of the German 
Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety 
(BMUB) and the German Chemical Industry Association (VCI). It is indicative of the early-
stage nature of research in this area that authorities in developed countries are still working 
on development of acceptable methodologies and that there still exist no measurements of 
the extent to which Lilial is entering human breast tissue. 
The overall message to be taken from the present study is that Lilial, at these 
concentrations produces effects on two closely related breast epithelial cell lines that are 
consistent with its being an initiator or promotor of oncogenesis.  Over the range of Lilial 
concentrations studied here, the colony forming response of both MCF10A and MCF10F 
showed a clear positive dose response when measured either by colony numbers or size 
irrespective of the length of incubation; this effect was reproduced when measured as total 
individual cell numbers at 21 days culture.  None of these plots indicated that the effect had 
plateaued at 10-5M. 
There is little in the literature covering comparable ground; the only recent work on Lilial & 
cancer is that of Di Sotto (2014) in the breast cancer cell line MCF-7.  Differences in using 
genotoxicity (Ames) assays for mutagenicity and a micronucleus assay for clastogenicity 
are likely to account for the differences in their results from those presented here.  Bacteria 
present convenient high-throughput models for assessing genotoxicity and breast 
carcinoma cells, especially those derived from metastatic deposits, will differ from normal 
epithelial cells. The present results using near-normal cell lines demonstrate that effects 
can sometimes be observed in human epithelial cells where they are not evident in 
bacteria. 
There is insufficient research to link definitively effects seen in laboratory studies such as 
this with clinical evidence of harm.  There is, however, enough concern over the   potentially 
carcinogenic, mutagenic or reprotoxic (CMR2) 
(https://echa.europa.eu/documents/10162/13562/cmr_report_en.pd) status of Lilial that 
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chemists such as Schroeder (2014) record efforts to find replacement substances (such as  
5,7,7-Trimethyl-4-methyleneoctanal) and attempt to define the structural requirements in 
compounds for a 'Lilial' odour. The results reported in this thesis should add to this concern 
and future risk assessment.  
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3.3 Triclosan 
Triclosan is used as a synthetic broad-spectrum antimicrobial agent. It is extensively used 
in pharmaceutical and personal care products and household cleaners, also in commercial 
products including textiles and plastics (Liu et al., 2002).  Studies from the Reading 
laboratories have established that triclosan can exert oestrogenic and androgenic effects on 
breast cancer cells in vitro (Gee et al., 2008a, Charles and Darbre, 2009a) Triclosan is 
among a group of Endocrine Disrupting Compounds that are taken seriously as a risk, with 
both biochemical (Taboada-Puig et al., 2015) and ultraviolet radiation based techniques   
(Carlson et al., 2015)  piloted for its industrial scale removal from waste waters.  
For female physiology, a rat model used by Manservisi (Manservisi et al., 2015)  yielded 
profound mammary changes, assessed by gene expression, on triclosan treated rats, which 
subsequently impacted on survival of the young exposed by drinking the milk.  Clinically, 
negative associations have been found between urinary triclosan and thyroid hormonal 
parameters in obese patients (Geens et al., 2015). In men, high internal body 
concentrations of endocrine disrupting chemicals, including triclosan, suffer an increased 
risk of infertility along with disturbed hormone balance (Den Hond et al., 2015) 
3.3.1 Suspension growth of MCF10A and MCF10F cells and colonies 
exposed to triclosan: morphology. 
MCF10A and MCF10F cells were grown in semi-solid suspension culture with varying 
concentrations of triclosan and 10-8M 17β- oestradiol for up to 21 days.  Photomicrographs 
of colonies after21 days are shown in Figure 3.37 in the absence of treatment, only small 
colonies were seen (Figure 3.37A). Large colonies were evident are growth in the presence 
of 10-8M E2 or 10-7M triclosan, shown in Figure 3.37 panels B and C respectively  
 107 
 
 
                                                              
 (A) No treatment                       (B) 17β- oestradiol (E2)                  (C) Triclosan 
FIGURE 3.37 Colonies of MCF10A human breast epithelial cells growing in semi-solid 
methocel suspension culture after 21 days exposure to triclosan. 
 
Cells were grown with: - (A) no treatment (B), 70 nM 17β- oestradiol (C), 10-7M triclosan. 
Phase contrast images.   
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A. MCF10A cells 
 
 Day 7    Day 14    Day 21 
B. MCF10F cells 
 
                Day 7      Day 14        Day 21 
FIGURE 3.38  Effect of different concentrations of triclosan on the size of colonies of 
MCF10A (A) and MCF10F (B) cells growing in semi- solid methocel suspension 
culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70nM 17β-oestradiol, with10-5M 
triclosan, with10-6M triclosan, with10-7M triclosan , with10-8M triclosan, with 10-9M triclosan 
or with10-10M triclosan. Average colony size was calculated from 15 fields per well of view 
and results are presented as the overall average of readings and standard error of triplicate 
wells from three replicate experiments.* indicates p˂ 0.05** p˂ 0.01 and *** p ˂0.001 
compared to no addition (grey bar, black asterisk) and cells with 17β-oestradiol 
(black bar, red asterisk).  
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A. MCF10A cells    
 
                      Day 7      Day 14         Day 21 
B. MCF10F cells 
 
                     Day 7     Day 14                   Day 21 
FIGURE 3.39   Effect of concentrations of triclosan on number of colonies of MCF10A 
(A) and MCF10F (B) cells growing in semi- solid methocel suspension culture from 7 
days to 21 days. 
Cells were grown in stock medium with no addition, with10-5M triclosan, with10-6M triclosan, 
with10-7M triclosan, with10-8M triclosan, with 10-9M triclosan or with10-10M triclosan. Colony 
growth is shown as the number of colonies per well from 7 days to 21 days, as determined 
under light microscope. Error bars are standard error of triplicate wells for each experiment.   
** indicates p˂ 0.01 and *** p ˂0.001 compared to no addition (grey bar, black 
asterisk) and cells with 17β-oestradiol (black bar, red asterisk). 
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A. MCF10A cells      B. MCF10F cells  
 
FIGURE 3.40   Effect of concentrations of triclosan on total numbers of MCF10A (A) 
and MCF10F (B) cells in semi- solid methocel suspension culture after 21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with10-5M 
triclosan, with10-6M triclosan, with10-7M triclosan , with10-8M triclosan, with 10-9M triclosan 
or with10-10M triclosan. Cell growth is shown as the number of cells per well after 21 days, 
as counted using a Coulter counter. Error bars are the standard error of triplicate wells.  
** indicates p˂ 0.01 and ***p ˂0.001 compared to no addition (grey bar, black asterisk) 
and cells with 17β-oestradiol (black bar, red asterisk) 
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3.3.2  Comet assay of DNA damage after exposure to triclosan 
An alkaline single-cell gel electrophoresis (SCGE) technique was employed to detect single 
strand and double strand breaks in DNA and alkaline labile DNA adducts in the 
immortalised human breast epithelial cell lines MCF10A and MCF10F after exposure to 
triclosan. 
Cells in the photomicrograph in Figure 3.41 panel D (triclosan) show comet formation with 
long tail.  Some indications of comet formation are seen in panel B.   
The bar charts for MCF10A (Figure 3.42) show comet tail length peaking at 10-7M (p<0.001 
vs control) while the numbers of comets as % of total cells decreases with increasing 
concentrations of triclosan after 10-8M.   The lowest concentration (10-9M) was completely 
ineffective, giving comet parameters at control levels.  MCF10F cells show increased tail 
length using triclosan compared to DES, but a smaller proportion of cells are classified as 
comet-forming.   
 
            
A: Untreated MCF10A cells        B:Diethylstilboestrol (DES)     C: Triclosan treated 24 hours  
FIGURE 3.41  Comet assay for detection of DNA damage in MCF10A cells exposed to 
triclosan. 
Panel A is of untreated cells (control) treated for one hour. B) Cells treated with 10-5 M 
Diethylstilboestrol (DES) (positive control) treated for one hour. C)  Cells treated with 10-7M 
triclosan treated for 24 hours. Cells viewed by fluorescence microscopy. 
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MCF10A cells 
  
MCF10F cells  
                   
FIGURE 3.42  Effect of triclosan on DNA damage in MCF10A and MCF10F human 
breast epithelial cells as assessed by a comet assay. Measuring DNA tail length (A, 
C) or % of cells with comets (B, D) 
 
Cells were grown in stock medium and treated one hour with untreated cells (control).Plots 
A and C illustrate tail length, plots B and D, comet numbers as percent of cells counted.  
Cells were treated with 10-5 M diethylstilboestrol (DES), (positive control).Treated cells with 
10-5M triclosan. Treated cells with 10-6M triclosan. Treated cells 10-7M triclosan. Treated 
cells 10-8M triclosan. Treated cells 10-9M triclosan. Error bars represent standard deviation 
of 50 comets scored.  
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3.3.3 Triclosan:  mRNA expression of DNA repair genes 
Following proliferation studies (data not shown), concentration of 10-6M and above were 
found to be toxic to MCF10A and MCF10F cells. Therefore, the long term studies used 10-
7M triclosan and not 10-5M as for the previous chemicals 
Levels of BRCA1 mRNA after exposure to triclosan 
Short (1 week) and long term (30 weeks) effects on BRCA1 mRNA expression of exposing  
MCF-10A (Figure 3.43) and MCF10F (Figure3.44) cells to 10-7M triclosan in terms of levels 
of mRNA for BRCA1, was investigated using RT-PCR.  Significant reduction was found 
after long term triclosan exposure in MCF10A cells. A similar trend with E2 was not 
statistically significant. In MCF10F cells the long-term effect of exposure to E2, and 
triclosan was a significant reduction in expression of BRCA1 mRNA in both cases. 
MCF10A cells 
 
FIGURE 3.43 Real -time RT- PCR analysis of BRCA1 mRNA in MCF10A cells following 
short term (A) or long term (B) exposure to triclosan. 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-7M triclosan. The 
relative expression of BRCA1 mRNA was normalised to that of the endogenous control β-
actin mRNA, and average values calculated for triplicate technical replicates. Results are 
shown ± standard error for biological triplicate values.  
* indicates p˂ 0.05, compared to control by one way ANOVA with post-hoc Dunnett 
test.  
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MCF10F cells 
 
FIGURE 3.44  Real -time RT- PCR analysis of BRCA1 mRNA in MCF10F cells following 
short term (A) or long term (B) exposure to triclosan. 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-7M triclosan. The 
relative expression of BRCA1 mRNA was normalised to that of the endogenous control β-
actin mRNA, and average values calculated for triplicate technical replicates. Results are 
shown ± standard error for biological triplicate values.  
*** indicates p˂ 0.001, compared to control by one way ANOVA with post-hoc 
Dunnett test.  
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Levels of   ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, 
RAD50, Rad51 and STK111 mRNA after exposure to triclosan 
In MCF10A cells short (1 week) and long term (30 weeks) effects of exposure to triclosan 
are shown in Figure 3.45. The short-term effect of exposure to 10-7M triclosan showed a 
significant reduction in expression of p53 mRNA in MCF10A cells. The long-term effect of 
exposure to 10-7M triclosan showed a significant reduction in expression of ATM, ATR, 
BRCA2, BRIP1, CHK1, PALB2, PARP1, PTEN, RAD50 and STK111 mRNA in MCF10A 
cells 
 Effect of exposure of MCF10F cells are shown in Figure 3.46. The short-term effect of 
exposure to 10-7M triclosan showed a significant reduction in expression of ATM and BRIP1 
mRNA in MCF10F cells.  However, long-term exposure to 10-7M triclosan there was a 
significant reduction in expression of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, and p53, 
PALB2, PARP1, PTEN, Rad50 and Rad51 mRNA in MCF10F cells. 
MCF10A cells 
 
FIGURE 3.45 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells 
following short term (A) or long term (B) exposure to triclosan 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-7M triclosan. The relative expression of mRNAs were normalised to 
that of the endogenous control β-actin mRNA, and average values calculated for triplicate 
technical replicates. Results are shown ± standard error for biological triplicate values.  
* indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared to control by one way ANOVA 
with post-hoc Dunnett test.   
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MCF10F cells 
 
 
FIGURE 3.46 Real -time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10F cells  short 
term (A)or long term (B) exposure to triclosan 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-7M triclosan. The relative expression of mRNAs were normalised to 
that of the endogenous control β-actin mRNA, and average values calculated for triplicate 
technical replicates. Results are shown ± standard error for biological triplicate values.  
* indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared to control by one way ANOVA 
with post-hoc Dunnett test.  
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 3.3.4  Level of BRCA1 protein after exposure to triclosan 
The effect of long term exposure to triclosan on expression of BRCA1 protein using western 
Immunoblotting in MCF10A cells is shown in Figure 3.47.  A representative of the western 
immunoblot is shown in Figure 3.47A. Figure 3.47B shows a quantitative plot.  The 
BRCA1 band is visibly and quantitatively weaker than E2 or control (p<0.01 against control 
value). Figure 3.48 shows the effect of long term exposure to triclosan on expression on 
BRCA1 protein using western Immunoblotting in MCF10Fcells. Both qualitative and 
quantitative analyses are shown.  The results mirror the mRNA levels, with control values > 
E2 > triclosan (p<0.01 vs control) 
 
          
FIGURE 3.47 Level of BRCA1 protein in triclosan treated MCF10A cells using western 
Immunoblotting. 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10A human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-7M triclosan compared to 10-8M 
oestradiol (E2). * indicates p˂ 0.05, ** p˂ 0.01 and compared to control by one way 
ANOVA with post-hoc Dunnett test. 
A 
B 
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FIGURE 3.48 Level of BRCA1 protein in triclosan treated MCF10F cells using western 
Immunoblotting. 
 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10F human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-7M triclosan compared to 10-8M 
oestradiol (E2).  
* indicates p˂ 0.05, ** p˂ 0.01 and compared to control by one way ANOVA with post-
hoc Dunnett test. 
 
A 
B 
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3.3.5  Summary of results using triclosan 
The exposure of both cell lines to triclosan give comparable results as set out in Table 3.3.  
They constitute clear evidence that triclosan has transforming potential to breast epithelial 
cells and is potentially genotoxic 
 
Table 3-3 SUMMARY OF TRICLOSAN RESULTS 
 
ASSAY MCF10A MCF10F 
Colony growth in methocel: 
number or size of colonies 
Dose response for all 
parameters showing peak 
growth promotion at 10-10M 
Dose response for all 
parameters showing peak 
growth promotion at 10-10M 
Colony growth in methocel: 
total cell count 
Mirrors colony growth Mirrors colony growth 
Comet assay Not clear comet formation 
morphologically.  Peak tail 
length at 10-7M Numbers fall 
off with increasing 
concentration. 
Tail length increased over 
DES and control.  Numbers 
reduced at concentration 
tested 
BRCA1 mRNA & protein mRNA only significantly 
reduced after 30 weeks of 
triclosan.  E2 ineffective 
E2 and triclosan show 
reduced protein product 
E2 and Triclosan effective in 
reducing mRNA. 
Only triclosan reduced 
expression of protein 
product. 
Other DNA repair mRNAs mRNAs suppressed by 30 
weeks exposure, except for 
CHK2, P53 & RAD51.  High 
values associate with large 
standard deviations. 
Extremely consistent and 
strong suppression of 
mRNA by 30 weeks 
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3.3.6  Discussion of results of exposure to Triclosan 
The outcome demonstrates that exposure of non-transformed human breast epithelial cells 
to triclosan can enable anchorage-independent growth in methocel culture, can cause DNA 
damage as measured by comet assays and can reduce levels of mRNAs encoding DNA 
repair proteins. Particularly, levels of both BRCA1 mRNA and BRCA1 protein were reduced 
after long-term exposure to the triclosan. Alterations were found in the dose-responses of 
the triclosan and effects in the short-term (1 week) were not comparable to those after 
longer exposure times (30 weeks). An overall summary of the results is given in Table 3-3 
3.3.6.1 Anchorage independent growth 
Triclosan is an antimicrobial with ubiquity of exposure in a number of populations (Pycke et 
al 2014). The results presented here demonstrate that exposure of MCF-10A cells and 
MCF10F cells to triclosan can enable anchorage-independent growth in methocel culture. 
This has been shown to be a property closely related to transformation (Soule et al,1990), 
thus by inducing colony growth in methocel, triclosan has demonstrated an ability to induce 
a transformed phenotype.  
 In the present study, the actions of triclosan on colony size are to promote growth of 
individual colonies, peaking at 10-7M and reducing at higher concentrations. This maximal 
effect contrasts with the cyclosiloxanes D4 and D5 and with Lilial which show continuously 
rising growth stimulation to 10-5M (the highest dose tested).  Triclosan may be toxic at the 
higher concentrations because there is sharp fall-off in comet numbers and tail length 
between  10-6 and 10-5M these assays.  A similar effect was observed by Henry (2013) who 
showed triclosan to be toxic (to MCF-7 cells) above 100µg/ml (3x10-8M), making those 
neoplastic cells more sensitive to the agent.  In the Reading laboratories, proliferation 
studies indicated that concentrations of 10-6M and above were toxic to the immortal but not 
transformed MCF10A and MCF10F cells using relatively short exposure times, measured in 
days. Therefore, the long term studies here used 10-7M triclosan and not 10-5M as for the 
previous chemicals  
The dose response is similar irrespective of the measure used. As with the cyclosiloxanes 
and with Lilial, the results measuring numbers closely resemble those measuring size.  The 
peak stimulation is also at 10-7M. In the present study, the actions of triclosan on colony 
size are to promote growth of individual colonies, reducing at higher concentrations, evident 
irrespective of the measure used. 
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3.3.6.2  DNA damage assessed by comet assay 
DNA clastogenicity as measured by the alkaline comet assay resulted in peak tail length for 
MCF10A cells at 10-7M.  Numbers decreased with increasing concentration, suggesting 
total breakdown of cells. Numbers of comets recorded were not greater with triclosan than 
with DES, a synthetic oestrogen which was adopted here (as opposed to the natural 
oestrodiol used in other assay systems) to make results comparable with previous studies 
from the Reading laboratories. However, the tail length – i.e. the extent of damage 
represented by shorter more mobile fragments – was higher in the triclosan treated 
cultures.  These results might reflect less efficient repair in the presence of triclosan, 
despite a similar cell death rate.  There are a number of issues surrounding the 
interpretation of comet assays.  It is possible that repair mechanisms activated during the 
incubation may alter the percentage and physical characteristics of the comets (Lorenzo et 
al., 2013)).  Standardization of assay methodology is important both on intra- and inter-
laboratory basises (Valverde and Rojas, 2009)).  Statistical analysis should, according to 
Lovell (Lovell and Omori, 2008), incorporate power and sample size calculations and 
interpretation based upon  size of effects and their confidence intervals and meaningfulness 
is as important as reporting based purely on statistical significance tests.  
3.3.6.3  DNA repair and proliferation control gene expression 
BRCA mRNA and protein expression long term treatment with 10-7M triclosan and E2 
resulted in reduced BRCA1 mRNA expression.   Protein results indicated that both E2 and 
triclosan reduced measurable levels of BRCA1 protein in MCF10A cells, but only triclosan 
did so in MCF10F cells. In both cases the reduction by triclosan was significant at the 
p=0.01 level. The importance of the BRCA1 in the context of the comet assay results, is 
that BRCA1 is one of the first lines of defence against DNA strand breaks, so that if the cell 
attempts to repair DNA BRCA1 will be expressed, if it fails fragmentation will occur and 
comet tails will form. 
mRNA from the panel of other DNA repair related genes resulted in uniform reduction of 
expression in all cases with MCF-10F cells at 30 weeks; no effects were observed for short 
term exposure to triclosan.   MCF10A cells reacted similarly, except that CHK2, P53 and 
RAD51 were unchanged at 30 weeks. Such a circumstance is suggested by the gene panel 
results, where, certainly with MCF-10F there were reduced BRCA1 levels, significant to 
p<0.01.  mRNA from the panel of DNA repair related genes resulted in uniform reduction of 
expression in all cases with MCF10F cells at 30 weeks; no effects were observed for short 
term exposure to triclosan.   MCF10A cells reacted similarly, except that CHK2, P53 and 
RAD51 were unchanged at 30 weeks. 
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It is not clear whether this apparent cytotoxic combination effect is additive, supra-additive 
or depends on some other type of interaction between two compounds simultaneously 
applied. Differences in reported action may well result from variations in exposure times.  
This study has highlighted differences between short and long term (30 week) exposure in 
vitro.  The study by Gee, for example was limited to 21 days.  Although cells as monolayers 
might be expected to be more sensitive to agents directly applied to them, the human social 
use of cosmetics is likely to involve decades of continual use which would be expected to 
result in continued build-up of any toxic agents. 
Like the other agents tested in the present study, the effects of triclosan are exacerbated by 
long exposure times. As with many bioactive compounds, triclosan is beneficial for its 
antimicrobial properties but its application in uncontrolled, non-clinical settings such as 
personal hygiene or is arguably unwise. Johnson (Johnson   2011), applying the Navigation 
Guide Systematic Review Methodology, concluded that there was "sufficient" non-human 
evidence and "inadequate" human evidence of an association between triclosan exposure 
and human reproductive and developmental health. Early development, like cancer, is 
heavily dependent on highly regulated proliferation and differentiation. 
3.3.6.4  Physiological relevance of these studies 
 
To address the absorption of triclosan and the relevance of the concentrations used in this 
study:-   In experiments on skin absorption (Moss et al., 2000) Radiolabelled triclosan was 
applied to the skin of rats; twenty-four hours after application 12% of label was recovered in 
the faeces, 8% in the carcass 1% in the urine, 30% in the stratum corneum and 26% could 
be rinsed from the skin surface. In a human study on 2,517 urine samples   (Calafat et al., 
2008), using automated solid-phase extraction coupled to isotope dilution–high-
performance liquid chromatography–tandem mass spectrometry, concentrations of total 
(free plus conjugated) triclosan occurred in in 74.6% of samples at concentrations of 2.4–
3,790 µg/L.  There was more in the urine of individuals from higher income households 
appearing maximally in the third decade of life.  This very wide range of concentrations is 
consistent with those applied to the breast cancer cells in this study.  The high-end figure 
quoted by Calafat is in the 10-6M region.  In this study activity on MCF10 cells in vitro is 
observed at lower concentrations.  Triclosan 10-7 M concentation  (289.54 x 10-7 g/l),  
represents 28.954 x 10-7 µg/l, Triclosan 10-6 M equates to 2.8954 x 10-7 µg/l. This 
demonstrates the physiological relevance of this work. With breast cancer tissue being 
often composed largely of hard matrix it is difficult to equate values in homogenised 
material to cellular exposure and clearly the only relevance of excreted concentrations is 
that they point to circulating levels over the period of collection and are subject to variations 
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in urine strength, which can be compensated for by comparing to the relatively continuous 
and stable levels of creatinine excretion. (Stevens et al., 2013) 
Triclosan accumulates in the liver and in fatty tissue (Geens, 2012), which is characteristic 
of breasts.  Much work on this compound centres on reproduction, so estimates of 
prevalence in the community tend to focus on pregnant women.  Measurable levels in urine 
from pregnant women occurred in 87% of samples tested by Weiss et al (2015) and half of 
serum samples (Ye 2011). 
Urine levels may reflect concentration by the kidneys, however and fluid intake levels 
(Stevens et al., 2013).  Measuring tissue samples, Geens (Geens et al., 2012) found 
highest concentrations in rat livers (3.14ng/g and fat 0.61ng/m). This group consider that, 
despite concentrations in adipose tissue, these compounds seem to have ‘a low 
bioaccumulation potential’ (Geens et al 2012).  Measurements have however been made in 
human breast milk. Although the recent paper by Azzouz (Azzouz et al., 2016) is largely a 
technical report, highlighting pretreatments of fluids such as milk to deplete them of protein 
(which might remove some bound agent), they have measured concentrations between 3.3 
and 50,000 ng/l in human milk. 
In conclusion, Triclosan has been shown to have qualitatively similar genotoxic properties 
and influences on three dimensional growth characteristics as the cyclosiloxanes BPA and 
Lilial.  This might be expected of a compound that shares with those compounds a profile in 
the literature of physiological effects  often characterized by endocrine mimicking/disrupting 
properties (Gatidou et al., 2007). 
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3.4  Bisphenol A  
Bisphenol-A (BPA) is an environmental contaminant because it is polymerized in the 
production of bottles including those for feeding neonates.  Epoxy resins coat the insides of 
almost all food and drink cans. BPA is therefore ingested by leaching from these products, 
the rate of leaching increasing with damage or on storage.  BPA, known to enter the human 
breast (Bonefeld-Jorgensen et al., 2007), has been included in this study because it is 
currently under regulatory consideration. Although not directly a cosmetic ingredient many 
personal care products are stored long term in plastic containers.  The experiments 
followed the same pattern as for the previous cosmetic ingredients tested. 
3.4.1  Suspension growth of MCF10A and MCF10F cells and colonies exposed 
to BPA: morphology. 
MCF10A and MCF10F cells were grown in semi-solid suspension culture with of 17β- 
oestradiol and varying concentration Bisphenol-A (BPA).  Photomicrographs of colonies 
after 21 days are shown in Figure 3.49. In the absence of treatment, only small colonies 
were found, compared with the additional large colonies induced by E2 and by the even 
larger and denser colonies induced by BPA, as shown in Figure 3.49, panels B-C 
3.4.2 Suspension colony parameters in the presence of BPA: quantitative. 
MCF10A and MCF10F cells were grown with 17β-oestradiol or BPA in suspension culture 
for 7, 14 and 21 days. Colony size (Figure 3.50), colony number (Figure 3.51) and total cell 
number (Figure 3.52) were measured after 7, 14 or 21 days. Increasing concentrations of 
Bisphenol-A (BPA) (10-10 M to 10-5M) gave increased colony size and colony number. The 
increase had not peaked by 10-5M.  All twelve plots, covering both cell lines show a similar 
dose- response pattern.  
                                   
   (A) No treatment                  (B) 17β- oestradiol (E2)          (C) Bisphenol A (BPA) 
 
FIGURE 3.49   Colonies of MCF10A cells growing in semi-solid methocel suspension 
culture after 21 days. CELLS WERE GROWN WITH:- (A) NO TREATMENT  (B), 70 NM 17Β- 
OESTRADIOL (C), 10-5M BISPHENOL A (BPA). PHASE CONTRAST IMAGES.   
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A. MCF10A  cells 
 
  Day 7    Day 14    Day 21 
B. MCF10F cells  
 
                    Day 7    Day 14    Day 21 
FIGURE 3.50 Effect of different concentrations of BPA on the size of colonies of 
MCF10A (A) and MCF10F (B) cells growing in semi- solid methocel suspension 
culture from 7 to 21 days. 
Cells were grown in stock medium with no addition, with70nM 17β-oestradiol or with10-5M 
BPA, with10-6M BPA, with10-7M BPA, with10-8M BPA, with10-9M BPA or with10-10M BPA. 
Average colony size calculated from 15 fields per well of view and results are presented as 
the overall average of readings and standard error of triplicate wells from three replicate 
experiments. ** indicates p˂ 0.01 and *** p ˂0.001 compared to no addition (grey bar, 
black asterisk) and cells with 17β-oestradiol (black bar, red asterisk). 
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MCF10A cells 
 
       Day 7    Day 14    Day 21 
A. MCF10F cells  
 
                    Day 7    Day 14    Day 21 
 
FIGURE 3.51 Effect of different concentrations of BPA on number of colonies of 
MCF10A (A) and MCF10F (B) cells growing in semi- solid methocel suspension 
culture from 7 days to 21 days. 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with10-5M 
BPA, with10-6M BPA, with10-7M BPA, with10-8M BPA, with10-9M BPA or with10-10M BPA. 
Colony growth is shown as the number of colonies per well from 7 days to 21 days. Error 
bars are standard error of triplicate wells for each experiment.   
** indicates p˂ 0.01 and *** p ˂0.001 compared to no addition (grey bar, black 
asterisk) and cells with 17β-oestradiol (black bar, red asterisk). 
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A. MCF10A cells                                                                  B.  MCF10F cells 
 
 
FIGURE 3.52 Effect of different concentrations of bisphenol A on growth of MCF10A 
(A) and MCF10F (B) cells in semi- solid methocel suspension culture after 21 days. 
 
Cells were grown in stock medium with no addition, with70 nM 17β-oestradiol, with10-5M 
BPA, with 10-6M BPA, with10-7M BPA, with10-8M BPA, with10-9M BPA or with10-10M BPA. 
Cell growth is shown as the number of cells per well after 21 days, as counted using a 
Coulter counter. Error bars are the standard error of triplicate wells.  
***indicates p ˂0.001 compared to no addition (grey bar, black asterisk) and cells 
with 17β-oestradiol (black bar, red asterisk) 
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3.4.3  Comet assay of DNA damage after exposure to bisphenol A (BPA) 
An alkaline single-cell gel electrophoresis (SCGE) technique was employed to detect single 
strand and labile DNA adducts in the immortalised human breast epithelial cell lines 
MCF10A and MCF10F cells after exposure to BPA. 
Some cells in the photomicrograph in Figure 3.53 panel D (bisphenol A (BPA)) show comet 
formation after 24 hours exposure to BPA.  Some indications of comet formation are seen 
in panel B after exposure to DES.  The bar charts in Figure 3.54 show comet tail length and 
percentage of cells.  Comets are less frequent with BPA treatment than with the other 
agents tested in this study:  less than half in both cell types. However, comets are present 
at 1 hour of incubation.  BPA at 10-5M evokes the longest tails.  DES also produced a large 
percentage of small comets.  Comet formation is, however apparently induced by BPA. 
 
            
 A: Untreated MCF10A cells   B: Diethylstilboestrol (DES)   C: Bisphenol-A (BPA) treated 24 hours 
 
FIGURE 3.53 Comet assay for detecting DNA damage in MCF10A cells exposure to 
bisphenol A (BPA). 
Panel A is of untreated cells (control) treated for one hour. B) Cells treated with 10-5 M 
Diethylstilboestrol (DES) (positive control) treated for one hour. C)  Cells treated with 10-5M 
bisphenol A (BPA) treated for 24 hours. Cells viewed by fluorescence microscopy.  
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MCF10A cells 
 
MCF10F cells 
     
FIGURE 3.54  Effect of bisphenol A (BPA) on DNA damage in MCF10A and MCF10F 
human breast epithelial cells as assessed by comet assay. Measuring DNA tail length 
(A,C) or % of cells with comets (B,D) 
Cells were grown in stock medium and treated one hour with untreated cells (control).  
Treated cells with 10-5 M diethylstilboestrol (DES), (positive control).Treated cells with 10-5M 
Bisphenol A (BPA).Treated cells with 10-6M Bisphenol A (BPA). Error bars represent 
standard deviation of 50 comets scored.  
  
 130 
 
3.4.4  Bisphenol A:   Effect of mRNA expression of DNA repair genes: 
 
Levels of BRCA1 mRNA after exposure to bisphenol A (BPA) 
Short (1 week) and long term (30 weeks) effects of exposing MCF10A (Figure 3.55) and 
MCF10Fcells (Figure 3.56) to10-5M bisphenol A (BPA), in terms of levels of mRNA for 
BRCA1, was investigated using RT-PCR.  Significant reduction was found in the long term 
for E2 and bisphenol A (BPA) exposure in MCF10A cells (Figure 3.55). In MCF10F cells, 
the short-term effect of exposure to bisphenol A (BPA) showed a significant increase in 
expression of BRCA1 mRNA in MCF10F cells but in the long-term the effect of exposure to 
E2, and bisphenol A (BPA) showed a significant reduction in BRCA1 mRNA expression 
(Figure 3.56). 
MCF10A cells 
 
FIGURE 3.55 Real-Time RT- PCR analysis of BRCA1 mRNA in MCF10A cells following 
short term (A) or long term (B) exposure to bisphenol A (BPA). 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-5M bisphenol A (BPA). 
The relative expression of BRCA1 mRNA was normalised to that of the endogenous control 
β-actin mRNA, and average values calculated for triplicate technical replicates. Results are 
shown ± standard error for biological triplicate values.  
* indicates p˂ 0.05, **p˂ 0.01 compared to control by one way ANOVA with post-hoc 
Dunnett test.  
 131 
 
MCF10F cells 
 
 
FIGURE 3.56 Real-time RT- PCR analysis of BRCA1 mRNA in MCF10F cells following 
short term (A) or long term (B) exposure to bisphenol A (BPA). 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the present of 10-8 17β- oestradiol (E2) or in the presence of 10-5M bisphenol A (BPA). 
The relative expression of BRCA1 mRNA was normalised to that of the endogenous control 
β-actin mRNA, and average values calculated for triplicate technical replicates. Results are 
shown ± standard error for biological triplicate values.  
*** indicates p˂ 0.001, compared to control by one way ANOVA with post-hoc 
Dunnett test.  
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Levels of   ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN, 
RAD50, Rad51 and STK111 mRNA  after exposure to bisphenol A (BPA) 
Short (1 week) and long term (30 weeks) effects of exposure to bisphenol A (BPA) are 
shown for MCF10A cells in Figure 3.57 and MCF10F cells in Figure 3.58.  The short-term 
effect of exposure showed a significant reduction in expression of PTEN mRNA in MCF10A 
cells.  The long-term effect of exposure to BPA was a significant reduction in expression of 
ATM, ATR, BRCA2, BRIP1, CHK1, PALB2 and PARP1 mRNA in MCF10A cells; in all but 
one of these (CHK1)  p<0.001.   
In MCF10F cells the short-term effect of exposure to bisphenol A (BPA) was a significant 
reduction in expression of CHK2 mRNA.  However, the long-term effect of exposure was a 
significant reduction in expression of BRIP1, CHK2, PALB2, PARP1, PTEN, Rad50 and 
Rad51 mRNA in the same cells.  P53, ATR and STK111 gave high mean values with poor 
variance. 
MCF10A cells 
 
FIGURE 3.57 Real-time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10A cells 
following short term (A) or long term (B) exposure to bisphenol A (BPA) 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M bisphenol A (BPA). The relative expression of ATM, ATR, 
BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values.  * indicates p˂ 0.05, ** p˂ 0.01 *** p˂ 0.001 compared 
to control by one way ANOVA with post-hoc Dunnett test.  
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MCF10F cells  
 
 
FIGURE 3.58   Real-time RT- PCR analysis of ATM, ATR, BRCA2, BRIP1, CHK1, CHK2, 
p53, PALB2, PARP1, PTEN, Rad50, Rad51 and STK111 mRNA in MCF10Fcells 
following short term (A) or long term (B) exposure to bisphenol A (BPA) 
 
Cells were grown in stock medium for 1 week (A) or 30 weeks (B) with no addition (control) 
or in the presence of 10-5M bisphenol A (BPA). The relative expression of ATM, ATR, 
BRCA2, BRIP1, CHK1, CHK2, p53, PALB2, PARP1, PTEN,Rad50, Rad51 and 
STK111mRNA were normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values.  
* indicates p˂ 0.05, ** p˂ 0.01 compared to control by one way ANOVA with post-hoc 
Dunnett test.  
 
 
 
 
 
 134 
 
3.4.5  Level of BRCA1 protein after exposure to bisphenol A (BPA) 
Figure 3.59 shows the effect of long term exposure to bisphenol A (BPA) on expression of 
BRCA1 protein using western Immunoblotting in MCF10A cells.  The image at A is a 
qualitative photograph shown above a quantitative plot (B).Figure 3.60 shows the effect of 
long term exposure to bisphenol A (BPA) on expression of BRCA1 protein using western 
Immunoblotting in MCF10F cells. Both qualitatively (A) and quantitatively (B).In plot B for 
MCF10A cells both E2 and BPA significantly reduce protein accumulation; for MCF10F 
cells only BPA induces a reduced protein level.    
 
                        
FIGURE 3.59 Level of BRCA1 protein in BPA treated MCF10A cells using western 
Immunoblotting. 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10A human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M bisphenol A (BPA) compared to 
10-8M oestradiol (E2). 
 ** indicates p˂ 0.01, *** p˂ 0.001 and compared to control by one way ANOVA with 
post-hoc Dunnett test. 
 
A 
B 
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FIGURE 3.60 Level of BRCA1 protein in BPA treated MCF10F cells using western 
Immunoblotting. 
BRCA1 protein levels were normalised to total protein using BioRad stain-free technology. 
BRCA1 protein levels in MCF10F human breast epithelial cells were observed after 30 
weeks of no addition (control) or in the presence of 10-5M bisphenol A (BPA) compared to 
10-8M oestradiol (E2).  
 
** indicates p˂ 0.01 and compared to control by one way ANOVA with post-hoc 
Dunnett test. 
 
 
3.4.6  Summary of results using Bisphenol-A 
A visual overview of the relevant results appears in Table 3.4.  As with the other agents 
tested neoplastic transformation is exhibited on exposure and DNA repair mechanism-
related mRNA and protein levels change after 30 weeks, consistent with a reduction in the 
cells’ homoeostatic capacity.   
A 
B 
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TABLE 3-4  Summary of Bisphenol-A results 
 
ASSAY MCF10A MCF10F 
Colony growth in methocel: 
number or size of colonies 
Dose response for all 
parameters showing 
exponential rise with 
concentration 
Dose response for all 
parameters showing 
exponential rise with 
concentration 
Colony growth in methocel: 
total cell count 
Mirrors colony growth Mirrors colony growth 
Comet assay Only significantly longer tails 
at 24h. Comet numbers with 
BPA < with DES but 
>control 
Tail length increased by 
BPA over DES and control.  
Numbers reduced at 
concentration tested 
BRCA1 mRNA & protein mRNA drops at 30 weeks.  
Protein expression reduced 
at 30 weeks by E2 & BPA 
Short term rise in BRCA 
mRNA followed by drop 
below controls at 30 weeks 
Protein falls at 30 weeks in 
response to BPA only 
Other DNA repair mRNAs ATM, ATR, BRCA2, BRIP1, 
CHK1, PALB2, PARP1, 
suppressed after 30 weeks 
exposure. CHK1 raised. 
High values associate with 
large variances 
CHk2 significantly lower at 1 
week. Consistent 
suppression of mRNAs by 
30 weeks except or ATR, 
P53 and STK111 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 137 
 
3.4.7  Discussion of results of exposure to Bisphenol A (BPA) 
 
The results described here demonstrate that exposure of non-transformed human breast 
epithelial cells to BPA yield results strikingly similar to those obtained using the other 
chemicals the cyclosiloxanes, Lilial and triclosan.  BPA is described here enabling 
anchorage-independent growth of three-dimensional colonies in methocel-based medium, 
increasing in efficacy between 10-10 and 10-5M. It can also cause comet formation, 
indicating DNA damage and can reduce levels of mRNAs encoding DNA repair proteins. 
Most notably, levels of both BRCA1 mRNA and BRCA1 protein were reduced after long-
term exposure to 10-5M BPA. Dose-responses of BPA and after1 week exposure were not 
equivalent to those after longer exposure times (30 weeks). An overall summary of the 
results is given in Table 3-4   
 
3.4.7.1 Anchorage independent colony formation 
The results demonstrate that exposure of non-transformed human breast epithelial cells to 
Bisphenol A (BPA) can enable anchorage-independent growth in methocel culture. The 
reactions to BPA encountered in this study were similar to those for triclosan in that there 
was a clear positive association between concentration and colony growth, whether 
measured as colony size, or colony numbers or cell count between 10-10 and 10-5M. 
BPA has been shown to cause proliferation of breast cancer cells in monolayer culture 
(Soto et al., 2008), but these experiments show that BPA can enable growth of non- 
transformed breast cells in suspension culture. This is an indication that the cells have 
attained a transformed phenotype and can now grow unattached to a matrix in the manner 
of cancer cells. (Soule et al., 1979) 
 
3.4.7.2 DNA damage assessed by comet assay 
Comet tail length was enhanced by 10-5M BPA treatment.  Comet assays with BPA 
included different exposure times from 1 hour to 24 hours.  A 24 hr exposure yielded more 
comets and longer tails than a 1-hour exposure.   The type and irreversibility of DNA 
damage by BPA due to repair failure was defined using comet assays by Tayama et al 
2008. They were, however, not able to explain their observation that different DNA damage 
was effected by E2 (chromosome abnormalities but not DNA migration), compared to DES 
and the oestrogen-like chemicals tested – which included BPA.  Timing is important in all 
such studies, as while initial DNA damage may cause genetic signs of enhanced repair 
activity in the short-term, longer continued insults may cause cells to switch to a suicide 
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mode.  In terms of cancer induction it is important to distinguish between damage that can 
be repaired, damage that induces cell death and the critical medium level and gene specific 
pro-carcinogenic damage that causes aberration of cell cycle control but is not fatal to the 
cell clone.  
 
  
3.4.7.3  DNA repair gene mRNA and protein products 
 
BPA shows more differential molecular genetic responses between the two cell lines than 
the other agents.  There is a sharp short-term increase in BRCA1 mRNA as well as smaller 
long-term rises in CHK2 and P53 in MCF10F cells.  In both animals and humans, loss of 
normal BRCA1 function increases sensitivity to genotoxic insults, through defective DNA 
repair (Jones et al., 2010).  BPA is included in this study as, although it is not a cosmetic  
ingredient, it is used in the packaging of many consumer products and  it is currently 
undergoing intense regulatory scrutiny as a potential environmental endocrine disrupter and 
mutagen.  Over 6 billion pounds per year of BPA are used to manufacture polycarbonate 
plastic products, in resins lining metal cans, in dental sealants, and in blends with other 
plastics (Welshons et al., 2006). The ester bond linking BPA molecules can undergo 
hydrolysis, resulting in the release of free BPA into food, beverages, and the environment. 
In vitro dose responses to BPA resemble oestradiol, causing changes in a range of cell 
functions at concentrations between 1 pm and 1 nm, according to a systematic review by 
Vom Saal (Vom Saal 2007).   
 
Russo et al (2012) published molecular genetic studies on MCF10F cells that bears some 
direct comparison to the work presented here.  They used microarrays to quantify the 
expression of mRNA to from a panel of DNA repair related and apoptosis controlling genes 
after a 2 week exposure to BPA at 10-5 and 10-6M concentration.  The cells showed an 
increased expression of BRCA1, BRCA2, BARD1, CtIP, RAD51, and BRCC3 (DNA repair 
related genes) and down-regulation of PDCD5 and BCL2L11, both apoptosis pathway 
genes. The DNA methylation analysis indicated hypermethylation of BCL2L11, PARD6G, 
FOXP1, and SFRS11, and hypomethylation of NUP98 and CtIP (RBBP8) after exposure to 
BPA.  The overlap between genes studied by Russo and in this work is not extensive, but 
both  indicate that normal human breast epithelial cells exposed to BPA tend to increase 
the expression of genes involved in DNA repair in order to overcome the DNA damage 
induced by this chemical, at least in the short term (1 or 2 weeks).  In the present study 
although this was clearly a trend over the range of genes studied, high variability limited the 
number of statistically significant rises at 1 week.  The subsequent drop below control levels 
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after 30 weeks exposure was statistically more robust but the stand-out genes (ATR, P53 
and STK111) that countered this trend with elevated results also suffered high variability. 
 
 
Despite its different source as an environmental hazard, the reactions to BPA encountered 
in this study were similar to those for Lilial or triclosan in terms of anchorage independent 
colony growth and comet formation.  Comet tail length was particularly enhanced by BPA 
treatment.  However, BPA shows more by way of differential molecular genetic responses 
to the two cell lines than the other agents.  There is a short-term sharp increase in BRCA1 
mRNA as well as more modest long-term rises in CHK2 and P53 in MCF-10F cells.  This is 
of particular interest as Dairkee (2013) shows, in HRBEC cell lines, inactivation of the “p53 
axis” by this material, leading to deregulation of proliferation kinetics. 
 
 
3.4.7.4  Relevance of this work to human exposure  
There are many studies which have been conducted to address the issue of the potential 
for BPA to impact human health as well as wildlife: more research is clearly needed. The 
formulation of hypotheses underpinning epidemiological and ecological studies can be 
facilitated by extrapolation from laboratory animal studies when potential mechanistic 
pathways are similar in laboratory animal models, wildlife and humans (Michalowicz, 2014, 
Vom Saal  2007).  This review highlights the circumstance that while traditional toxicological 
studies – mostly on animals – involve high dosages, these do not reflect the lifelong 
exposure to low concentrations of BPA that characterise the human experience in 
developed countries. 
 As a ubiquitous plastics constituent it is, in the modern era, difficult to assemble suitable 
control subjects for epidemiological studies.  Similarly it is difficult to establish truly relevant 
exposure conditions in the design of cell culture experiments, especially where monolayers 
of a single cell type on a non-organic substrate are envisaged.  It is necessary to construct 
mechanistic hypotheses by considering results from a range of approaches.  
 The American National Health and Nutrition examination Survey concludes that the 
average consumption of BPA was 34ng/kg/day  (Lakind and Naiman, 2011).  Uptake by 
individuals was not related to consumption of bottled water or canned tuna (which had been 
suspected), but was associated with soft drinks, school meals and meals “prepared outside 
the home” – presumably referring primarily to “fast food”.  
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BPA has been detected and measured in urine and milk (Hines et al., 2015) in Californian 
women. BPA was found in >53% of urine samples, but less frequently in milk.  Overall, Hine 
considers urine to be the most reliable (as well as more readily available) vector for 
exposure assessment. BPA exposure as so estimated did not correspond quantitatively to 
other measurements, including triclosan, suggesting “considerable variability” in exposures.  
Certainly the route of exposure to BPA and triclosan is different, the former being through 
leaching from plastic containers, the latter from direct skin application in cosmetic 
preparations or from oral intake in mouthwashes and toothpaste. 
 
BPA is readily transported around the body and in pregnant mice it is found to accumulate 
in foetuses, leading to increased mammary cancer susceptibility in later life (Doherty et al, 
2010). Exposure of prepubertal rats has similar consequences on proteomics and cancer 
incidence (Betancourt et al., 2012).  However its role in human breast cancer is less well 
documented, with Yang (Yang et al., 2009) claiming that although there is a positive 
association between BPA and other risk factors, no direct effect was observed on exposure 
and cancer incidence between 167 cancer and control subjects. In this study, there does 
seem to be a direct relationship between exposure and cellular responses, particularly the 
colony assay, where a whole-cell and inter-cell phenotypic response is seen, rather than 
the individual narrow measures of genetic expression measurements.  Taken together, all 
of the assay modes in this study point towards concerted pro-carcinogenic influences of 
BPA.  
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3.5  Aluminium chloride and aluminium chlorohydrate 
This study has been published (Farasani and Darbre, 2015). The results demonstrated that 
exposure to aluminium salts causes DNA damage, as measured using a comet assay, and 
down regulation of five of the panel of mRNAs regarded as essential for detection and 
repair of DNA double strand breaks in MCF10A cells. The effect of the aluminium salts on 
suspension growth of MCF10A cells has already been previously documented (Sappino et 
al., 2012). 
3.5.1 Comet assay of DNA damage after exposure to aluminium chloride and 
aluminium chlorohydrate 
An alkaline single-cell gel electrophoresis (SCGE) technique was employed to detect single 
strand and labile DNA adducts in the immortalised human breast epithelial cell line 
MCF10A after exposure to Al chloride and Al chlorohydrate. Cells in the photomicrograph 
Figure 3.61 panel B & C (Al chloride and Al chlorohydrate respectively) show comet 
formation after 24 hours exposure.   
The bar charts in Figure 3.62 show comet tail length to correlate with percent of cells 
forming comets (i.e. with damaged DNA) in MCF10A cells.  However there is a shifted peak 
to the dose responses between the compounds, with 10-5M Al chloride producing the 
longest tails and highest numbers of comets in MCF10A and 10-6M affecting these 
parameters maximally for the chlorohydrate 
    
           
A)-Control         B) Al chloride treated 24 hours    C: Al chlorohydrate treated 24 hours 
FIGURE 3.61 Comet assay for detection of DNA damage in MCF10A cells exposure to 
Al chloride and Al chlorohydrate. 
Panel A is of untreated cells (control) treated for one hour. B) Cells treated with 10-5 M Al 
chloride treated 24 hours. C)  10-5 M Al chlorohydrate treated 24 hours. Cells viewed by 
fluorescence microscopy. 
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Al Chloride 
       
AL chlorohydrate    
   
FIGURE 3.62   Effect of Al chloride and Al-chlorohydrate on DNA damage in MCF10A 
human breast epithelial cells as assessed by a comet assay. 
Cells were grown in stock medium and treated one hour with untreated cells 
(control).Treated cells with 10-4M Al chloride and Al chlorohydrate. Treated cells with 10-5M 
Al chloride and Al chlorohydrate, 10-6M Al chloride and Al chlorohydrate,10-7M Al chloride 
and Al chlorohydrate, 10-8M Al chloride and Al chlorohydrate. Error bars represent standard 
deviation of 50 comets scored.  
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3.5.2  Aluminium:  Effect of mRNA expression of DNA repair genes: 
A time period of 19–21 weeks was chosen in line with previously published gene 
expression studies on Al in human breast cells  and mRNA/protein samples were 
harvested from independent cell cultures after 19, 20 and 21 weeks to ensure biological 
replicates. The concentration of 10−4 M Al was chosen for study as the highest 
concentration of Al which had previously been shown to have no detrimental effect on 
proliferation of human breast cells in the long term (Darbre, 2005a). 
Levels of BRCA1 mRNA after exposure to Al chloride and Al chlorohydrate 
 Long term (19-21 weeks) effects of exposing  MCF10A cells (Figure 3.61)  to 10−4 M 
concentration of Al chloride and Al chlorohydrate in terms of levels of mRNA for BRCA1, 
was investigated using RT-PCR.  Highly (p<0.001) significant reductions were found after 
long term (19-21 weeks) exposure to Al chloride and Al chlorohydrate in MCF10A cells.    
 
FIGURE 3.63  Real-time RT- PCR analysis of BRCA1 mRNA in MCF10A cells 
following long term (19-21 weeks) exposure to Al chloride and Al-chlorohydrate. 
Cells were grown in stock medium for 19-21 weeks  with no addition (control) or in the 
presence of 10-4M Al chloride and  10-4M Al chlorohydrate. The relative expression of 
BRCA1 mRNA was normalised to that of the endogenous control β-actin mRNA, and 
average values calculated for triplicate technical replicates. Results are shown ± standard 
error for biological triplicate values. *** indicates p˂ 0.001 compared to control by one 
way ANOVA with post-hoc Dunnett test.  
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Levels  of ATR, BRCA2, CHK1, CHK2 and  Rad51 mRNA after  exposure to Al 
chloride and Al chlorohydrate 
Long term (19-21 weeks) effects on MCF10A cells (Figure 3.64) of exposure to 10−4 M 
concentrations of Al chloride and Al chlorohydrate in MCF10A cells was then investigated 
on a panel of other mRNAs. Al chloride gave a significant reduction in expression of 
BRCA2, CHK2, Rad51 and ATR mRNA. The long-term effect of exposure to Al 
chlorohydrate showed a significant reduction in expression of BRCA2, CHK1, CHK2, 
Rad51 and ATR mRNA. 
 
FIGURE 3.64  Real-time RT- PCR analysis of BRCA2, CHK1, CHK2, Rad51 and ATR 
mRNA in MCF10A following long term (19-21 weeks) exposure to Al chloride and Al 
chlorohydrate. 
Cells were grown in stock medium for 19-21 weeks  with no addition (control) or in the 
presence of 10-4M Al chloride and  10-4M Al chlorohydrate. The relative expression of 
mRNAs were normalised to that of the endogenous control β-actin mRNA, and average 
values calculated for triplicate technical replicates. Results are shown ± standard error for 
biological triplicate values. Results are shown ± standard error for biological triplicate 
values.  
*indicates p˂ 0.05 *** p˂ 0.001 compared to control by one way ANOVA with post-
hoc Dunnett test.  
 
 
 145 
 
3.5.3 Immunoblotting for BRCA1 protein after exposure of cells to Al 
The effect of long term exposure to Al chloride and Al chlorohydrate on expression of 
BRCA1 protein using western Immunoblotting in MCF10A cells is shown in Figure 3.65.  
Both agents reduce expression, the chloride result (p<0.05) less strongly significant than 
the chlorohydrate (p<0.01).  This is evident visually in the photograph (A) as well as 
quantitated the histogram (B).  The higher level of significance in the chlorohydrate result 
is also consistent with a greater drop in expression.                                                                                      
 
  
FIGURE 3.65  Level of BRCA1 protein in Al chloride and Al chlorohydrate treated 
MCF10A cells using western Immunoblotting. 
BRCA1 protein levels were normalised to β-actin using BioRad stain-free technology. 
BRCA1 protein levels in MCF10A human breast epithelial cells were observed after 19-21 
weeks of no addition (control) or in the presence of 10-4M Al chloride and 10-4 M Al 
chlorohydrate compared to control. * indicates p˂ 0.05**  p˂ 0.01 and compared to 
control by one way ANOVA with post-hoc Dunnett test. 
 
 
  B 
A 
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3.5.4  Summary of results using Aluminium salts 
These results do not include the anchorage independent growth assay.  The comet assay 
for DNA damage and the effects of exposure on mRNA and protein expression in a panel of 
DNA repair related genes indicate, as with the other cosmetic constituents tested, an ability 
to compromise cellular integrity and drive cells towards an immortal growth pattern. 
 
 
TABLE 3-5 Summary of Aluminium results 
 
ASSAY MCF10A Al chloride MCF10A Al Chlorohydrate 
Comet assay Both tail length and comet 
numbers peak at 10-5M 
Both tail length and comet 
numbers peak at 10-6M  
BRCA1 mRNA & protein Expression reduced p<0.05 Expression reduced p<0.01 
Other DNA repair mRNAs mRNA drops markedly for 
all genes tested:  ATR, 
BRCA2, CHK2, RAD51, Not 
CHK1 
mRNA drops markedly for 
all genes tested:  ATR, 
BRCA2, CHK1, CHK2, 
RAD51 
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3.5.5  Discussion of results of exposure to aluminium 
3.5.5.1  The present study 
The results demonstrate that non-transformed human breast epithelial cells exposed to Al 
chloride and Al chlorohydrate, can cause comet formation, i.e. DNA fragmentation and also 
reduces expression of mRNAs encoding DNA repair proteins. Both BRCA1 mRNA and 
BRCA1 protein were reduced, but only after long-term exposure to the Al chloride and Al 
chlorohydrate. The effect of the aluminium salts on suspension growth of MCF10A cells has 
already been previously documented (Sappino et al., 2012). An overall summary of the 
results is given in Table 3-5. The main differences between the two salts lies in the comet 
and BRCA1 gene assays, as indicated in detail below. 
3.5.5.2  DNA damage assessed by comet assay 
In the present study only the MCF10A cell line was assessed.  Aluminium formulations 
produced visually classical comets. Both Al chloride and Al chlorohydrate induced comets.  
Cells were more sensitive to the chlorohydrate than the chloride in this assay, here being 
an order of magnitude between peak result concentrations (10-5M for the chloride, 10-6M for 
chlorohydrate. This adds weight to the previous report demonstrating that Al chloride could 
cause double strand breaks in the DNA of MCF10A cells (Sappino et al 2012). 
 
3.5.5.3  DNA repair gene mRNA and protein product expression 
Exposure of MCF10A cells to both forms of aluminium results in a reduction of intracellular 
levels of BRCA1 mRNA and of BRCA1 protein, changes that would work towards impaired 
DNA repair.  Apart from BRCA1, all mRNAs measured in the 5-member repair-gene panel 
tested were significantly reduced by Al chlorohydrate after a 20 week exposure period.  
Incubating with Al chloride, only CHK1 was not significantly reduced. In the present study 
exposure of MCF-10A cells results in a reduction of intracellular levels of BRCA1 mRNA  
and of expressed protein, changes that would work towards impaired DNA repair.  Results 
were similar with other members of the repair-gene panel over a long exposure period.  
Only CHK1 was not significantly reduced after exposure to aluminium chloride; the 
chlorohydrate results were all significantly reduced and to a greater extent.   The results 
add weight to the concept of aluminium as present in antiperspirants may adversely affect 
cancer risks through impairing repair of DNA damage. 
3.5.5.4  Physiological relevance of these studies  
 
Despite the limited and apparently high concentrations of Al used, the Al concentration (10− 
4 M) used in these experiments is not inconsistent with measurements of Al in human 
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breast tissues, which can also be high, Levels of Al in ranging from 4–437 nmol/g dry 
weight of tissue (Exley et al, 2007). Assuming this is about 20% of wet weight and the 
relative density to be not far from unity these levels calculate out  to 0.80 × 10− 6 M–0.87 × 
10− 4 M. Nipple aspirate fluids have been recorded ranging from 150–520 μg/l (mean 268.4 
± 28.1 μg/l) (House et al, 2013) i.e. 0.56–1.93 × 10− 5 M.  The concentrations of Al used in 
this study can therefore be seen in clinical situations. 
 
The impact of aluminium on the breast microenvironment is likely to play an increased role 
in populations both living longer and using more cosmetics over a long period of time.  
However, so far only one out of three epidemiological studies has shown a link between 
aluminium and breast cancer (McGrath, 2003), with incidence of disease occurring at an 
earlier age with greater use.  The negative studies are those of Mirick (Mirick et al., 2002) 
and Fakri (Fakri et al., 2006).  The impact of aluminium in combination with other mutagens 
&/or endocrine disruptors has yet to be investigated in terms of the lowest observed effect 
concentrations (LOEC) or the equivalent parameter from no observed effect (NOEC). 
There is however more aluminium found in breast tissue than in blood (Darbre, 2016), 
which suggests accumulation or a means of  delivery other than through the circulation. 
The effects of aluminium in combination with other mutagens is identified as an important 
topic for future research (Darbre 2015). 
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Chapter 4 General Discussion 
 
 
This project reports experimental results demonstrating the ability of the selected potentially 
genotoxic compounds to influence genomic instability through DNA damaging activity 
and/or through compromising DNA repair processes. Many environmental compounds 
which can enter human breast tissue have been characterised as possessing activity which 
can drive the hallmark of sustained proliferative signalling in oestrogen responsive breast 
epithelial cells (Darbre, 2015). However, these results demonstrate that the compounds 
tested here (cyclosiloxanes, Lilial, triclosan and bisphenol A and aluminium salts) can also 
influence genomic instability, which is an enabling characteristic underpinning the 
development of the hallmarks of cancer (Hanahan and Weinberg, 2011). 
 
Transforming properties of each of the endocrine disrupting chemicals were studied using 
the MCF10A and MCF10F cell lines by their ability to enable anchorage-independent 
growth of these non-transformed human breast epithelial cells. All three of the 
cyclosiloxanes, Lilial, triclosan and bisphenol A were found to induce dose-dependent 
increase in colony formation in semi-solid methocel suspension culture. Aluminium salts 
were not tested for this property because they had already been reported to induce growth 
of MCF10A cells in suspension culture  (Sappino et al., 2012) In line with previously 
published data (Russo and Russo, 2006), exposure to 70nM 17β-oestradiol induced colony 
formation in each experiment. The ability of non-transformed epithelial cells to grow under 
anchorage-independent conditions has long been acknowledged as an in vitro property 
which correlates with tumour growth in vivo (Shin et al, 1975). Use of the MCF10A and 
MCF10F immortalised cell lines has been validated by Russo and Russo as an assay 
showing that exposure to high concentrations (70nM) of 17β-oestradiol can induce 
transforming properties in these cells (Russo et al., 2006).  Therefore, it can be concluded 
that exposure to these compounds can also induce a transformed phenotype in human 
breast epithelial cells. 
 
Comet assays did demonstrate DNA damage following exposure to some of these 
compounds but the assay gave less clear-cut results, with comets not always being of a 
classical appearance and with disparity between tail length and percent of comet producing 
cells.  Exposure to 10-5M DES, which was used as a positive control, gave comets each 
time  is line with previously published data (Anderson et al., 1998). However, the contrast 
between genotoxically stimulated and totally unstimulated cell populations is clear in that 
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exposure to such materials invariably resulted in enhanced comet formation.  Tail length 
and proportions of comet-forming cells gave opposite dose responses to cyclosiloxanes, 
tails becoming more common but shorter with increasing concentration of agent. This 
pattern was also obtained with triclosan, but Lilial gave increasing tail length and comet 
numbers the positive association extending over the entire concentration range. These 
results presented here can be interpreted as variations in sensitivity between chemicals, 
illustrated well with the two aluminium formulations, where both gave a peaked dose 
response curve for comet assays, but the chlorohydrate one was shifted to the right – i.e. 
the sensitivity of the cells was lower to this compound.  
 
RTPCR assays demonstrated that exposure to these compounds did result in alterations to 
mRNA levels of several DNA repair proteins. Importantly, effects after one week (short 
term) were often not the same as effects observed after 30 weeks (longer term) exposure.  
Exposure for one week did not give consistent and significant changes in mRNA from the 
panel of 14 DNA repair genes.  However, in MCF10A BRCA1 mRNA expression was raised 
after one week, but lowered by 30 weeks of exposure to D3 and D4 relative to untreated 
cells.  This could be interpreted as an initial attempt to correct damage, eventually the effort 
being withdrawn when damage limitation became impossible.   Indeed, the reduction in 
BRCA1 mRNA was paralleled by loss of the BRCA1 protein.   After long-term exposure, 
levels of several of the other members of the panel of mRNAs were reduced.  If loss of the 
other mRNAs were found to also be paralleled by loss of the relevant protein, then this 
could imply reduced capacity within the cell for DNA repair which would lead to genomic 
instability.  This loss of DNA repair capability, coupled with actual DNA damage visualised 
in the comet assays after prolonged exposure to these cosmetic chemicals is the feature of 
these results with greatest practical impact potential (Maqbool 2016). 
Inheritance of loss of function of the BRCA1 gene is a well-established risk factor for 
susceptibility to breast cancer development (Betancourt et al., 2012).  The BRCA1 gene 
was identified,  and cloned in 1994 (Lalle et al., 1994) based on its linkage to early onset 
breast cancer and to familial multi-cancer syndromes that included breast cancer.  It is 
rarely mutated in sporadic breast cancer (Rosen et al., 2003).  It transpired to be recessive 
and therefore acting as a “tumour suppressor gene”, pathology being activated by loss of 
heterozygosity. The normal physiological significance of the gene transpired to be as a key 
factor in DNA repair, acting to prevent DNA polymerase stalling and facilitate chromatid 
recombination (Scully, 2000).  This is a first report that BRCA1 gene expression can also be 
reduced following exposure to environmental chemicals which are used routinely in 
personal care products and to bisphenol A which is used widely in plastic products.  
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Work using the alkyl esters of p- hydroxybenzoic acid (parabens) has demonstrated that 
assessment of functional significance requires consideration of combined effects where 
multiple forms are present simultaneously. Barr et al (2012) detected five paraben esters in 
60% of human breast tissues and whilst some parabens might be present individually at 
concentrations sufficient to stimulate proliferation of human breast cancer cells in vitro, 
parabens in other tissues reached functionally significant levels for proliferation only when 
all five esters were combined (Charles and Darbre, 2015). It is therefore possible that 
similar additive effects might occur for genotoxic end points if mutagenic compounds are 
co-located at lower concentrations than those needed for each to act individually. The main 
unknown element here remains as to how much of each of these compounds tested in this 
thesis are actually present in human breast tissue. Future studies are needed to measure 
concentrations of cyclosiloxanes, Lilial and triclosan in human breast tissue in order to 
inform future in vitro assay work.  
In the present study, the effects of triclosan are consistent with those of the cyclosiloxanes, 
particularly  D4 & D5 and with Lilial, showing similar dose responsiveness in tests for 
anchorage independent colony formation, DNA clastogenicity and suppression of DNA 
repair mechanism genes by both RT PCR and Western blotting techniques. Since the 
MCF10A/10F cells are non- transformed it would be interesting to repeat these studies in 
cancer cells, such as the MCF7 human breast cancer cell line. Although MCF7 cells grow in 
suspension culture and have a non –diploid genotype, it would be interesting to know 
whether DNA repair system can be compromised by these elements in cancer cells as well.     
 
 
Overall, the study presented here demonstrates that the environmental genotoxic 
compounds tested modified gene and protein expression as well as behavioural 
characteristics of individual near-normal cells in monoculture models in a manner that is 
highly suggestive of a role for these compounds in breast cancer aetiology and progression. 
The experiments presented here do not prove carcinogenicity or tumour promoting 
properties, but are strongly suggestive of either or both of these actions if the effects 
translate into a whole-body situation.  The chemicals studied here have been detected in 
the environment and have been shown possess endocrine disruption properties. However 
less is known about genotoxic properties.   
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Serious controversy arises when human activity and preferences are involved.  At one 
level, there is also little doubt that breast cancer has some hormone dependence, it may 
regress on ovariectomy in premenopausal women (Ingle et al., 1986). However, the 
epidemiological impact of endocrine disrupting chemicals, including those of underarm 
cosmetic preparations, in the development of breast cancer is still controversial after a 
decade of study.  A World Health Organisation report in 2013 authored by Bergman et al 
was cautiously supportive of there being a pathogenic effect, trending in parallel with 
exposure (WHO-UNEP, 2013).  This drew harsh criticism from a large group of 
stakeholders (Lamb et al., 2014), sufficiently strident to attract an equally strongly worded 
rebuttal, describing Lamb’s critique as “industry sponsored”, from a group of authors 
headed by Bergman (Bergman et al., 2015). 
A more academically oriented organisation, the Endocrine Society, published a ‘scientific 
statement’ in its journal Endocrine Reviews, where Diamante-Kandrakis  
(http://press.endocrine.org/edc) advocates a number of measures “invoking the 
precautionary principle” and the involvement of individual and scientific stakeholders to 
raise public awareness and implement changes in policy. This principle is discussed 
positively by Resnik and Kriebel  (Resnik, 2004, Kriebel et al., 2001) but criticised by 
Peterson (Peterson, 2006).  It is a principle that, if agreed upon, would apply to the 
projection of the results from this project, drive further lines of research and reach out to link 
with regulatory bodies and processes. 
In Europe, the Danish Environmental project No. 1531 (2014) and the European 
Commission’s Scientific committee on Consumer Safety (SCCS) have produced reports 
covering products including the cyclosiloxanes.  The former concluded that “No human data 
regarding carcinogenic effects following exposure to D3, D4, D5 and D6 have been 
located”.  The SCCS (SCCS_1241_10) held a 3rd round-table meeting in May 2015 to 
evaluate progress in their investigations; this timing illustrates the complexity in achieving a 
consensus.   There is a need to involve heads of academic faculties and research 
laboratories more widely and openly in discussing the way in which biochemistry and 
biology at levels through in vitro and animal models can inform the likely relevance of these 
absorbable chemicals. Co-operation with industry can touch on carcinogenic or cancer 
promoting effects and to promote rational research into the development of less harmful 
alternatives.  
There are consistent risk/benefit balances to be struck and apparent paradoxes to solve in 
the exposure to compounds for legitimate purposes that might however have unintended 
consequences.  For instance regarding antimicrobials and preservatives, while the present 
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study highlights risks to the general population from triclosan exposure, Sadowski (2016) 
suggests triclosan as a potential prostate cancer therapy, due to its ability to inhibit fatty 
acid synthase. It is no coincidence that most cancer chemotherapeutics are toxic.  They are 
used specifically because they kill or disable cells analyses are necessary in these 
circumstances. 
 
All of the compounds tested here on the near-normal (immortalized) MCF10 breast cancer 
epithelial cell lines showed positive results in a phenotypic assay of anchorage independent 
3-dimensional colony formation range of genotoxicity tests, including  characteristics, DNA 
fragmentation and DNA repair gene function.   It is therefore appropriate that these results 
should now be incorporated into risk assessment of long –term exposure to personal care 
products. Previous studies have tended to report only short effect over few days, but these 
provided a new  relevance to long term exposure of the human breast to these chemicals.    
In vitro studies are always limited by the lack of physiological interaction between organ 
systems.  Monoculture models, as used here, suffer the additional disadvantage of lacking 
contact based or paracrine interaction between cell types.  However, monoculture models 
using established cell lines are useful due to the reproducibility of results and by lending 
themselves to high throughput assay systems. Future studies are needed for 
measurements in breast tissue.   
The MCF-10A & 10F cells complement the earlier studies performed in Reading and 
elsewhere on the cancer-derived cell line MCF-7. Research programmes should in the 
future increasingly diversify from their origins in exogenous hormone mimicking or 
disruptive activity towards passage of chemicals through basal membrane constructs and to 
study how these chemicals gain access to cells, can be increasingly removed through efflux 
pumps or. Models including mesodermal cells such as fibroblasts, which can construct 
stromal elements around epithelial clusters, might also be informative. 
 
They indicate potential for carcinogenesis rather than progression. It is appropriate to start 
at the simplistic end of the experimental hierarchy and work upwards.  A further cell line 
exists in the MCF- series – MCF-12A.  It is a spontaneously immortalised normal breast 
epithelial cell line (https://www.atcc.org/~/ps/CRL-10782.ashx ), whereas, although non-
tumorigenic, the MCF-10 cells originated from a 36 year old breast with fibrocystic disease.  
Spontaneous immortalization is where a primary culture goes through a “crisis” in it 
propagation; most cells die (Hayflick, 1984, Hayflick, 2000) but some adapt by expressing 
telomerase into immortality. Spontaneous immortalization entirely generated in vitro might 
give different response patterns than cells derived from breast tissue where proliferative 
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pathologies already exist and there is locally abnormal interaction with mesenchymal 
stroma producing cells. 
Further experiments going up the experimental model hierarchy might involve co-culture 
with mesenchymal type cells such as fibroblasts.  These could be subsequently cleared 
from the cultures using a selective medium containing D-valine (which fibroblasts are 
reported not to tolerate (Gilbert and Migeon, 1975) . Further up the scale, in vivo models 
using xenotransplantation of cells that will form tumours in immunodeprived (‘nude’ or ‘scid’  
(Pantelouris, 1971, Bosma and Carroll, 1991))  mice or studies of mammary development in 
neonatal rodents after treatment of their parents, might be attempted.   Human studies 
might make use of tissue arrays for high throughput gene or protein expression.  Ultimately, 
epidemiological studies, although very hard to control, might with sufficient numbers of 
participants, provide answers that will be of use to regulatory authorities in determining safe 
usage of these compounds or banning them outright.  In that event, replacement 
compounds will be sought and developed and the whole investigatory cycle repeated. 
In conclusion, despite their limitation these studies provide evidence that these cosmetic 
chemicals can enable non- transformed cells to change towards a transformed phenotype 
with genomic instability. This raises the need for further research into their effects in 
combination at physiologically relevant doses and in animal models. These results should 
also be useful for including into future risk assessments.     
 
 
 
 
      
 
 
 
 
  
 155 
 
Chapter 5:  References 
 
ABDULRAHMAN, G. O., JR. & RAHMAN, G. A. 2012. Epidemiology of breast cancer in 
europe and Africa. J Cancer Epidemiol, 1, 915610. 
ABRAHAM, R. T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. 
Genes & Development, 15, 2177-96. 
ADOLFSSON, E., PETTERSSON M, AND, P. J. & J, S. 2002. Triclosan, a commonly used 
bactericide found in human milk and in the aquatic environment in Sweden. 
Chemosphere 46, 1485–1489. 
AHMED, M. & RAHMAN, N. 2006. ATM and breast cancer susceptibility. Oncogene, 25, 
5906-11. 
AL-KURAYA, K., SCHRAML, P., SHEIKH, S., AMR, S., TORHORST, J., TAPIA, C., 
NOVOTNY, H., SPICHTIN, H., MAURER, R., MIRLACHER, M., SIMON, R. & 
SAUTER, G. 2005. Predominance of high-grade pathway in breast cancer 
development of Middle East women. Modern Pathology, 18, 891-897. 
AL TAMIMI, D. M., SHAWARBY, M. A., AHMED, A., HASSAN, A. K. & ALODAINI, A. A. 
2010. Protein expression profile and prevalence pattern of the molecular classes of 
breast cancer - a Saudi population based study. BMC Cancer, 10,233 
ALSNER, J., YILMAZ, M., GULDBERG, P., HANSEN, L. L. & OVERGAARD, J. 2000. 
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. 
Clinical Cancer Research : an official journal of the American Association for Cancer 
Research, 6, 3923-31.  
 APFEL RJ, FISHER SM.   1984. To do no harm: DES and the dilemmas of modern 
medicine. New Haven: Yale University Press. ISBN 0-300-03192-0.  
ASCHENGRAU, A., COOGAN, P. F., QUINN, M. & CASHINS, L. J. 1998. Occupational 
exposure to estrogenic chemicals and the occurrence of breast cancer: an 
exploratory analysis. Am J Ind Med, 34, 6-14. 
AZZOUZ, A., RASCON, A. J. & BALLESTEROS, E. 2016. Simultaneous determination of 
parabens, alkylphenols, phenylphenols, bisphenol A and triclosan in human urine, 
blood and breast milk by continuous solid-phase extraction and gas 
chromatography-mass spectrometry. J Pharm Biomed Anal, 119, 16-26. 
BANASIK, A., LANKOFF, A., PISKULAK, A., ADAMOWSKA, K., LISOWSKA, H. & 
WOJCIK, A. 2005. Aluminum-induced micronuclei and apoptosis in human 
 156 
 
peripheral-blood lymphocytes treated during different phases of the cell cycle. 
Environ Toxicol, 20, 402-6. 
BANDARIAN, V., M.L. LUDWIG, AND R.G. MATTHEWS, 2003. Factors modulating 
conformational equilibria in large modular proteins: a case study with cobalamin-
dependent methionine synthase. Proceedings of the National Academy of Sciences 
of the United States of America, 100, 8156-63. 
BARDEESY, N., SINHA, M., HEZEL, A. F., SIGNORETTI, S., HATHAWAY, N. A., 
SHARPLESS, N. E., LODA, M., CARRASCO, D. R. & DEPINHO, R. A. 2002. Loss 
of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to 
transformation. Nature, 419, 162-7. 
BARTKOVA, J., GULDBERG, P., GRONBAEK, K., KOED, K., PRIMDAHL, H., MOLLER, 
K., LUKAS, J., ORNTOFT, T. F. & BARTEK, J. 2004. Aberrations of the Chk2 
tumour suppressor in advanced urinary bladder cancer. Oncogene, 23, 8545-51. 
BELL, D. W., VARLEY, J. M., SZYDLO, T. E., KANG, D. H., WAHRER, D. C., SHANNON, 
K. E., LUBRATOVICH, M., VERSELIS, S. J., ISSELBACHER, K. J., FRAUMENI, J. 
F., BIRCH, J. M., LI, F. P., GARBER, J. E. & HABER, D. A. 1999. Heterozygous 
germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, 286, 2528-31. 
BCNEFELD-LARGENSEN, E. & LONG, M. H., MV. ET AL. 2007. Endocrine-disrupting 
potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-
octylphenol in vitro: new data and a brief review. Environ Health Perspect, 115, 69-
76. 
BEN-JONATHAN, N. A. H., R   2001. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev, 
22, 724-63. 
BENSON, J. R., JATOI, I., KEISCH, M., ESTEVA, F. J., MAKRIS, A. & JORDAN, V. C. 
2009. Early breast cancer. Lancet, 373, 1463-79. 
BESSER, M., GANOR, Y. & LEVITE, M. 2005. Dopamine by itself activates either D2, D3 
or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective 
secretion of either IL-10, TNFalpha or both. J Ne Uroimmunol, 169, 161-71. 
BETANCOURT, A. M., WANG, J., JENKINS, S., MOBLEY, J., RUSSO, J. & 
LAMARTINIERE, C. A. 2012. Altered carcinogenesis and proteome in mammary 
glands of rats after prepubertal exposures to the hormonally active chemicals 
bisphenol a and genistein. The Journal of Nutrition, 142, 1382S-8S. 
BITSCH, N., DUDAS, C., KORNER, W., FAILING, K., BISELLI, S., RIMKUS, G. & BRUNN, 
H. 2002. Estrogenic activity of musk fragrances detected by the E-screen assay 
 157 
 
using human MCF-7 cells. Archives of Environmental Contamination and 
Toxicology, 43, 257-264. 
BONEFELD-JORGENSEN, E. C., LONG, M., HOFMEISTER, M. V. & VINGGAARD, A. M. 
2007. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-
n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. 
Environmental Health Perspectives, 115 Suppl 1, 69-76. 
BOSMA, M. J. & CARROLL, A. M. 1991. The SCID mouse mutant: definition, 
characterization, and potential uses. Annu Rev Immunol, 9, 323-50. 
BOULTON, S. J. 2006. Cellular functions of the BRCA tumour-suppressor proteins. 
Biochemical Society Transactions, 34, 633-45. 
BROOKE D, CROOKES MJ et al  2009 ww.gov.uk/government/uploads/ 
system/uploads/attachment_data/file/290561/scho0309bpqx-e-e.pdf 
BRZOZOWSKI, A. M., PIKE, A. C., DAUTER, Z., HUBBARD, R. E., BONN, T., 
ENGSTROM, O., OHMAN, L., GREENE, G. L., GUSTAFSSON, J. A. & 
CARLQUIST, M. 1997. Molecular basis of agonism and antagonism in the 
oestrogen receptor. Nature, 389, 753-8. 
BUISSON, R., DION-COTE, A. M., COULOMBE, Y., LAUNAY, H., CAI, H., STASIAK, A. Z., 
STASIAK, A., XIA, B. & MASSON, J. Y. 2010. Cooperation of breast cancer proteins 
PALB2 and piccolo BRCA2 in stimulating homologous recombination. Nature 
Structural & Molecular Biology, 17, 1247-54. 
BUCKLEY, D. 2007. Fragrance ingredient labelling in products on sale in the U.K. Br. J. 
Dermatol, 157, 295–300. 
BUSTIN, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription 
polymerase chain reaction assays. Journal of Molecular Endocrinology, 25, 169-
193. 
CALAFAT, A. M., YE, X., WONG, L. Y., REIDY, J. A. & NEEDHAM, L. L. 2008. Urinary 
concentrations of triclosan in the U.S. population: 2003-2004. Environ Health 
Perspect, 116, 303-7. 
CANTOR, S. B. & GUILLEMETTE, S. 2011. Hereditary breast cancer and the BRCA1-
associated FANCJ/BACH1/BRIP1. Future Oncology, 7, 253-61. 
CARCINOGENICITY, MUTAGENICITY AND REPRODUCTIVE TOXCITY. [ Available at] 
https://echa.europa.eu/documents/10162/13562/cmr_report_en.pd (Accessed: 05 
September 2016).      
 158 
 
CARLSON, J. C., STEFAN, M. I., PARNIS, J. M. & METCALFE, C. D. 2015. Direct UV 
photolysis of selected pharmaceuticals, personal care products and endocrine 
disruptors in aqueous solution. Water Research, 84, 350-61. 
CHARLES A. 2010. The oestrogenic and genotoxic properties of cosmetic chemicals in 
human breast epithelial cells. PhD thesis, University of Reading, UK  
CHARLES, A. K. & DARBRE, P. D. 2009. Oestrogenic activity of benzyl salicylate, benzyl 
benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer 
cells in vitro. Journal of Applied Toxicology : JAT, 29, 422-34. 
CHIANG, A., TUDELA, E. & MAIBACH, H. I. 2012. Percutaneous absorption in diseased 
skin: an overview. J Appl Toxicol, 32, 537-63. 
COLLINS, A. R. 2004. The comet assay for DNA damage and repair: principles, 
applications, and limitations. Mol Biotechnol, 26, 249-61. 
DALY, R. J., KING, R. J. & DARBRE, P. D. 1990. Interaction of growth factors during 
progression towards steroid independence in T-47-D human breast cancer cells. 
Journal of Cellular Biochemistry, 43, 199-211. 
DARBRE, P. & CHARLES, A. 2010. Environmental Oestrogens and Breast cancer: 
Evidence for Combined Involvement of Dietary, Household and Cosmetic 
Xenoestrogens Anticancer Research     30, 815-828  
DARBRE, P. D. 2005a. Aluminium, antiperspirants and breast cancer. Journal of Inorganic 
Biochemistry, 99, 1912-9. 
DARBRE, P. D. 2005b. Recorded quadrant incidence of female breast cancer in Great 
Britain suggests a disproportionate increase in the upper outer quadrant of the 
breast. Anticancer Research, 25, 2543-50. 
DARBRE, P. D. 2006. Metalloestrogens: an emerging class of inorganic xenoestrogens 
with potential to add to the oestrogenic burden of the human breast. Journal of 
Applied Toxicology : JAT, 26, 191-7. 
DARBRE, P. D. 2006a. Environmental oestrogens, cosmetic and breast cancer. Basic 
Practice & Research Clinical Endocrinology & Metabolism, 20, 121-143. 
DARBRE, P. D. 2010. Exposure to Environmental Estrogenic Chemicals and Breast 
Cancer. CML- Breast Cancer 22, 113-22. 
DARBRE, P. D. 2011. Personal Care Products and Breast Cancer. Encyclopedia of 
Environmental Health, 395-406. 
 159 
 
DARBRE, P. D. 2012. Molecular mechanisms of oestrogen action on growth of human 
breast cancer cells in culture. Hormone Molecular Biology and Clinical Investigation, 
9, 65-85. 
DARBRE, P. D. & HARVEY, P. W. 2008. Paraben esters: review of recent studies of 
endocrine toxicity, absorption, esterase and human exposure, and discussion of 
potential human health risks. Journal of Applied Toxicology : JAT, 28, 561-78. 
DARBRE, P. D. Endocrine Disruption and Human Health. Academic Press/ 
Elsevier,NY.2015.  
DARBRE, P. D. 2016. Aluminium and the human breast. Morphologie, 100, 65-74. 
DAVID, H. A. & GUNNINK, L. 1997. The Paired t Test Under Artificial Pairing. The 
American Statistician 51, 9–12. 
DEN HOND, E., TOURNAYE, H., DE SUTTER, P., OMBELET, W., BAEYENS, W., 
COVACI, A., COX, B., NAWROT, T. S., VAN LAREBEKE, N. & D'HOOGHE, T. 
2015. Human exposure to endocrine disrupting chemicals and fertility: A case-
control study in male subfertility patients. Environment International, 84, 154-60. 
DIDERICH, K., ALANAZI, M. & HOEIJMAKERS, J. H. 2011. Premature aging and cancer in 
nucleotide excision repair-disorders. DNA repair, 10, 772-80. 
DNA, GENES AND CHROMOSOMES. 2012. [Available at] 
http://www.vivo.colostate.edu/hbooks/genetics/medgen/index.html (Accessed: 03 
August 2016)      
DNA REPLICATION. 2006-2012. [Available at]  http://www.dnareplication.info/ (Accessed:    
03 August 2016).      
DNA STRUCTURE & DNA REPLICATION. 2000. [Available at]  http://www.biology- 
online.org/1/5_DNA.htm  (A) & 
http://legacy.etap.org/demo/biology1/lesson5/instruction1tutor.html (B) (Accessed: 03 
August 2016).   
DURANDE, M., KASS, L. & PIVA, J. E. A. 2007. Prenatal bisphenol A exposure induces 
preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 
115, BO-6. 
DURANT, S. T. & NICKOLOFF, J. A. 2005. Good timing in the cell cycle for precise DNA 
repair by BRCA1. Cell Cycle, 4, 1216-1222. 
DONG, X., WANG, L., TANIGUCHI, K., WANG, X., CUNNINGHAM, J. M., MCDONNELL, 
S. K., QIAN, C., MARKS, A. F., SLAGER, S. L., PETERSON, B. J., SMITH, D. I., 
CHEVILLE, J. C., BLUTE, M. L., JACOBSEN, S. J., SCHAID, D. J., TINDALL, D. J., 
 160 
 
THIBODEAU, S. N. & LIU, W. 2003. Mutations in CHEK2 associated with prostate 
cancer risk. Am J Hum Genet, 72, 270-80. 
DVORAK, H. F. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma 
generation and wound healing. The New England Journal of Medicine, 315, 1650-9. 
ECHA  cha.europa.eu/.../committee-for-risk-assessment-concludes-on-restricting-d4-and- 
d5 
 
ELKS J.  2014. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and  
Bibliographies. Springer. pp. 396.  
ENDOCRINE DISRUPTING CHEMICALS. 2015. [ Available at] 
http://press.endocrine.org/edc (Accessed: 10  October 2016)      
ENGELBERGS, J., THOMALE, J. & RAJEWSKY, M. F. 2000. Role of DNA repair in 
carcinogen-induced ras mutation. Mutat Res, 450, 139-53. 
 
EUKARYOTIC CELL CYCLE . [Available at] https://www.ncbi.nlm.nih.gov/books/NBK9876/ 
The Eukaryotic Cell Cycle - The Cell - NCBI Bookshelf (Accessed: 08 September 
2016). 
 
EXLEY, C., CHARLES, L. M., BARR, L., MARTIN, C., POLWART, A. & DARBRE, P. D. 
2007. Aluminium in human breast tissue. J Inorg Biochem, 101, 1344-6. 
 
EZZAT, A. A., IBRAHIM, E. M., RAJA, M. A., AL-SOBHI, S., ROSTOM, A. & STUART, R. 
K. 1999. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a 
young population. Medical Oncology, 16, 95-103. 
 
FAKRI, S., AL-AZZAWI, A. & AL-TAWIL, N. 2006. Antiperspirant use as a risk factor for 
breast cancer in Iraq. East Mediterr Health J, 12, 478-82. 
 
FAGBEMI, A. F., ORELLI, B. & SCHARER, O. D. 2011. Regulation of endonuclease activity 
in human nucleotide excision repair. DNA Repair, 10, 722-9. 
FARASANI, A. & DARBRE, P. D. 2015. Effects of aluminium chloride and aluminium 
chlorohydrate on DNA repair in MCF10A immortalised non-transformed human 
breast epithelial cells. Journal of Inorganic Biochemistry, 152, 186-9 
FARASANI A, DARBRE PD. 2016. Exposure to cyclic volatile methylsiloxanes (cVMS) 
causes anchorage-independent growth and reduction of BRCA1 in non-transformed 
human breast epithelial cells. Journal of Applied Toxicology.  DOI 10.1002/jat.3378 
 161 
 
FERLAY J, S. I., ERVIK M, ET AL. 2013. Cancer Incidence and Mortality Worldwide: 
[Online].  Available from: http://globocan.iarc.fr (link is external)]. 
FINKEL, T., SERRANO, M. & BLASCO, M. A. 2007. The common biology of cancer and 
ageing. Nature, 448, 767-74. 
FITZGERALD, M. G., BEAN, J. M., HEGDE, S. R., UNSAL, H., MACDONALD, D. J., 
HARKIN, D. P., FINKELSTEIN, D. M., ISSELBACHER, K. J. & HABER, D. A. 1997. 
Heterozygous ATM mutations do not contribute to early onset of breast cancer. 
Nature Genetics, 15, 307-10. 
FLAREND, R., BIN, T., ELMORE, D. & HEM, S. L. 2001. A preliminary study of the dermal 
absorption of aluminium from antiperspirants using aluminium-26. Food Chem 
Toxicol, 39, 163-8. 
FLASSBECK, D., PFLEIDERER, B., KLEMENS, P., HEUMANN, K., ELTZE, E. & HIRNER, 
A. 2003. Determination of siloxanes, silicon, and platinum in tissues of women with 
silicone gel-filled implants. Anal Bioanal Chem, 375, 356-62. 
FLATEN, T. P. 1990. Geographical associations between aluminium in drinking water and 
death rates with dementia (including Alzheimer's disease), Parkinson's disease and 
amyotrophic lateral sclerosis in Norway. Environmental Geochemistry and Health, 
12, 152-67. 
FORAN, C., BENNETT, E. & BENSON, W. 2000. Developmental evaluation of a potential 
non-steroidal estrogen: triclosan. Marine Environmental Research 50, 153-156. 
FRITZ, F. 2000. Estrogens, Estrogen Receptor and Breast Cancer IOS Press. Amsrerdam. 
FROHLICH, E. & SALAR-BEHZADI, S. 2014. Toxicological assessment of inhaled 
nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci, 15, 
4795-822. 
GATES, K. S. 2009. An overview of chemical processes that damage cellular DNA: 
spontaneous hydrolysis, alkylation, and reactions with radicals. Chem Res Toxicol, 
22, 1747-60. 
GATIDOU, G., THOMAIDIS, N. S., STASINAKIS, A. S. & LEKKAS, T. D. 2007. 
Simultaneous determination of the endocrine disrupting compounds nonylphenol, 
nonylphenol ethoxylates, triclosan and bisphenol A in wastewater and sewage 
sludge by gas chromatography-mass spectrometry. J Chromatogr A, 1138, 32-41. 
GEE, R. H., CHARLES, A., TAYLOR, N. & DARBRE, P. D. 2008. Oestrogenic and 
androgenic activity of triclosan in breast cancer cells. Journal of Applied Toxicology : 
JAT, 28, 78-91. 
 162 
 
GEENS, T., DIRTU, A. C., DIRINCK, E., MALARVANNAN, G., VAN GAAL, L., JORENS, P. 
G. & COVACI, A. 2015. Daily intake of bisphenol A and triclosan and their 
association with anthropometric data, thyroid hormones and weight loss in 
overweight and obese individuals. Environment International, 76, 98-105. 
GEENS, T., NEELS, H. & COVACI, A. 2012. Distribution of bisphenol-A, triclosan and n-
nonylphenol in human adipose tissue, liver and brain. Chemosphere, 87, 796-802. 
GILBERT, S. F. & MIGEON, B. R. 1975. D-valine as a selective agent for normal human 
and rodent epithelial cells in culture. Cell, 5, 11-7. 
GOMEZ, E., PILLON, A., FENET, H., ROSAIN, D., DUCHESNE, M. J., NICOLAS, J. C., 
BALAGUER, P. & CASELLAS, C. 2005. Estrogenic Activity of Cosmetic 
Components in Reporter Cell Lines: Parabens, UV Screens, and Musks. Journal of 
Toxicology and Environmental Health, Part A, 68, 239-251. 
HALL, J. M., LEE, M. K., NEWMAN, B., MORROW, J. E., ANDERSON, L. A., HUEY, B. & 
KING, M. C. 1990. Linkage of early-onset familial breast cancer to chromosome 
17q21. Science, 250, 1684-9. 
HANAHAN, D. & WEINBERG, R. A. 2000. The hallmarks of cancer. Cell, 100, 57-70. 
HANAHAN, D. & WEINBERG, R. A. 2011. Hallmarks of cancer: the next generation. Cell, 
144, 646-74. 
HARVEY, P. W. & DARBRE, P. 2004. Endocrine disrupters and human health: could 
oestrogenic chemicals in body care cosmetics adversely affect breast cancer 
incidence in women? Journal of Applied Toxicology : JAT, 24, 167-76. 
HAYDEN, J. & BARLOW, S. 1972. Structure–activity relationships of organosiloxanes and 
the female reproductive system. Toxicology and Applied Pharmacology, 21, 68–79. 
HAYFLICK, L. 1984. Immortality. Science, 225, 268. 
HAYFLICK, L. 2000. The illusion of cell immortality. Br J Cancer, 83, 841-6. 
HELLEDAY, T., ET AL., 2007 DNA double-strand break repair: from mechanistic 
understanding to cancer treatment. DNA repair, (6): p. 923-35. 
HENRY, N.D. & FAIR, P.A. 2013.Comparison of in vitro cytotoxicity, estrogenicity and anti-
estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J 
Appl Toxicol, 33(4):265-72. 
HINES, E. P., MENDOLA, P., VON EHRENSTEIN, O. S., YE, X., CALAFAT, A. M. & 
FENTON, S. E. 2015. Concentrations of environmental phenols and parabens in milk, 
urine  and serum of lactating North Carolina women. Reprod Toxicol, 54, 120-8. 
 163 
 
HOEIJMAKERS, J. H. 2001. DNA repair mechanisms. Maturitas, 38, 17-22; discussion 22-
3. 
HORII, Y. & KANNAN, K. 2008. Survey of organosilicone compounds, including cyclic and 
linear siloxanes, in  personal-care and household products. Arch Environ Contam 
Toxicol, 55, 701-710. 
HOUTGRAAF, J. H., VERSMISSEN, J. & VAN DER GIESSEN, W. J. 2006. A concise 
review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc 
Revasc Med, 7, 165-72. 
HUGGETT, J., DHEDA, K., BUSTIN, S. & ZUMLA, A. 2005. Real-time RT-PCR 
normalisation; strategies and considerations. Genes and Immunity, 6, 279-284. 
HUNTER, S. E., JUNG, D., DI GIULIO, R. T. & MEYER, J. N. 2010. The QPCR assay for 
analysis of mitochondrial DNA damage, repair, and relative copy number. Methods, 
51, 444-451. 
JACKSON, S. P. & BARTEK, J. 2009. The DNA-damage response in human biology and 
disease. Nature, 461, 1071-8. 
JAMES, M., LI, W., SUMMERLOT, D., FAUX, L. & WOOD, C. 2010. Triclosan is a potent 
inhibitor of estradiol and estrone sulfonation in sheep placenta. Environment 
International, 36 942–949. 
JIRICNY, J. 2006. The multifaceted mismatch-repair system. Nature reviews. Molecular 
Cell Biology, 7, 335-46. 
JONES, L. P., SAMPSON, A., KANG, H. J., KIM, H. J., YI, Y. W., KWON, S. Y., BABUS, J. 
K., WANG, A. & BAE, I. 2010. Loss of BRCA1 leads to an increased sensitivity to 
Bisphenol A. Toxicol Lett, 199, 261-8. 
KANG, J., KONDO, F. & KATAYAMA, Y. 2006. Human exposure to bisphenol A. 
Toxicology, 226 79–89. 
KEEDY, K. S., ARCHIN, N. M., GATES, A. T., ESPESETH, A., HAZUDA, D. J. & 
MARGOLIS, D. M. 2009. A limited group of class I histone deacetylases acts to 
repress human immunodeficiency virus type 1 expression. J Virol, 83, 4749-56. 
KEY, T. J., VERKASALO, P. K. & BANKS, E. 2001. Epidemiology of breast cancer. Lancet 
Oncol, 2, 133-40. 
KHANNA, S. & DARBRE, P. D. 2013. Parabens enable suspension growth of MCF-10A 
immortalized, non-transformed human breast epithelial cells. J Appl Toxicol, 33, 
378-82. 
 164 
 
KIM, Y., MURUGESAN, K., SCHMIDT, S., BOKARE, V., JEON, J., KIM, E. & CHANG, Y. 
2011. Triclosan susceptibility and co-metabolism – A comparison for three aerobic 
pollutant-degrading bacteria. Bioresource Technology 102, 2206–2212. 
KITAGISHI, Y., KOBAYASHI, M. & MATSUDA, S. 2013. Defective DNA repair systems and 
the development of breast and prostate cancer (review). International Journal of 
Oncology, 42, 29-34. 
KROEMER, G., GALLUZZI, L. & BRENNER, C. 2007. Mitochondrial Membrane 
Permeabilization in Cell Death. Available at:  
http://physrev.physiology.org/content/87/1/99  (Accessed: 02 August 2016).                                 
KUKLENYIK, Z., BRYANT, X. A., NEEDHAM, L. L. & CALAFAT, A. M. 2007. SPE/SPME-
GC/MS approach for measuring musk compounds in serum and breast milk. J 
Chromatogr B Analyt Technol Biomed Life Sci, 858, 177-83. 
KURUTO-NIWA, R., TATEOKA, V. & USUKI, V. E. A. 2007. Measurement of bisphenol A 
concentrations in human colostrum. Chemosphere, 66, 1160-4. 
LALLE, P., DE LATOUR, M., RIO, P. & BIGNON, Y. J. 1994. Detection of allelic losses on 
17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in 
a familial context. Oncogene, 9, 437-42. 
 
LANKOFF, A., BANASIK, A., DUMA, A., OCHNIAK, E., LISOWSKA, H., KUSZEWSKI, T., 
GOZDZ, S. & WOJCIK, A. 2006. A comet assay study reveals that aluminium 
induces DNA damage and inhibits the repair of radiation-induced lesions in human 
peripheral blood lymphocytes. Toxicol Lett, 161, 27-36. 
LIEBERMAN, M., LYKISSA, E. & BARRIOS, R. E. A. 1999. Cyclosiloxanes produce fatal 
liver and lung damage in mice. Environmental Health Perspectives, 107, 161–165. 
LI, G., ZU, L., WONG, P. K., HUI, X., LU, Y., XIONG, J. & AN, T. 2012. Biodegradation and 
detoxification of bisphenol A with one newly-isolated strain Bacillus sp. GZB: 
kinetics, mechanism and estrogenic transition. Bioresour Technol, 114, 224-30. 
LINDAHL, T. 1993. Instability and decay of the primary structure of DNA. Nature, 362, 709-
15. 
LIMA, P. D., LEITE, D. S., VASCONCELLOS, M. C., CAVALCANTI, B. C., SANTOS, R. A., 
COSTA-LOTUFO, L. V., PESSOA, C., MORAES, M. O. & BURBANO, R. R. 2007. 
Genotoxic effects of aluminum chloride in cultured human lymphocytes treated in 
different phases of cell cycle. Food Chem Toxicol, 45, 1154-9. 
 165 
 
LIPWORTH, L. 1995. Epidemiology of breast cancer. European Journal of Cancer 
Prevention 4, 7–30. 
LIU B, W. Y., FILLGROVE KL & ANDERSON VE 2002. Triclosan inhibits enoyl-reductase 
of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast 
cancer cells. Cancer Chemotherapy and Pharmacology, 49 187–193. 
LIU, Q., GUNTUKU, S., CUI, X. S., MATSUOKA, S., CORTEZ, D., TAMAI, K., LUO, G., 
CARATTINI-RIVERA, S., DEMAYO, F., BRADLEY, A., DONEHOWER, L. A. & 
ELLEDGE, S. J. 2000. Chk1 is an essential kinase that is regulated by Atr and 
required for the G(2)/M DNA damage checkpoint. Genes & Development, 14, 1448-
59. 
LORD, C. J. & ASHWORTH, A. 2012. The DNA damage response and cancer therapy. 
Nature, 481, 287-94. 
LORENZO, Y., COSTA, S., COLLINS, A. R. & AZQUETA, A. 2013. The comet assay, DNA 
damage, DNA repair and cytotoxicity: hedgehogs are not always dead. 
Mutagenesis, 28, 427-32. 
LOVELL, D. P. & OMORI, T. 2008. Statistical issues in the use of the comet assay. 
Mutagenesis, 23, 171-82. 
LUU, H. & HUTTER, J. 2001. Bioavailability of octamethylcyclotetracyclosiloxane (D4) after 
exposure to silicones by inhalation and implantation. . Environmental Health 
Perspectives, 109, 1095–1101. 
LYONS, T. R., SCHEDIN, P. J. & BORGES, V. F. 2009. Pregnancy and breast cancer: 
when they collide. Journal of Mammary Gland Biology and Neoplasia, 14, 87-98. 
MANNELLO, F., TONTI, G. A., MEDDA, V., SIMONE, P. & DARBRE, P. D. 2011. Analysis 
of aluminium content and iron homeostasis in nipple aspirate fluids from healthy 
women and breast cancer-affected patients. Journal of Applied Toxicology : JAT, 
31, 262-9. 
MANSERVISI, F., GOPALAKRISHNAN, K., TIBALDI, E., HYSI, A., IEZZI, M., 
LAMBERTINI, L., TEITELBAUM, S., CHEN, J. & BELPOGGI, F. 2015. Effect of 
maternal exposure to endocrine disrupting chemicals on reproduction and mammary 
gland development in female Sprague-Dawley rats. Reproductive Toxicology, 54, 
110-9. 
MARMOT, M., ALTMAN, D., CAMERON, D., DEWAR, J., THOMPSON, S. & WILCOX, M. 
2012. The benefits and harms of breast cancer screening: an independent review. 
Lancet, 380, 1778-86. 
 166 
 
MCBRIDE, O. W., MERRY, D. & GIVOL, D. 1986. The gene for human p53 cellular tumor 
antigen is located on chromosome 17 short arm (17p13). Proceedings of the 
National Academy of Sciences of the United States of America, 83, 130-4. 
MCGRATH, K. G. 2003. An earlier age of breast cancer diagnosis related to more frequent 
use of antiperspirants/deodorants and underarm shaving. Eur J Cancer Prev, 12, 
479-85. 
MCKIM, J., WILGA, P. & BRESLIN, W. E. A. 2001. Potential estrogenic and antiestrogenic   
activity of the cyclic siloxane ocatamethylcyclotetrasiloxane (D4) and the linear 
siloxane hexamethyldisiloxane (HMDS) in immature rats using the uterotrophic assay. 
Toxicological Sciences, 63, 37–46. 
MERCK, I. 2006. An Encyclopedia of Chemicals, Drugs and Biologicals, Merck Research 
Laboratories, NJ, USA. 
MICHALOWICZ, J. 2014. Bisphenol A--sources, toxicity and biotransformation. Environ 
Toxicol Pharmacol, 37, 738-58. 
MIKI, Y., SWENSEN, J., SHATTUCK-EIDENS, D., FUTREAL, P. A., HARSHMAN, K., 
TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNETT, L. M., DING, W. & ET AL. 
1994. A strong candidate for the breast and ovarian cancer susceptibility gene 
BRCA1. Science, 266, 66-71. 
MILEVA G., BIELAJEW C., KONKLE A.T. 2013 Estrous cycle: Physiology, endocrinology 
and role in breeding and reproductive management. In: Durand L., editor. Sex 
Differences in Physiology and Behaviour: The Importance of Hormones and Rearing 
Environment. Nova Science Publisher; Hauppauge, NY, USA:  
Mirick.,D.K., Davis.,S&Thomas.D.B.2002. Antiperspirant Use and the Risk of Breast 
Cancer. J Natl Cancer Inst, 94 (20): 1578-1580. 
MODRICH, P. 2006. Mechanisms in eukaryotic mismatch repair. The Journal of Biological 
Bhemistry, 281, 30305-9. 
MOSS, S. M., NYSTROM, L., JONSSON, H., PACI, E., LYNGE, E., NJOR, S. & 
BROEDERS, M. 2012. The impact of mammographic screening on breast cancer 
mortality in Europe: a review of trend studies. Journal of Medical Screening, 19, 26-
32. 
MOSS, T., HOWES, D. & WILLIAMS, F. M. 2000. Percutaneous penetration and dermal 
metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). Food Chem 
Toxicol, 38, 361-70. 
 167 
 
MURRAY, C. J. L. & LOPEZ, A. D. 1997. Mortality by cause for eight regions of the world: 
Global Burden of Disease Study. Lancet, 349, 1269-1276. 
OETTEL, M. & SCHILLINGER, E. 1999. Estrogens and Antiestrogens, Berlin, Germany, 
Springer Verlag. 
OHMANN, C. & KUCHINKE, W. 2009. Future developments of medical informatics from the 
viewpoint of networked clinical research. Interoperability and integration. Methods 
Inf Med, 48, 45-54. 
OSSOVSKAYA, V., KOO, I. C., KALDJIAN, E. P., ALVARES, C. & SHERMAN, B. M. 2010. 
Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative 
Breast Cancer and Other Primary Human Tumor Types. Genes & Cancer, 1, 812-
21. 
PAI, V. P., HERNANDEZ, L. L., STULL, M. A. & HORSEMAN, N. D. 2015. The type 7 
serotonin receptor, 5-HT 7 , is essential in the mammary gland for regulation of 
mammary epithelial structure and function. BioMed research international, 2015, 
364746. 
PANDEY, A. K., BAJPAYEE, M., PARMAR, D., RASTOGI, S. K., MATHUR, N., SETH, P. 
K. & DHAWAN, A. 2006. DNA damage in lymphocytes of Indian rickshaw pullers as 
measured by the alkaline Comet assay. Environ Mol Mutagen, 47, 25-30. 
PANTELOURIS, E. M. 1971. Observations on the immunobiology of 'nude' mice. 
Immunology, 20, 247-52. 
PAULL, T. T., CORTEZ, D., BOWERS, B., ELLEDGE, S. J. & GELLERT, M. 2001. Direct 
DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the 
United States of America, 98, 6086-6091. 
PENNINGTON, K. P. & SWISHER, E. M. 2012. Hereditary ovarian cancer: beyond the 
usual suspects. Gynecologic Oncology, 124, 347-53. 
PERETZ, J., VROOMAN, L., RICKE, W. A., HUNT, P. A., EHRLICH, S., HAUSER, R., 
PADMANABHAN, V., TAYLOR, H. S., SWAN, S. H., VANDEVOORT, C. A. & 
FLAWS, J. A. 2014. Bisphenol a and reproductive health: update of experimental 
and human evidence, 2007-2013. Environ Health Perspect, 122, 775-86. 
PINEAU, A., GUILLARD, O., FAVREAU, F., MARRAULD, A. & FAUCONNEAU, B. 2012. In 
vitro study of percutaneous absorption of aluminum from antiperspirants through 
human skin in the Franz diffusion cell. J Inorg Biochem, 110, 21-6. 
PRADELLA, L. M., EVANGELISTI, C., LIGORIO, C., CECCARELLI, C., NERI, I., ZUNTINI, 
R., AMATO, L. B., FERRARI, S., MARTELLI, A. M., GASPARRE, G. & 
 168 
 
TURCHETTI, D. 2014. A novel deleterious PTEN mutation in a patient with early-
onset bilateral breast cancer. BMC Cancer, 14, 70. 
PUGAZHENDHI, D. & DARBRE, P. D. 2010. Differential effects of overexpression of ERα 
and ERβ in MCF10A immortalised, non-transformed human breast epithelial cells. 
Hormone Molecular Biology and Clinical Investigation, 1, 117–126. 
RAHMAN, N., SEAL, S., THOMPSON, D., KELLY, P., RENWICK, A., ELLIOTT, A., REID, 
S., SPANOVA, K., BARFOOT, R., CHAGTAI, T., JAYATILAKE, H., MCGUFFOG, 
L., HANKS, S., EVANS, D. G., ECCLES, D., EASTON, D. F. & STRATTON, M. R. 
2007. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer 
susceptibility gene. Nature Genetics, 39, 165-7. 
RAYEZA, M., FRITSCHA, A., RAYEZA, J., FOURNIERB, H., BROCHONB, C. & SOUMB, 
A. 1999. Structures and Si–N bond strengths of some cyclodi- and cyclotrisilazanes. 
Journal of Molecular Structure: THEOCHEM, 487, 241–250  
REINER, J. L., WONG, C. M., ARCARO, K. F. & KANNAN, K. 2007. Synthetic musk 
fragrances in human milk from the United States. Environ Sci Technol, 41, 3815-20. 
ROCHESTER, J. R. 2013. Bisphenol A and human health: A review of the literature. 
Reproductive toxicology, 42, 132-55. 
ROSEN, E. M., FAN, S., PESTELL, R. G. & GOLDBERG, I. D. 2003. BRCA1 gene in 
breast cancer. J Cell Physiol, 196, 19-41. 
ROY, R., CHUN, J. & POWELL, S. N. 2012. BRCA1 and BRCA2: different roles in a 
common pathway of genome protection. Nat Rev Cancer, 12, 68-78. 
RUSSO, J., FERNANDEZ, S. V., RUSSO, P. A., FERNBAUGH, R., SHERIFF, F. S., 
LAREEF, H. M., GARBER, J. & RUSSO, I. H. 2006. 17-Beta-estradiol induces 
transformation and tumorigenesis in human breast epithelial cells. FASEB journal : 
official publication of the Federation of American Societies for Experimental Biology, 
20, 1622-34. 
RUSSO, J. & RUSSO, I. H. 2006. The role of estrogen in the initiation of breast cancer. The 
Journal of Steroid Biochemistry and Molecular Biology, 102, 89-96. 
SANCAR, A., LINDSEY-BOLTZ, L. A., UNSAL-KACMAZ, K. & LINN, S. 2004. Molecular 
mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu 
Rev Biochem, 73, 39-85. 
SAPPINO, A. P., BUSER, R., LESNE, L., GIMELLI, S., BENA, F., BELIN, D. & 
MANDRIOTA, S. J. 2012. Aluminium chloride promotes anchorage-independent 
 169 
 
growth in human mammary epithelial cells. Journal of applied toxicology : JAT, 32, 
233-43. 
SAVITSKY, K., SFEZ, S., TAGLE, D. A., ZIV, Y., SARTIEL, A., COLLINS, F. S., SHILOH, 
Y. & ROTMAN, G. 1995. The complete sequence of the coding region of the ATM 
gene reveals similarity to cell cycle regulators in different species. Human Molecular 
Genetics, 4, 2025-32. 
SCHEDIN, P. 2006. Pregnancy-associated breast cancer and metastasis. Nature Reviews. 
Cancer, 6, 281-91. 
SCSS/1450/2016 [Available at] 
ec.europa.eu/health/scientific_committees/consumer.../sccs_o_029.pdf (Accessed: 
05 September 2016).      
SCULLY, R. 2000. Role of BRCA gene dysfunction in breast and ovarian cancer 
predisposition. Breast Cancer Res, 2, 324-30. 
SHEIKH, A., HUSSAIN, S. A., GHORI, Q., NAEEM, N., FAZIL, A., GIRI, S., SATHIAN, B., 
MAINALI, P. & AL TAMIMI, D. M. 2015. The spectrum of genetic mutations in breast 
cancer. Asian Pacific Journal of Cancer Prevention : APJCP, 16, 2177-85. 
SHIN, S.I., FREEDMAN, V.H., RISSER, R. & POLLACK, R. Proc. Nat. Acad. Sci. USA 72 
(1975) 4435–4439. 
SIMONI, R. D. 2002. The Discovery of Estrone, Estriol, and Estradiol and the Biochemical 
Study of Reproduction. The Work of Edward Adelbert Doisy J. Biol. Chem, 217. 
SINGH, N. P., MCCOY, M. T., TICE, R. R. & SCHNEIDER, E. L. 1988. A simple technique 
for quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 175, 
184-91. 
SOTO, A., VANDENBERG, L., MAFFINI, M. & SONNENSCHEIN, C. 2008. Does Breast 
Cancer Start in the Womb? Basic Clin Pharmacol Toxicol. , 102, 125. 
SOULE, H. D., MALONEY, T. M., WOLMAN, S. R., PETERSON, W. D., JR., BRENZ, R., 
MCGRATH, C. M., RUSSO, J., PAULEY, R. J., JONES, R. F. & BROOKS, S. C. 
1990b. Isolation and characterization of a spontaneously immortalized human 
breast epithelial cell line, MCF10. Cancer Research, 50, 6075-86. 
SPERKA, T., WANG, J. & RUDOLPH, K. L. 2012. DNA damage checkpoints in stem cells, 
ageing and cancer. Nat Rev Mol Cell Biol, 13, 579-90. 
STEVENS, P. E., LEVIN, A. & KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES 
CHRONIC KIDNEY DISEASE GUIDELINE DEVELOPMENT WORK GROUP, M. 
2013. Evaluation and management of chronic kidney disease: synopsis of the 
 170 
 
kidney disease: improving global outcomes 2012 clinical practice guideline. Ann 
Intern Med, 158, 825-30. 
TABOADA-PUIG, R., LU-CHAU, T. A., EIBES, G., FEIJOO, G., MOREIRA, M. T. & LEMA, 
J. M. 2015. Continuous removal of endocrine disruptors by versatile peroxidase 
using a two-stage system. Biotechnology Progress, 31, 908-16. 
TAYAMA, S., NAKAGAWA, Y., TAYAMA K. 2008. Genotoxic effects of environmental 
estrogen-like compounds in CHO-K1 cells. Mutat Res 649:114-125 
TAYLOR, A. M. & BYRD, P. J. 2005. Molecular pathology of ataxia telangiectasia. Journal 
of Clinical Pathology, 58, 1009-15. 
THARP, A. P., MAFFINI, M. V., HUNT, P. A., VANDEVOORT, C. A., SONNENSCHEIN, C. 
& SOTO, A. M. 2012. Bisphenol A alters the development of the rhesus monkey 
mammary gland. Proc Natl Acad Sci U S A, 109, 8190-5. 
TOKUOKA, S., ASANO, M., YAMAMOTO, T., TOKUNAGA, M., SAKAMOTO, G., 
HARTMANN, W. H., HUTTER, R. V., LAND, C. E. & HENSON, D. E. 1984. 
Histologic review of breast cancer cases in survivors of atomic bombs in Hiroshima 
and Nagasaki, Japan. Cancer, 54, 849-54. 
TUDEK, B., CIESLA, Z., JANION, C., BOITEUX, S., BEBENEK, K., SHINAGAWA, H., 
BARTSCH, H., LAVAL, J., VAN ZEELAND, A. A., MULLENDERS, L. F., SZYFTER, 
K., COLLINS, A. & KRUSZEWSKI, M. 2003. 32nd annual meeting of European 
Environmental Mutagen Society. DNA damage and repair fundamental aspects and 
contribution to human disorders. DNA repair, 2, 765-81. 
UENO, D., MORIBE, M. & INOUE, K. E. A. 2009. Synthetic Musk Fragrances in Human 
Breast Milk and Adipose Tissue from Japan. Interdisciplinary Studies on 
Environmental Chemistry — Environmental Research in Asia, 1, 247–252. 
UPTON, G. & COOK, I. 2008. A Dictionary of Statistics, Oxford University  
VALVERDE, M. & ROJAS, E. 2009. Environmental and occupational biomonitoring using 
the Comet assay. Mutat Res, 681, 93-109. 
VAN NOORDEN, R. 2014. Online collaboration: Scientists and the social network. Nature, 
512, 126-9. 
VANDENBERG, L. N., COLBORN, T., HAYES, T. B., HEINDEL, J. J., JACOBS, D. R., JR., 
LEE, D. H., SHIODA, T., SOTO, A. M., VOM SAAL, F. S., WELSHONS, W. V., 
ZOELLER, R. T. & MYERS, J. P. 2012. Hormones and endocrine-disrupting 
chemicals: low-dose effects and nonmonotonic dose responses. Endocrine reviews, 
33, 378-455. 
 171 
 
VAN DYK, E. & PRETORIUS, P. J. 2005. DNA damage and repair in mammalian cells 
exposed to p-hydroxyphenylpyruvic acid. Biochem Biophys Res Commun, 338, 815-
9. 
VANDENBERG, L., HAUSER, R., MARCUS, M., OLEA, N. & WELSHONS, W. 2007. 
Human exposure to bisphenol A (BPA) Reproductive Toxicology, 24, 139–77. 
VOM SAAL FS, et al  2007. Chapel Hill bisphenol A expert panel consensus statement: I ls 
of exposure.Reprod Toxicol; 2): 131–138. 
VOGELSTEIN, B. & KINZLER, K. W. 2001. Achilles' heel of cancer? Nature, 412, 865-6. 
WATSON, L. C., GIES, D., THOMPSON, E. & THOMAS, B. 2012. Randomized control trial: 
evaluating aluminum-based antiperspirant use, axilla skin toxicity, and reported 
quality of life in women receiving external beam radiotherapy for treatment of Stage 
0, I, 
WELSHONS, W., NAGEL, S. & VOM SAAL, F. 2006. Large effects from small exposures. 
III. Endocrine mechanisms mediating effects of bisphenol A at levels of human 
exposure. Endocrinology, 147, S56–S69. 
World Health Organization and United Nations Environment Programme (WHO-UNEP), 
2013a 
World Health Organization, United Nations Environment Programme (WHO-UNEP) A. 
Bergman, J.J. Heindel, S. Jobling, K.A. Kidd, R.T. Zoeller (Eds.), State of the 
Science of Endocrine Disrupting Chemicals - 2012 (2013), p. 289 [Available at] 
http://www.who.int/ceh/publications/endocrine/en/index.html (Accessed: 10 
September 2016). 
WONG, M. L. & MEDRANO, J. F. 2005. Real-time PCR for mRNA quantitation. 
Biotechniques, 39, 75-85. 
WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGION, J., 
COLLINS, N., GREGORY, S., GUMBS, C. & MICKLEM, G. 1995. Identification of 
the breast cancer susceptibility gene BRCA2. Nature, 378, 789-92. 
WOOSTER, R., NEUHAUSEN, S. L., MANGION, J., QUIRK, Y., FORD, D., COLLINS, N., 
NGUYEN, K., SEAL, S., TRAN, T., AVERILL, D. & ET AL. 1994. Localization of a 
breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, 265, 
2088-90. 
XIA, B., SHENG, Q., NAKANISHI, K., OHASHI, A., WU, J., CHRIST, N., LIU, X., JASIN, M., 
COUCH, F. J. & LIVINGSTON, D. M. 2006. Control of BRCA2 cellular and clinical 
functions by a nuclear partner, PALB2. Molecular cell, 22, 719-29. 
 172 
 
YANG, M., RYU, J. H., JEON, R., KANG, D. & YOO, K. Y. 2009. Effects of bisphenol A on 
breast cancer and its risk factors. Arch Toxicol, 83, 281-5. 
ZATTA, P., DRAGO, D., BOLOGNIN, S. & SENSI, S. L. 2009. Alzheimer's disease, metal 
ions and metal homeostatic therapy. Trends in Pharmacological Sciences, 30, 346-
55. 
ZHAO, C., HELLMAN, L., ZHAN, X., BOWMAN, W., WHITEHEART, S. & FRIED, M. 2010. 
Hexahistidine-tag-specific optical probes for analyses of proteins and their 
interactions. Anal Biochem, 15, 237-45. 
ZHENG, Y., TAN, Y. X., DAI, L. N., LV, Z., ZHANG, X. Z., XIE, Z. M. & ZHANG, Z. J. 2012. 
Synthesis, characterization, and thermal properties of new polysiloxanes containing 
1,3-bis(silyl)-2,4-dimethyl-2,4-diphenylcyclodisilazane. Polymer Degradation and 
Stability, 97, 2449-2459. 
 
  
